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SUMMARY
The aroC gene encoding chorismate synthase and the ndk gene encoding nucleoside 
diphosphate kinase were cloned from Staphylococcus aureus by complementation of the 
Aro" phenotype of the aroC E. coli strain, GLW40. Two partial open reading frames 
(ORFs) encoding 3-dehydroquinate synthase and a protein which had similarity with the 
putative gerCC gene product from B. subtilis were also cloned. In S. aureus the aroC gene 
is likely to form the first gene in an operon which includes the aroB and aro A genes. It has 
been demonstrated in this study that the ndk genes and the gerCAgerCBgerCC genes in S. 
aureus are situated upstream from the aroCaroB genes; this gene organisation has also been 
observed in B. subtilis.
The S. aureus aroC gene was expressed from the T7 promoter on plasmid pTB361. This 
expression system resulted in the accumulation of very high levels of soluble S. aureus 
chorismate synthase and facilitated the purification of the enzyme to near homogeneity, 
producing lOOmg of enzyme from 13g of cells. No detectable immunological cross­
reactivity was observed between S. aureus chorismate synthase and antibodies raised against 
E. coli chorismate synthase. This contrasts with other chorismate synthases and indicates 
that there are structural differences between the chorismate synthases from S. aureus and E. 
coli. S. aureus chorismate synthase was determined to be a homotetramer using gel 
filtration and chemical crosslinking.
The pH optimum determined for S, aureus chorismate synthase was found to be non- 
symmetrical in MOPS buffer with an optimum of activity around pH 7.0. The apparent 
for EPSP of the S. aureus enzyme was calculated to be 12.7pM and the apparent for 
FMN was calculated to be 4.8pM. The apparent value for FMN for the S. aureus 
enzyme is two orders of magnitude greater compared to other chorismate synthases, 
excluding the B. subtilis enzyme.
S. aureus chorismate synthase was investigated using pre-steady state kinetics and a flavin 
intermediate was observed during turnover with a difference spectrum resembling that 
obtained with the E. coli enzyme. The spectral characteristics of the S. aureus flavin 
intermediate were different, however, with respect to its maxima, minima and its overall 
shape. The rate of decay (6.5s"l) of the intermediate was eight times slower than that 
observed for the E. coli enzyme (52s"l) and this compares well with a 7 fold lower Vmax-
Tyrosine 121 of & aureus chorismate synthase was changed to phenylalanine or alanine 
using site-directed mutagenesis. The conversion to alanine resulted in a loss of activity 
while the phenylalanine mutant retained 1 0% of wild-type activity.
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CHAPTER 1. INTRODUCTION.
1.1. The shikimate pathway.
The genesis of the three aromatic amino acids, phenylalanine, tryptophan and 
tyrosine, and most of the aromatic compounds found in microorganisms and plants 
begins with the two carbohydrate precursors, phosphoenolpyruvate and D-erythrose 4- 
phosphate. These precursors are converted by a seven step enzymic process, the 
shikimate pathway, via shikimic acid to chorismate (Figure 1.1) (Pittard, 1987; 
Bentley, 1990; Haslam, 1993).
Shikimic acid was the first intermediate of the pathway to be identified after it was 
isolated from the fruits of the Illicium tree in 1885 by J. F. Eykmann. It was 
confirmed as a key intermediate of the shikimic acid pathway in the 1950s with the 
study of auxotrophic mutants of Escherichia coli when it was shown to replace the 
requirement of these mutants for the three aromatic amino acids (Davis, 1955). 
Similarly, the accumulation by auxotrophs of intermediates preceding blocked steps 
in the pathway led to the identification of 3-dehydroquinate, 3-dehydroshikimate and 
shikimate 3-phosphate.
Earlier reactions of the pathway were elucidated with more difficulty. A mutant strain 
of E. coli that accumulated shikimic acid was grown on D-glucose variously labelled 
with 14c to determine the distribution of specific carbon atoms from glucose in the 
shikimate molecule (Sprinson, 1961). It was demonstrated that of the seven precursor 
carbon atoms entering the pathway, three originated from glycolysis and four from the 
pentose phosphate pathway. Cell extracts and partially purified enzyme preparations 
were shown to convert phosphoenolpyruvate (PEP) and erythrose 4-phosphate (E4P) 
to 3-deoxy-D-ara6mo-heptulosonate 7-phosphate (DAHP) and 3-dehydroqumate 
(DHQ). The position of 5-eno/pyruvylshikimate 3-phosphate (EPSP) in the pathway 
was determined from the conversion of shikimate 3-phosphate and PEP by cell 
extracts.
Chorismate, the final compound of the classic shikimate pathway was identified only 
after the production o f multiply mutant strains blocked in each of the three aromatic 
amino acid pathways. While shikimate took its name from the Japanese for the 
oriental tree from which it was first isolated, chorismate was named after the Greek
io
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Introduction
for separation on the assumption that it was the main branchpoint compound of the 
pathway (Haslam, 1993).
1.2. The enzymes and enzymology of the pre-chorismate pathway.
The first enzyme of the shikimate pathway, DAHP synthase, catalyses the 
condensation of the carbohydrate precursors phosphoenolpyruvate (PEP) and 
erythrose 4-phosphate (E4P) to produce DAHP (Figure 1.1). 3-dehydroquinate 
(DHQ) synthase catalyses the cyclisation of DAHP to give 3-dehydroquinate. The 
elimination o f water by 3-dehydroquinate dehydratase produces 3-dehydroshikimate 
and introduces the first double bond. Subsequent reduction of the keto group by 
shikimate dehydrogenase produces shikimate which is phosphorylated by shikimate 
kinase to give shikimate 3-phosphate. Condensation of PEP and shikimate 3- 
phosphate catalysed by EPSP synthase yields EPSP, the substrate for the final enzyme 
of the pathway, chorismate synthase, which introduces the second double bond and 
produces chorismate.
The seven enzyme pathway described above and shown in Figure 1.1 is now often 
referred to as the pre-chorismate pathway. The enzyme reactions of the pathway have 
been shown to be common to every organism in which the pathway has been studied 
and, furthermore, while present in bacteria, fungi and plants the pathway is absent in 
animals. Consequently, humans and animals must obtain the three aromatic ammo 
acids and certain cofactors produced by post-chorismate pathways from their diet.
Wliile the intermediates and enzymatic reactions of the pre-chorismate pathway are 
believed to be identical in all organisms, the genes and opérons o f the pathway are 
organised differently in different species possibly reflecting contrasting evolutionary 
histories and the functional and regulatory constraints experienced by each species 
(Henner & Yanofsky, 1993). In the following sections differences in the structural, 
functional, and regulatory features of the pre-chorismate pathway are compared with 
particular reference to E. coli and Bacillus subtilis.
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1.2.1. DAHP synthase.
The condensation of PEP and E4P to produce DAHP is the first committed step in the 
biosyntliesis of aromatic compounds and is catalysed by DAHP synthase. 
Consequently, the flow of metabolites into the pre-chorismate pathway is controlled by 
feedback regulation of this enzyme by either intermediates or end-products of the 
pathway. E. coli utilises a different strategy for control from that of B. subtilis.
In E. coli, there are three DAHP synthase isoenzymes, phenylalanine sensitive DAHP 
(phe), tryptophan sensitive DAHP (tip) and tyrosine sensitive DAHP (tyr). The three 
DAHP synthase enzymes display an inhibition pattern in which their activity and rate of 
synthesis are differentially affected by one of the three aromatic amino acids (Pittard, 
1987). Thus each aromatic amino acid influences the flux of the patliway.
Enzyme Gene Map pos. 
(min)
Amino
acids
Mr
(calc.)
Quaternary
stmctmc
DAHP synthase 
DAHP synthase (tyr) aroF 57 356 38804 Dimer
DAHP synthase (phe) aroG 17 350 37997 Tetramer
DAHP synthase (tip) aroH 37 347 39000 Dimer
3-Dehydi'oquinate synthase aroB 75 362 38880 Monomer
3-Dehydroquinate dehydratase aroD 37 240 26377 Dimer
Shikimate dehydrogenase aroE 72 272 29380 Monomer
Shikimate kinase^ aroL 9 173 18937 Monomer
EPSP synthase aroA 20 427 46112 Monomer
Chorismate synthase oroC 51 357 38183 Tetramer
Table 1.1. The pre-chorismate pathway enzymes of Escherichia coli.
 ^ a second shikimate kinase exists encoded by aroK hni is excluded here for reasons discussed in 1.2.5. 
2 Taken from Haslam, 1993.
____________
Chorismate
Chorismate mutase
Prephenate
Prephenate
dehydratase
NAD
Prephenate
dehydrogenase
Phenylpyruvate 
glutamate —v.
CO2, H2O
tyrosinelphenylalanine aminotran^erase 
or
hlstidinol-phosphate anünotran^erase
CO 2
4-Hydroxyphenylpyruvate 
glutamate
aKG
Phenylalanine
rs. aKG 
Tyrosine
Anthranilate
synthase
Anthranilate
phosphoribosyl
transferase
Chorismate + L-glutamine
glutamate, pyruvate
Antlnanilate 
PRPPr
S-k.Pt
Phosphoribosyl anthranilate
Phosphoribosyl
anthranilate
isomerase
1 -(o-carboxyphenylamino)-1 - 
deoxyribulose-5-phosphate
Indoleglycerol
phosphate
synthase
Tryptophan
synthase
S-*-C02
Indoleglycerol phosphate
L-serine
1 glycéraldéhyde -3-phosphate 
L-Tryptophan
Figure 1.2. Pathways to tyrosine and phenylalanine (top) and tryptophan 
(bottom) from chorism ate. Abbreviations: aK G , a-ketoglutarate; PRPP, phosphoribosyl 
pyrophosphate.
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In B. subtilis only one species of DAHP synthase exists which is not inhibited by the 
aromatic amino acids but rather prephenate, an intermediate of phenylalanine and 
tyrosine synthesis (Figure 1.2) (Jensen & Nester, 1966; Jensen et a l ,  1967; Llewellyn 
et a l,  1980). An excess of phenylalanine and tyrosine results in the feedback inhibition 
of prephenate dehydratase blocking the further conversion of prephenate. The resulting 
build-up of prephenate inhibits DAHP synthase and reduces the flow of metabolites into 
the pathway. This sequential feedback sti'ategy could potentially starve the cell for 
tiyptophan, whose synthesis branches from chorismate. However, chorismate mutase, 
which catalyses the conversion of chorismate to prephenate, is product inhibited by 
prephenate and this is suggested to be sufficient to channel chorismate into the 
tryptophan pathway (Henner & Yanofsky, 1993).
Enzyme Gene Map pos.^ 
(°)
Amino
acids
Mr
(calc.)
Quaternary
structure
DAHP synthase aroA 264 358 39,639 Monomer^
3-Dehydroquinate synthase aroB 203 362 40,817 Complex^
3 -Dehydi oquinate dehydratase"^ aroC 208 255 28,131 nd
Shikimate dehydrogenase aroD 226 nd nd nd
Shikimate kinase a 'd 28 186 21,863 Monomer^
EPSP synthase^ aroE 202 428 45,240 Monomer
Chorismate synthase aroF 203 368 39971 Complex^
nd, not determined
Table 1.2. The pre-chorismate pathway enzymes of Bacillus subtilis.
Ï Anagnostoupoulos et al„ 1993
2 See section 1.2.5.
3 Dehydroquinate synthase, chorismate synthase and a flavin reductase form a trifunctional complex. 
^ Sorokin et a l ,  1993.
 ^ Henner et a l ,  1986.
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Some strains of B. subtilis have DAHP synthases with different properties. The 
original Marburg strain of B. subtilis has a monofunctional DAHP synthase. Strain 
168, which was derived from the Marburg strain by X-ray irradiation, has a 
bifunctronal DAHP synthase which also exhibits chorismate mutase activity (Huang et 
al., 1974a). The bifunctional enzyme was thought to have arisen from an allosteric site 
for prephenate being converted to an active site for chorismate mutase activity 
(Llewellyn et aL, 1980). However, recent sequencing of tire aroA(G) gene of B . 
subtilis 168 and B. subtilis Marburg strain has demonstrated they have identical 
sequences such that the observed differences in DAHP synthase activity were suggested 
to result from other unspecified changes (Bolotin et a i, 1995).
In addition to Bacillus species Staphylococci, including S. aureus, S. roseus and S . 
epidermidis, have been found to use the pattern of sequential feedback inhibition for the 
control of DAHP synthase activity (Jensen et aL, 1967),
1.2.2. 3-Dehydroquinate synthase.
The conversion of DAHP to 3-dehydioquinate requires chemical steps of oxidation, 13- 
elimination, reduction and an mtramolecular condensation. This is performed by 3- 
dehydroquinate (DHQ) synthase in the presence of NAD+ as cofactor. The enzyme has 
been purified to homogeneity from both E. coli andjB. subtilis.
In E. coli the enzyme is a monofunctional polypeptide of around 40kD, is monomeric 
and requires NAD+ and Co^+ or Zn^+ for activity (Frost et aL, 1984). As with the 
other remaining enzymes of the pre-chorismate pathway in E. coli (with the exception 
of shikimate kinase) tire enzyme is synthesised constitutively. Its synthesis is not 
repressed by any of the ar omatic amino acids.
B. subtilis DHQ synthase was purified in association with chorismate synthase and an 
NADPH-dependent flavin reductase (Hasan & Nester, 1978c). The enzyme was only 
active when associated witli chorismate synthase whereas the presence or absence of the 
flavin reductase did not affect DHQ synthase activity. The enzyme required NAD+ and 
either Co^+ or Mn^+ for activity. The molecular' weight on SDS-PAGE gels was 24kD, 
however, the gene has been sequenced and encodes a polypeptide of 41kD.
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1.2.3. 3-Dehydroquinate dehydratase.
3-Deliydroquinate (DHQ) dehydratase (3-dehydroquinase) catalyses the third step in the 
pre~chorismate patliway and is responsible for initiating the process of aromatisation by 
introducing the first double bond. Two classes of 3-dehydroquinate dehydratase have 
been identified in organisms to date, type I and type II, which catalyse the reactions 
with opposite stereochemistry (Kleanthous et aL, 1992; Harris et aL, 1993). Both E. 
coli and B, subtilis possess the type I enzyme which is characterised by forming a 
Schiff base with the substrate (Shneir et aL, 1991). The stereospecific syn-dehydration 
of dehydroquinate results from the conformational change of the substrate due to Schiff 
base formation.
The aroD and aroC genes encodhig DHQ dehydratase in E. coli and B. subtilis, 
respectively, have been sequenced. From the nucleotide sequence of the E. coli gene 
the polypeptide consists of 240 amino acids with a subunit Mr of 26kD (Duncan et aL, 
1986). The protein has been purified to homogeneity and exists as a dimer (Table 1.1). 
The nucleotide sequence of the subtilis gene encodes a polypeptide of 255 amino 
acids producing a protein with subunit Mr of 28kD (Warbui'g et aL, 1984; Sorokin et 
aL, 1993). However, the protein has not been purified from B, subtilis and has been 
studied only in cmde extracts.
1.2.4. Shikimate dehydrogenase.
Shikimate dehydrogenase catalyses the reversible reduction of 3-dehydroshikimate to 
produce shikimate and is an NADP+ specific dehydrogenase. The aroE gene encoding 
shikimate dehydrogenase in E. coli has been sequenced and encodes a polypeptide of 
272 amino acids with a subunit Mr of 29kD. The protein has been purified to 
homogeneity and exists as a monomer (Table l.l)(Chaudhuri & Coggins, 1985). The 
aroD gene encoding shikimate dehydrogenase in B. subtilis has been mapped but not 
cloned, although it should soon be sequenced under the B. subtilis genome project.
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1.2.5. Shikimate kinase.
Shikimate kinase catalyses the phosphorylation of shüdmic acid to yield shikimate 3- 
phosphate. The flux through the pre-chorismate pathway is further regulated at this 
step in both E. coli and B. subtilis although different mechanisms for control are 
observed.
E. coli synthesises two shikimate kinase enzymes encoded by the aroL gene for 
shikimate kinase II and the aroK gene for shikimate kinase I. Shikimate kinase II 
appeal's to play the dominant role in the pre-chorismate pathway and is regulated by 
both the TyrR and TrpR proteins with the amino acids tyrosine and tryptophan as 
cofactors. The role of shikimate kinase I is less clear. Expression is constitutive and 
the enzyme has a very much lower affinity for shikimate (Km of 20mM compared to 
200|tM for shikimate kinase II)(Defeyter & Pittard, 1986; Mülar et al., 1986). It has 
been postulated that in E. coli, shikimate kinase I has been displaced in importance by 
the more catalytically active and better regulated shikimate kinase II (Whipp & Pittard, 
1995).
In B. subtilis 168 there is a single shikimate kinase which forms a complex with the 
bifiinctional DAHP synthase-chorismate mutase as discussed above. Tlie kinase is 
mactive when dissociated from the complex and the complex is postulated to act as a 
unit of feedback control (Huang et a l ,  1974a; Nakatsukasa & Nester, 1972). The 
situation in the wild-type Marburg strain of B. subtilis is unclear since DAHP synthase 
and chorismate mutase are monofunctional and it has not yet been determined whether 
shikimate kinase forms part of a complex in this strain.
1.2.6. 5-i5wu/pyruvylshikimate 3-phosphate (EPSP) synthase.
EPSP synthase catalyses the transfer of the eno/pyruvyl moiety from 
phosphoenolpyruvate (PEP) to shikimate 3-phosphate to form 5-gno/pyiuvylshikimate 
3-phosphate and inorganic phosphate. The enzyme has been very extensively studied 
in a broad range of plants and microorganisms. This is principally due to it being the 
target of the broad spectrum herbicide glyphosate. Furthermore the aroA gene has been 
a target for the production of live, attenuated vaccines based on aro null mutants. Botli 
of these aieas are discussed in more detail in a later section.
CHpPOg
Flavin mononucleotide (FMN) 
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(radical or semiquinone form)
[H.]
FMNH2 
(reduced or hydroquinone form)
Figure 1.3. The oxidation states of flavin mononucleotide (FMN).
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The aroA gene encoding EPSP synthase in E. coli has been sequenced and encodes a 
polypeptide of 427 amino acids. The protein has a subunit Mr of 46kD, has been 
puiified to homogeneity, and exists as a monomer (Table 1.1)(Duncan et al,, 1984). 
Similarly, the aro A gene has been cloned from J9. subtilis and encodes a polypeptide of 
428 amino acids (Henner et a l, 1986), The protein has a subunit Mr of 45kD, has been 
purified to near homogeneity and also exists as a monomer. The purified B. subtilis 
enzyme was found to exhibit allosteric behaviour, a feature unique among the EPSP 
synthases studied to date (Majumder et a l, 1995).
1.2.7. Chorismate synthase.
Chorismate synthase, the final enzyme of the pre-chorismate pathway, catalyses the 
conversion of 5-e«<?/pyruvylshikimate 3-phosphate to chorismate. The reaction 
involves the absti'action of the C-(6pro-R)-hydrogen with the concomitant elimination 
of phosphate generating the second double bond of the aromatic ring.
The enzyme reaction is unusual in its requirement for a reduced flavin cofactor despite 
there being no ovemll change in the redox state. A major difference between the 
chorismate synthases studied to date is their ability to generate the reduced flavin 
cofactor required for catalysis. Chorismate synthase from Neurospora crassa has been 
shown to possess an intrinsic NADPH-dependent flavin oxidoreductase activity (Welch
COg
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OH
EPSP
FMNH,
Chorismate
synthase
C0 2 -6 1O CO2'
OH
Chorismate
et a l ,  1974; Boocock, 1983; Henstrand et a l, 1995b). However, chorismate 
synthases purified from other sources, namely the bacteria, E. coli (White et a l ,  1988) 
and B. subtilis (Hasan & Nester, 1978b), the protist, Euglena gracilis (Schaller et a l ,  
1991a), and the plant, Corydalis senipervirens (Schaller e ta l,  1990, 1991b), are all
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Figure 1.4. Spectrum of the flavin intermediate formed during the 
JF. coli chorismate synthase reaction (Ramjee, 1992).
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monofunctional and must be supplied exogenously with reduced flavin. The enzymes 
fromB. subtilis (Hasan & Nester, 1978a) and E. gracilis are observed to form enzyme 
complexes with an NADPH-dependent flavin oxidoreductase. The remaining 
monofunctional enzymes are postulated to obtain reduced flavin from endogenous 
flavin reductase activity.
1 .2 .71 . The role of flavin in enzyme reactions.
The flavin molecule is utilised as a cofactor in a wide array of enzyme catalysed 
reactions in contrast to most other coenzymes which are involved in a more restricted 
set of chemical events. Flavins are involved, for example, in the dehydrogenation of 
various different substrates, one-electron transfers, bioluminescence and 
photobiochemical processes. In the vast majority of enzyme reactions involving flavins 
there is at some stage a transfer of electrons between the substrate and the flavin itself 
(Ghisla & Massey, 1989). These electron transfers can on occasions be coupled to the 
transfer of protons. The flavin molecule may also form covalent intermediates duiing 
catalysis such as a C(4a)-adduct and a charge transfer complex.
A feature of the involvement of flavins in redox reactions is their abihty to exist in three 
redox states, quinone, semiquinone and hydroquinone, where semiquinone and 
hydroquinone states are progressive reductions of the quinone state (Figure 1.3)(Voet 
& Voet, 1990).
I.2.7.2. The role of flavin in the chorismate synthase reaction.
The role of the flavin moiety during the chorismate synthase reaction is not yet clear. 
However, pre-steady state kinetic analysis of the reaction has revealed transient changes 
in the absorbance spectrum of FMNH2 during single turnover experiments with EPSP 
using a stopped flow spectrophotometer under strict anaerobic conditions (Figure 
1.4)(Ramjee et aL, 1991). This provides unambiguous spectroscopic evidence of a 
redox active role for the flavin in the catalytic cycle. Furthermore, the spectrum 
suggests tlie presence of a C(4a)-adduct and a charge transfer complex. It has been 
postulated that the FMNH2 does not simply undergo a one or two electron oxidation 
during turnover (Ramjee et aL, 1991)
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Figure 1.5. Some suggested mechanisms for the enzymic conversion 
of EPSP to chorismate. (1) EPSP, (2) chorismate, (3) ‘iso-BPSP’, (4) enzyme- 
bound species.
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With the substiate analogue (6 R)-6 -F-EPSP the FMNH2 cofactor is quantitatively 
oxidised to yield a stable flavin semiquinone radical which is not reduced in the 
presence of dithionite (a strong reducing agent). It has been speculated that the free 
radical is a transient intermediate during the normal catalytic cycle with EPSP where it 
does not accumulate (Bomemann et aL, 1993). Further evidence for a direct role of 
flavin in the catalytic cycle has been obtained with the flavin analogue 5-deaza-FMN 
which binds tightly to E. coli chorismate synthase yet exhibits only 1% of the activity 
obtained with FMN (Bornemann et a i, 1993).
Recently, pre-steady state analysis of E. coli chorismate synthase with tlie substrate 
analogue (6 R)-[6 % ]EPSP has demonstrated a deuterium kinetic isotope effect under 
single turnover showing that the flavin intermediate forms before the C-(6pr<?R)-H 
bond is cleaved (Bornemann et aL, 1995).
1.2.7.3. The reaction mechanism of chorismate synthase.
The stereospecific nature of the chorismate synthase reaction was originally 
demonsuated by growing an E. coli mutant blocked both before and after 3- 
dehydi'oshikimate with stereospecifically labelled shhdmic acid ((6 R)-[6 % ] and (6 S)- 
[6 ^H]) as sole carbon source. Many bacteria have uptake systems for shiMmic acid and 
quinic acid. An analysis of the tyrosine and phenylalanine residues from cellular 
extracts revealed that only the C- (6  pm-R)-hydrogen had been eliminated (HiU & 
Newkome, 1969; Onderka & Floss, 1969). The reaction was thus shown to proceed 
via a r m / i 1,4-ehmination.
The elimination is thought to proceed by a stereochemicaUy-favoured non-concerted 
route for which several models have been proposed. These include an X-group 
mechanism (Floss et aL, 1972), an allyhc rearrangement of phosphate followed by a 
1 ,2-elimination (Ganem, 1978) and the stepwise loss of phosphate and a proton via a 
cationic intermediate (Hawkes et aL, 1990) (Figure 1.5). However, there is as yet no 
consensus regarding the overall reaction mechanism.
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1.2.7 4. Enzymology of chorismate synthase.
Chorismate synthase activity has been studied in a number of organisms and the aroC 
gene encoding the enzyme has been cloned from eleven organisms (Figure 3.6). To 
date the enzyme has been purified and characterised from the bacteria subtilis (Hasan 
& Nester, 1978b) and E. coli (White et aL, 1988), the protist E. gracilis (Schaller et aL, 
1991a), the fungus N. crassa (Gaeitner & Cole, 1973; Welch et aL, 1974; Schaller et 
aL, 1991a; Henstrand et aL, 1995a) and the higher plant C. sempervirens (Schaller et 
aL, 1990, 1991b). A comparison of these chorismate synthases, excluding the B. 
subtilis enzyme, found tliey were very similar in terms of cofactor specificity, kinetic 
properties, isoelectric points and pH optima (Schaller et aL, 1991a). The only 
significant difference was the intrinsic flavin reductase activity shown by the N. crassa 
enzyme (see 1.2.7 & 1.2.7.4.3)
1.2.7.4.1. E scherich ia  coli.
Chorismate synthase has been overexpressed and purified to homogeneity from E. coli 
and has a subunit molecular weight of 39kD (Ramjee, 1992); the aroC gene encoding 
the enzyme has been cloned and sequenced (White et aL, 1988). The enzyme is 
monofunctional, requiring reduced flavin for catalysis and is generally assayed 
anaerobically using photoreduced FMN by the method of Ramjee et aL (1994). 
Synthesis of tlie enzyme is believed to be constitutive and it has been observed that the 
specific activity of chorismate synthase is only 1 0 -2 0 % that of the preceding enzyme, 
EPSP synthase (Tribe et aL, 1979). The enzyme is compared with other chorismate 
synthases in Table 1.3.
1 .2 .74 .2 . B acillus subtilis.
Chorismate synthase was purified to apparent homogeneity from B, subtilis 168 and 
was observed to form pait of a trifunctional complex with the second enzyme of tlie 
pathway, dehydroquinate synthase, and an NADPH-dependent flavin oxidoreductase 
(Hasan & Nester, 1978b). The aroF gene, encoding tlie enzyme, has been sequenced 
and was found to be the first gene in an operon containing dehydroquinate synthase and 
chorismate mutase (Henner et aL, 1990). Hasan & Nester, (1978b) measured the 
molecular weights of chorismate synthase, dehydroquinate synthase and flavin 
reductase to be 24kD, 21kD and 13kD, respectively. However, translation of tlie
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sequenced genes produces proteins with molecular weights of 40kD and 41kD for 
chorismate synthase and dehydroquinate synthase, respectively. The molecular weight 
of flavin reductases from a range of organisms is between 20 and 30kD. Clearly a 
reappraisal of this work would be useful to correct this anomaly.
1 ,2 .74 .3 . N eurospora crassa.
The chorismate synthase from N. crassa has been purified to homogeneity and is a 
bifunctional enzyme having both chorismate synthase and NADPH-dependent flavin 
reductase activities (Gaeitner & Cole, 1973; Welch et a l, 1974). The enzyme was 
observed to be slightly larger than chorismate synthase from other organisms with a 
subunit moleculai' weight of 46.4kD (Henstrand et aL, 1995a). This larger size was 
thought to be a consequence of the bifunctional character of tlie enzyme and the 
presence of a separate flavin reductase domain. Recently, the gene encoding chorismate 
synthase was sequenced and was found to have the domain(s) for reduction of the 
flavin within regions in which homology is shared among monofunctional chorismate 
synthases (Henstiand gf a/., 1995a).
1.2.7 4.4. E uglena gracilis.
Chorismate synthase was puiified 1200-fold from E. gracilis and was observed to be 
associated with an NADPH-dependent flavin oxidoreductase activity. The study did 
not unambiguously determine the subunit composition of the puiified enzymes or the 
nature of die association of the flavin reductase activity with the chorismate synthase 
(Schaller et aL, 1991a). The subunit molecular weight of 41.7kD resembles closely 
that obseived for the monofunctional chorismate synthases.
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Property E. gracilis N. crassa C. sempervirens E. coli
Apparent Km (EPSP) 27gM 2.7pM 53(iM l.SpM l
Apparent Km (FMN) 76nm 66nM 37nni
Cofactor specificity FMN>FAD FMN>FAD FMN>FAD FMN>FAD
Flavin reductase activity Present Present Absent Absent
Apparent Km (NADPH) 7.4pM 21.4|LiM
Mr (native) 110-138kD 198kD 80.1kD 162kDi
Mr (subunit) 41.7kD 46.4kD2 41.9kD 39kD l
No. of subunits nd 4 2 4
isoelectric point 5.5 4.9 5.0 6.451
pH optimum 8.2 8.1 8.0 7.5-8.01
Taken from Schaller et a l, 1991a.
Table 1.3. Comparison of the properties of chorismate synthases from a 
number of organisms.
1.3. Genetics and enzymology of the pre-chorismate pathway.
The genes and opérons responsible for aromatic amino acid biosynthesis are organised 
differently in the different organisms in which they have been studied. This may well 
reflect tlie different evolutionary histories and possibly the regulatoiy constraints 
experienced by each species (Henner & Yanofsky, 1993).
B. subtilis and E. coli differ significantly in the strategies they use to control expression 
of the genes of aromatic amino acid biosynthesis. In B. subtilis many of the genes aie 
organised into common, overlapping, or interdependent transcriptional units, making 
cross-pathway regulation rather than specific regulation the prefeiTed regulatory 
sti'ategy. These cross-pathway interactions have resulted in more complex regulatory 
relationships than ai'e observed for the corresponding genes in enteric bacteria (Nester et 
a i,  1969; Henner & Yanofsky, 1993).
 ^ Ramjee, 1992 
2 Henstrand et aL, 1995b.
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In E. coli the genes of the pre-chorismate pathway are scattered widely around the 
clii'omosome and the encoded proteins are structurally independent (Pittard & Wallace, 
1966; Pittard, 1987). This contrasts with the situation observed in B. subtilis where the 
genes of die pre-chorismate pathway are clustered mainly in one region of the 
chromosome (Table 1.2) and with many of the other genes for aromatic arnino acid 
biosynthesis. The aroFBH operon forms the start of a supraoperon (Figure 1.6) and 
overlaps the trp promoter; the aroH stop codon is within the trp promoter and the ttp 
attenuator is the initial transcription terminator for the aroFBH operon (Henner & 
Yanofsky, 1993). In vivo studies have shown that a transcript from the aroFBH 
operon enters the trp leader region and it is likely that the aroFBH promoter provides a 
functional tip üanscript (Henner & Yanofsky, 1993). The hisH gene (encoding 
histidinol phosphate aminotransferase), the tyrA gene (encoding prephenate 
dehydratase) and the aroE gene (encoding EPSP synthase) are located immediately 
downstream from the trp genes on the subtilis chromosome (Henner et aL, 1986). 
The expression of these three genes is subject to tryptophan control being located in a 
transcription unit with the ttp genes.
aroF aroB aroH trpE trpD trpC trpF trpB trpA hisH tyrA aroEEZZ3EZZ3Z3 ....p. p. p,
Figure 1.6. The aro-trp-aro  supraoperon of B. subtilis. P ’ indicates identified 
promoter element and transcription of the genes is from left to right
It has been suggested that the evolution of the pre-chorismate pathway in higher 
organisms such as plants and fungi has resulted in a decrease in the complexity of the 
shikimate pathway with the formation of multifunctional enzymes. In the fungi 
Neurospora crassa Aspergillus nidulans and Pneumocystis carinii, the yeast 
Saccharomyces cerevisiae and tlie protist Euglena gracilis the five central enzymes of 
the shikimate pathway, DHQ synthase, DHQ dehydratase, shikimate dehydrogenase, 
shikimate kinase and EPSP synthase are encoded by a single gene (Lumsden & 
Coggins, 1977, 1978; Gaertner & Cole, 1977; Berlyn & Giles, 1969, Banerji et aL,
1993). The expressed protein termed arom is a dimer with a subunit molecular weight 
of around 170kD. It has been suggested that the arom complex is the product of gene
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fusion events. DHQ dehydratase and shikimate dehydrogenase constitute a bifunctional 
protein in Physcomitrella patens (moss) (Policy, 1978) and Pisum sativum (pea 
seedlings) (Koshiba, 1978; Deka et aL, 1994). The structural organisation of tlie pre- 
chorismate pathway enzymes in a number of organisms is shown in Figure 1.7.
While many hypotheses exist to explain gene fusions, including the enhancement of 
catalytic efficiency, substrate channelling and coordinate expression of enzyme activities 
it would appear that only the latter explanation can be appUed to the arom polypeptide at 
present (Coggins etaL, 1985; Duncan etaL, 1987).
1.4. Beyond chorismate.
1.4.1. Phenylalanine and tyrosine pathways.
Both tlie phenylalanine and tyrosine pathways begin with the conversion of chorismate 
to prephenate by chorismate mutase (Figure 1.2). In E. coli the reaction is catalysed by 
a bifunctional chorismate mutase which exists as two isoenzymes. One has associated 
prephenate dehydratase activity, and therefore helps to channel chorismate towards L- 
phenylalanine synthesis. This enzyme is also subject to feedback inhibition by L- 
phenylalanine. The second isoenzyme has associated prephenate dehydrogenase activity 
dhecting the synthesis of L-tyrosine, and is correspondingly inhibited by L-tyrosine. 
The isoenzymes are dimers with subunit molecular weights of 40kD (Pittard, 1987),
B. subtilis has a monofunctional chorismate mutase which exists as a homodimer of 
14.6kD subunits, somewhat smaller than the enzyme from other organisms. The gene 
encoding the enzyme has been cloned and sequenced (Henner et aL, 1986) and the 
putative encoded sequence bears only minimal similarity with otiier chorismate mutases. 
The enzyme is product inhibited by prephenate. Prephenate dehydratase and prephenate 
dehydrogenase are strongly inhibited by L-phenylalanine and L-tyrosine, respectively in 
B. subtilis (Henner & Yanofsky, 1993).
The phenylalanine and tyrosine pathways coiTespoiidingly produce phenylpymvate and 
4-hydroxyphenylpyruvate. The final reaction in both pathways involves the 
transamination of the respective a-keto acids with glutamate as the amino group donor. 
In both E. coli and B. subtilis several enzymes with broad specificities are capable of 
catalysing this reaction (Haslam, 1993).
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1,4.2. T he tryptophan pathway.
The biosyntlietic route to tryptophan from chorismate requires seven enzymatic 
functions, designated A through G. In E. coli the seven enzymatic functions necessary 
for synthesis are encoded in seven genes that constitute a single operon. These 
functions are performed by two enzyme complexes E2 (G-D)2  and B2A2 and a single 
bifunctional enzyme C-F [dashes indicate covalent linkage] (Haslam, 1993; Pittard,
1987). In B. subtilis the seven enzymatic functions are encoded by seven genes which 
specify the complexes, EG and B2A2 with tlie remaining enzymes being independent 
(Henner & Yanofsky, 1993). Again, as in the pre-chorismate pathway the gene 
designations d iffering , subtilis from those in E, coli. Six of the seven trp genes are 
present m a supraoperon (section 1.3) while the seventh is located in an operon 
predominantly concerned with folic acid biosyntliesis.
The conversion of chorismate to anthranilate (Figure 1.2), catalysed by antliranilate 
synthase, is the first step in the pathway and is the major feedback-sensitive enzyme in 
tryptophan biosynthesis in both E. coli and B. subtilis. Anthranilate synthase is 
composed of the TrpE and TrpD polypeptides in E. coli and the TrpE and TrpG 
polypeptides in B. subtilis (Pittard, 1987; Henner & Yanofsky, 1993). The reaction 
involves the amination and aromatisation of chorismate, with either ammonia or 
glutamine serving as the amino donor,
Phosphoribosyl transferase the next enzyme in the tryptophan pathway is bifunctional 
in E. coli, one domain having amidotransferase activity and the other catalysing the 
condensation of anthranilate with the ribose-5-phosphate moiety of phosphoribosyl 
pyrophosphate (Somerville, 1983). In B. subtilis the TrpD polypeptide containing 
phosphoribosyl transferase activity does not associate with anthranilate synthase 
(TrpEG)(Henner & Yanofsky, 1993).
Phosphoribosyl anthranilate transferase isomerase and indole glycerol phosphate 
synthase catalyse the Amadori rearrangement of phosphoribosyl anthranilate followed 
by decai'boxylation and ring closure reactions to produce indoleglycerol phosphate, the 
immediate precursor of tryptophan. These reactions ai'e performed by a bifunctional 
enzyme in E, coli but independent monofunctional enzymes in B. subtilis (Somerville, 
1983; Henner & Yanofsky, 1993).
Tryptophan synthase the final enzyme in the tiyptophan pathway catalyses the 
pyiidoxal-phosphate-dependent conversion of indoleglycerol phosphate and serine to
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Figure 1.8. Chorismate and beyond, the primary metabolic pathways
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tiyptophan and glyceraldehyde-3-phosphate. In both E. coli and B. subtilis tryptophan 
synthase is a complex, T1PB2A2 (Somerville, 1983),
1.4.3. Other primary metabolites.
The production of chorismate by the pre-chorismate pathway is only the beginning of 
the biosynthesis of many other primary metabolites in bacteria. These are listed below 
in summary and detailed in Figure 1.8. Extensive reviews can be found in Bentley, 
(1990), Luckner, (1990) and Haslam, (1993).
p-aminobenzoate and folate coenzymes. Tetrahydrofolate, synthesised 
via p-aminobenzoate, holds a central position in one-carbon metabolism. Formyl 
groups, hydi’oxymethyl, and methyl groups may be transferred via a number of 
tetrahydrofolate derivatives. Tetrahydrofolate serves as the acceptor of the ^-carbon 
atom of L-serine when it is cleaved to yield L-glycine (Luckner, 1990). This reaction is 
of special significance as a source of active 1-carbon atoms required in the synthesis of 
methionine, thymine, and the purines.
Quinone biosynthesis. The lipid-soluble isoprenoid quinones paiticipate in 
the multienzyme temiinal oxidation respiratory complex. The quinones are believed to 
function in electron relay between other respiratory coenzymes and may have a more 
direct role in the process of oxidative phosphorylation (Bentley, 1990; Haslam, 1993). 
The ubiquinones (coenzyme Q) are found universally in natui’e with the exception of the 
Gram-positive bacteria and blue-green algae. The menaquinones (vitamin K2) are 
synthesised via isochorismate, have many similarities with the ubiquinones and are 
found only in bacteria and some fungi (Haslam, 1993).
Siderophores. Many organisms synthesise, via 2,3-dihydroxybenzoic acid, 
a class of compounds to sequester iron (Fe^+) under conditions of iron deprivation. 
These compounds, such as the catechol enterobactins, form one of the two major types 
of siderophore. The other stractural type being the hydroxamates which includes 
ferriclii'ome and aerobactin (Luckner, 1990; Bentley, 1990).
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1,4.4. Secondary metabolites.
A vast aiTay of secondary metabolites are biosyntliesised jBrom chorismate. These will 
not be discussed further here but include antibiotics, such as chloramphenicol and 
vancomycin as well as mycotoxins and phenazines (pigments).
1.5. Importance and significance of the shikimate pathway.
Wlrüe the shikimate pathway is of obvious importance to the host microorganism or 
plant there ar'e a number of important features of the pathway which are of direct benefit 
to humans and animals and some other features of the pathway which may be exploited 
for medical benefit. Of immediate importance, and frequently overlooked, is the 
production of the aromatic amino acids, folic acid and the vitamins Ki and K 2 . These 
are essential dietary requirements of humans and animals (with the exception of tyrosine 
which can be formed fiom the hydroxylation of phenylalanine) which during the course 
of evolution have ‘lost’ the ability to produce these components for themselves. The 
symbiotic relationship between the commensal gut bacteria in humans and animals is a 
prominent sour ce of some of these components.
Detailed in the following sections are some of the ways in which man has been able to 
exploit the pathway for medical benefit.
1.5.1. Engineering inhibitors/antibiotics.
As mentioned briefly above the shikimate patliway leads ultimately to the production, in 
some microorganisms, of secondary metabolites which have antimicrobial activity. The 
absence of tlie pre-chorismate pathway and its primary metabolic branches from 
humans has allowed for the possibility of producing syntlietic antimicrobials directed 
towards some of the enzyme reactions.
1.5.1.1. Sulphonam ides.
The sulphonamides are synthetic antibacterial agents which are structural analogues of 
para-amirio benzoic acid (PABA). Sulphonamides interfere with the synthesis of folic 
acid by inhibiting the condensation of PABA with 2-amino-4-hydroxy-6-
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dihyropteridinylmethyl pyrophosphate to fonn dihydropteroic acid. The sulphonamides 
compete with PABA in this leaction not simply by occupying the active site on the 
enzyme but by acting as alternative substrates for dihydropteroate synthase. (Willet, 
1988).
1.5.1.2. G lyphosate.
Interference with the biosynthesis of aromatic amino acids has been demonstrated with 
the active component of the nonselective, broad spectrum herbicide glyphosate (N- 
phosphonomethyl glycine). The primary target of this herbicide is EPSP synthase, 
although other enzymes ar e inlribited to a lesser extent in some organisms (Amrhein et 
aL, 1980). Glyphosate has been shown, with all the EPSP synthases studied to date, 
to be a competitive inhibitor of the substrate phosphoenolpyruvate (PEP). Resistance to 
glyphosate in microorganisms and plant tissue culture generally occurs as a result of 
increased levels of sensitive EPSP synthase or the production of an insensitive enzyme. 
The discovery of glyphosate owes more to serendipity than rational design but 
demonstrates tire specific inhibition of the pre-chorismate pathway (Haslam, 1993).
1 .5 .13 . (65)-6-F luorosh ikim ic acid.
The (6 S)-6 -fluoro analogue of shikimic acid was chemically synthesised with the 
expectation that it would inhibit the biosynthesis of primary aromatic metabolites in 
bacteria (Sutlrerland et aL, 1989). The compound was shown to be transported into the 
cytoplasm of the cell by the shikimate transport system and sequentially became a 
substrate for shikimate kinase, EPSP synthase and chorismate synthase (Davies et aL, 
1994; Ramjee, 1992; Ewart et aL, 1995; Jude et aL, unpublished). The original 
incorporation of a fluorine was based on the rationale that (6 S)-6 -fluoroshikimate 
would be biosynthesised through the pre-chorismate pathway to produce a lethal 
intermediate or end product of a post-chorismate pathway (Davies et aL, 1994)
This prediction turned out to be fully realised with the fluoro analogue producing 
inhibition of p-amino benzoic acid (PABA) synthesis, and thus folic acid production 
(Davies et aL, 1994; Ewart et al., 1995). The success of inlribiting this post-chorismate 
branch with the sulphonamide class of antibiotics and now (6 S)-fluoroshikimate is a 
consequence of the essential nature of the product of the pathway and the inability of 
bacteria to obtain PABA from vertebrate tissues (Hoiseth & Stocker, 1981; Davies et
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a i ,  1994). (65)-fluoroshikimate was demonstrated to protect mice against challenge 
with E, coli B (Davies et aL, 1994). However, a high frequency of spontaneous 
resistance to tlie compound was observed resulting from the loss of activity of the 
shikimate transport system in these resistant variants (Ewart et aL, 1995: Jude et aL, 
unpublished). The frequency of mutation was observed to occur at a level which would 
be expected to reduce the usefulness of this compound as an antibacterial agent.
The success of (65)“6-fluoroshikimate as an inhibitor of the shikimate pathway, 
regardless of the resistance problems, demonstrates the inherent vulnerability of the 
pathway, and in particular PABA synthesis, to the rational design of selectively toxic 
inhibitors.
1.5.2, Aromatic-dependent bacteria as live vaccines.
The increasing problem of antibiotic-resistant strains of bacteria in the developed world, 
and the non-availability of antibiotics and optimal medical cai^ e in the developing world 
has increased the need for the production of prophylactic bacterial vaccines. The ability 
to produce genetically defined lesions in bacteria has led to the use of live attenuated 
strains as vaccines. The pre-chorismate pathway has become a major target for the 
production of just such genetically defined lesions leading to live vaccine production.
Auxoh'ophic mutants, and in particular PABA-dependent mutants, of salmoneUae were 
first shown to be attenuated in the 1950s (Bacon et aL, 1951). However, it was in the 
1980s tliat Stocker demonstiated that an aroA lesion in a virulent strain of S . 
typhimurium produced attenuation in vivo (Hoiseth & Stocker, 1981). The critical 
product in this regard was PABA which bacteria are unable to assimilate from vertebrate 
tissue a feature also demonstrated with the effectiveness of sulphonamide 
chemotherapy. Thus while the bacteria will colonise a mammahan host, their potential 
for growth is severely hmited by the supplies of PABA. It has subsequently been 
shown that other genes in the pre-chorismate pathway, including aroC and aroD, are 
essential for in vivo growth (Chatfield et aL, 1992a).
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The immunogenicity of an aroCaroD deletion strain of Salmonella typhi has been tested 
in humans and shown to be effective. Aro mutants have been shown to produce 
protective immunity against salmonellosis in fowl and calves (Jones et aL, 1991; 
Griffin & Banow, 1993; Cooper et aL, 1992). Furthermore aromatic dependent {aro) 
mutants of the following pathogens have been shown to be avirulent and stimulate 
protective immunity: Shigella flexneri (Verma & Lindberg, 1991: Kamell et aL, 1993), 
Bordetellapertussis (Roberts a/., 1990), Yersinia enterocolitica (Bowe et aL, 1989), 
Aeromonas salmonicida (Vaughan et aL, 1993) and Bacillus anthracis (Ivins et aL, 
1990). Attenuated salmonella strains have also ben used as experimental oral carriers 
for the delivery of heterologous antigens to the immune system (Chatfield et aL, 1992b; 
Strugnell et aL, 1992; Poirier et aL, 1988). These experimental vaccines are attractive 
as salmoneUae are effective carriers inducing secretory and humoral antibodies and 
various cell mediated responses (Chatfield et aL, 1992a).
1.6, Flavin reductases.
All chorismate synthases have an essential requirement for a reduced flavin cofactor for 
activity. However, the ability to reduce the flavin cofactor differs markedly between the 
enzymes. The N. crassa enzyme has an intrinsic NADPH-dependent flavin reductase 
activity while chorismate synthase from j5. subtilis and E. gracilis are found associated 
with enzymes having flavin reductase activity. These enzymes can aU be assayed 
aerobicaUy by monitoring diene formation at 275nm. The lack of associated flavin 
reductase activity with the monofunctional chorismate synthases from E. coli and C . 
sempervirens means that the flavin cofactor must be reduced by chemical or 
photochemical means or alternatively by enzymic means with the addition of a flavin 
reductase.
NAD(P)H-dependent flavin oxidoreductases catalyse the reduction of flavins, flavin 
mononucleotide (FMN), flavin adenine dinucleotide (FAD) or riboflavin, by reduced 
pyridine nucleotides, NADPH or NADH. Flavin reductases have been purified from a 
number of microorganisms: E. coli (Fontecave et aL, 1987), B. subtilis (Hasan & 
Nester, 1978a), Pseudomonas aeruginosa (Halle & Meyer, 1992), Vibrio harveyi (Lei 
et at., 1994: Jablonski & DeLuca, 1978) and Entamoeba histolytica (Lo & Reeves, 
1980).
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The purified enzymes have a number of chaiacteristics in common. Most flavin 
reductases are cytosohc enzymes consisting of one polypeptide chain with molecular 
weights in tlie range of 20-30kD. With the exception of the V. harveyi enzyme they are 
not flavoproteins i.e. do not have flavin bound to the enzyme. Rather the polypeptide 
chain has an active site which allows both the reduced pyridine nucleotide and the flavin 
to transiently bind allowing a rapid electron transfer to proceed (Fontecave et at., 1994). 
The enzymes can act on a variety of flavin electron acceptors, although the respective 
affinities for each vary (Kn, between 1 and 40|aM). Flavin reductases may also be 
divided into three groups: one including enzymes specific for NADH, another for 
enzymes specific for NADPH, and a third for enzymes accepting both NADH and 
NADPH.
Several flavin reductases may be present in some microorganisms. Two flavin 
reductases have been purified from E. coli and the/re gene encoding one of these has 
been cloned and sequenced (Spryou et aL, 1991). Similarly two flavin reductases have 
been cloned and purified from V. harveyi (Lei et aL, 1994; Zenno & Saigo, 1994; 
Watanabe & Hastings, 1982).
Another interesting feature of the flavin reductases is that they have been found to be 
associated with other biological processes requiring reduced flavins. A flavin reductase 
from B. subtilis has been shown to be associated with the pre-chorismate pathway 
enzymes chorismate synthase and dehydroquinate synthase (Hasan & Nester, 1978a). 
The enzyme was found to be 13kD as discussed in section 1.2.7.4.2, but if this mass 
was underestimated by around half then the enzyme would be of similar molecular 
weight to those previously characterised.
Each of the puiified flavin reductases from Vibrio harveyi have been postulated to be 
capable of fonning a complex with luciferase (Jablonski & DeLuca, 1978; Duane & 
Hastings, 1975; Hastings et aL, 1985). Bacterial luciferase catalyses the oxidation of 
reduced FMN by oxygen in the presence of a long-chain aldehyde with the emission of 
light (bioluminescence). It was suggested that the flavin reductases were supplying 
reduced flavin to the luciferase reaction in vitro since coupling the reductase reaction to 
light emission decreased the apparent Km of the enzyme for NADH, NADPH and FMN 
(Jablonski & DeLuca, 1978). However, a decrease in the apparent Km was not seen 
when the reductase reaction was monitored directly in the presence of the luciferase 
reaction. Only when the coupled luciferase reaction was monitored could changes m 
the Km for the flavin reductase be observed.
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The best studied interaction of a flavin reductase with other enzymes is that with the 
complex multiprotein system that catalyses the transformation of an inactive form of 
ribonucleotide reductase into an active enzyme, containing a radical on Tyr-122 
(Fontecave et al., 1987, 1989). Tire function of the flavin reductase is to reduce the 
non-heme ferric centre of ribonucleotide reductase and is followed by tlie formation of 
the tyrosyl radical with the reaction of the reduced iron centre with molecular’ oxygen 
(Fontecave et aL, 1989; Fontecave et aL, 1994). The flavin reductase was in tliis 
context suggested to provide a mechanism for regulating ribonucleotide reductase and 
thus DNA synthesis (Fontecave etal., 1994)
1.7. Aims of the project.
To clone and sequence the gene encoding chorismate synthase from the 
pathogenic bacterium Staphylococcus aureus. At the time the project was 
started there were no sequences from Gram-positive bacteria known and of the four 
chorismate synthase sequences identified only two were bacterial and were from die 
evolutionarily related enteric bacteria Escherichia coli and Salmonella typhi.
Maximally overexpress 5. aureus  chorismate synthase to facilitate 
subsequent purification of the enzyme in lOOmg quantities. Tire high
overexpression of E. coli chorismate synthase using the tac promoter (White et aL,
1988) had enabled Ramjee, (1992) to purify 140mg of enzyme to around 95% purity 
from 2 0 g of cells.
Characterise the purified S. aureus enzyme in terms of subunit structure 
and native molecular weight and also investigate the enzyme using both 
steady state and pre-steady state kinetic techniques. A comparison of the 
enzyme with the well characterised enzyme from E. coli would be undertaken. The use 
of pre-steady state techniques had resulted in tire observation of a transient flavm 
intermediate during turnover of tlie E. coli enzyme (Ramjee et aL, 1991). The S . 
aureus enzyme would be investigated to determine whether such an intermediate was 
similarly obserwed.
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CHAPTER 2. MATERIALS AND METHODS.
2.0. Chemicals.
Chemicals and biochemicals were generally Analar grade or the highest grade available 
and unless stated were from Sigma Chemical Company, England or Fisons Chemicals, 
England. Individual manufacturers of reagents and enzymes are indicated in the text, 
where appropriate.
2.1. Strains and plasmids.
The bacteria used during this project ai'e detailed in Table 2.1. Staphylococcus aureus 
601055, Escherichia coli BL21(DE3) and Escherichia coli HMS174(DE3) were obtahied 
from Zeneca Phai'maceuticals Ltd. Escherichia coli GLW40, a recA stiain of AB2849 
(Pittai'd & Wallace, 1966) was obtained from Dr. I. Hunter, Laboratory of Genetics, 
University of Glasgow.
The plasmids used during this project are detailed in Table 2.2. Plasmid pCOC102 was 
tlie very kind gift of Professor Tim Foster, Moyne Institute, Dublin. Plasmid pTB361 
was the kind gift of Dr. Peter Barth, Zeneca Pharmaceuticals Ltd. Plasmid pMAYl was 
the kind gift of Dr. Anne Moir, Dept, of Molecular Biology and Biotechnology, 
University of Sheffield.
Bacterial Strain Genotype
Staphylococcus aureus 601055 wild type clinical isolate
Escherichia coli DH5a F~ (|)80d/<2cZAM15 recAl endAl
gyrA96 thi~l /i5dR17(rk",mk+) supEAA
relAldeoR A{lacZYA-argF)m69
Escherichia coli GLW40 aroC recAVi thi (from AB2849)
Escherichia coli BL21(DE3) F" ompT rB‘,mB-
Escherichia coli HMS174(DE3) F- recA i'kl2 ',mkl2 '^  ?^ DE3
Escherichia coli AB1321 aroAl proAl his4 thi lacYl
Table 2.1. Bacterial strains and their genotypes.
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2.1.1. Culture media and supplements.
The bacteria listed above were routinely cultured in Luria-Beitani medium (Bacto- 
tryptone lOgl'i, yeast extract 5gl’l, NaCl lOgl'^) and grown overnight at 37“C with 
shaking. For culture on solid media, Bacto agar (Difco, Detroit, USA) was added at 
1.5% w/v to the above medium. For culture on slopes, Bacto agar was added at 1% w/v 
to the medium.
For growth in minimal medium bacteria were cultured in M9S (NH4 CI IgF^ 
MgS0 4 .7 H2 0  ISOmgl'^ KH2PO4  3gl‘l, Na2HP0 4  6 gl" )^ with 12ml per litre of sterile 
glucose solution (D-glucose AR 15g and 7.5 ml of lOOmM CaCl2 made to 90ml with 
water). For the preparation of minimal agar 250ml of 2xM9S was autoclaved separately 
from an equal volume of water containing 2% w/v Oxoid N°1 (Oxoid Ltd., Basingstoke, 
England); this prevented tlie precipitation of the salts. When hand-hot, 6 ml of glucose 
solution was added to the M9S solution together with the appropriate amino acids and 
vitamins detailed in Table 2.3. The agar solution and the M9S solution were then mixed 
before the plates were poured.
Plasmid Remarks Reference
pUC18 general cloning vector Yanisch & Peron, 1982
pBluescript SKIT general cloning vector Short, J.M et a l,  1988
pCOC102 S. aureus 8325-4 O' Connel et al., 1993
aroAaroB partial aroC
pMAYl Bacillus subtilis gerCA Yazdi, 1989
gerCBgerCC genes
pGM605 aroC overexpression plasmid White et oL, 1988
pTB361 T7 expression plasmid Dr. Peter Bai th
pLysS T7 lysozyme plasmid Moffat & Studier, 1987
pLysE T7 lysozyme plasmid Moffat & Studier, 1987
pMJH701 S. aureus 601055 ndk, This study
aroC aroB aroA genes
pMJH702 S. aureus 601055 ndk, aroC genes This study
pMJH7EX2 aroC overexpression plasmid This study
Table 2.2. Plasmids.
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Antibiotics were added to the culture medium at the following concentrations: ampicillin 
100|lgml-l, tetracycline 12.5|lgml'l, chloramphenicol 17|igml"l (all from Sigma). Stock 
solutions were made up in water or ethanol as appropriate and filter sterihsed.
2.1,2. Storage of strains.
The long-tenn storage of bacteria was accomplished by making glycerol stocks of 
exponential or stationary phase cultures with the addition of sterile 80% v/v glycerol to a 
final concentration of 15% v/v. These were stored at -80“C and never defrosted. For 
inoculation an upper piece of the frozen culture was chipped or melted off. For medium- 
term storage agar slopes were prepared and stored in a cool, dark place. Short-term 
storage was accomplished with the use of agar plates sealed with lasso tape and 
maintained at 4®C.
Supplement to minimal 
medium
Concentration
L-histidine 50 mgl'l
L-proline 150 mgl’l
L-tryptophan 2 0 0  mgpl
L-phenylalanine 400 mgl‘l
L-tyrosine 2 0 0  mgl‘1
PABA 320 mgl-l
PHBA 320 mgl-l
Thiamine-HCl 2  mgl-l
Table 2.3. Supplements to minimal medium.
2.1.3. Strain identification
Staphylococcus aureus 601055 was a clinical isolate from Zeneca Pharmaceuticals culture 
collection. The strain was confirmed as Staphylococcus aureus using the apiSTAPH 
strain identification system (Bio Merieux, France) using the manufacturer's protocol and 
tire accompanymg computer software package. The organism was fust subcultured on 
LB agar for 18 hours at 37"C and checked for purity by Gram stain and wet-film
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microscopy. A homogenous suspension of the culture was made in an ampoule of 
apiSTAPH medium using 6  colonies before inoculating the test strip as directed and 
incubating at 37°C for 18 hours. A Staphylase test (Oxoid Diagnostic Reagents, 
England) was used as a supplementary and confirmatory test for S. aureus identification. 
As directed 3 colonies were smeai'ed on tire test strip and completely resuspended before 
adding 1 drop of test or control suspension. Clumping of the test suspension, rabbit 
fibrinogen sensitised sheep red blood cells, indicated a positive test.
2.2. Purification of genomic DNA from S, aureus,
A  50ml overnight culture was harvested by centrifugation at 10,000rpm (Sorvall RC-5B, 
SS-34) for 10 min. The cells were resuspended in 5ml of TB (lOinM Tris-HCl pH7.2, 
ImM EDTA) and lysostaphin (Sigma) was added to give a final concentration of 
lOOjig/irrl. This was incubated at 37'^C for 15irrin. 1ml of 0.5M EDTA, pH8.0 was 
added and the solution mixed before adding 1ml of 10% w/v SDS with further mixing to 
obtain a clear' viscous solution.
An equal volume of TE saturated phenol was added and the solution mixed well before 
centrifuging at 3,000rpm for lOmin. The aqueous layer was extracted with another equal 
volume of phenol and spun again. Two further organic extr actions were performed using 
TE saturated phenol/chloroform and then chloroform. Tire aqueous layer was removed 
and the DNA precipitated with the addition of 1/lOth volume of IM NaCl and an equal 
volume of isopropanol. After mixing, the DNA was centrifuged at 5,000rpm for lOmin. 
The pellet of DNA was washed in 70% v/v ethanol, drained, vacuum desiccated and 
redissolved in water overnight at 4°C.
2.3. Polymerase Chain Reaction (PCR).
This was perfoi'med in PCR tubes using a reaction volume of either 25pi or lOOpl. Both 
Taq polymerase (Promega, USA) and Vent polymerase (New England Biolabs, USA) 
were used. Vent polymerase was used in instances where a greater fidelity was requhed. 
Taq polymerase was mainly used for the amplification of genomic DNA from S. aureus 
using multiply degenerate primers.
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2.3.1. PCR using Vent polymerase.
Vent polymerase PCR reactions were performed in lOOpl volumes and were prepared 
by adding the following sequentially: lOpl of 10 x Vent buffer, water, lOpl of 10 x 
dNTPs (30mM), lOOng template DNA and lOOpmol of each primer.
The annealing temperature for the primers in the Vent PCR reaction was generally 
required to be lower than for Taq PCR in contrast to previous reports (Cease et a l,
1994). The typical cycle profile used was 94°C for Imin, 50°C for Imin and 72°C for 
70sec per kb of DNA to be amplified, with 20-30 cycles being performed.
2.3.2. Recovery of PCR products from reactions.
20pl of PCR product was run on a 1% w/v agarose gel to determine whether the PCR 
reaction had produced the desired amplicon and whether other secondary PCR products 
were present. When only the desired amplicon was observed after agarose gel 
electrophoresis a Wizard PCR clean-up kit (Promega, USA) was used with elution of 
the DNA into sterile distilled water. When secondary bands were observed after 
agarose gel electrophoresis, the desired DNA band was excised from the gel and 
purified using either a Geneclean kit (BIO-101, USA), a Spin-X column (Costar, 
France) or phenol/ chloroform extraction.
For phenol/chloroform extraction the PCR product was first separated on a low melting 
point agarose gel and the band excised. An approximately equal volume of TE, pH7.2 
was added together with an equal volume of TE-saturated phenol, pH7.2 and heated to 
65°C for 5min, vortexed and spun at full speed for 5min. The aqueous layer was then 
promptly removed and further extractions of the aqueous layer with phenol, TE- 
saturated phenol/chloroform and TE-saturated chloroform were performed. The DNA 
was recovered by adding an equal volume of isopropanol and 1/10th volume of IM 
NaCl, vortexing and spinning at ftill speed in a microfuge for 15min. The pellet was 
then dried and resuspended in a small volume of sterile, distilled water.
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2.4. Plasmid DNA sequencing.
Plasmid DNA sequencing was peifoimed on DNA isolated using a Qiagen plasmid kit 
(Qiagen, Germany). Typically 2.5~3[ig of DNA was used for each sequencing reaction 
using a Sequenase 2,0 kit (Amersham, England).
To denature the DNA: for each reaction, 8 )il of plasmid DNA (i.e. total volume contains 
2.5-3qg) and 2pl of IM NaOH, ImM EDTA were mixed in an eppendorf tube and 
incubated at room temperature for 5min. 3ql of 3M NaAc, 17)41 distilled water and 30pl 
of isopropanol were tlien added. Tlie tubes were centrifuged at full speed for 15min, 
diained, vacuum desiccated and the DNA dissolved in 7|il of water. For each annealing 
reaction, 2 pl of Sequenase reaction buffer and Ijitl of primer (1-2 pmol/jutl) was added. 
Tills was heated at 100"C for Imin before transfemng the tubes to a 37"C waterbath for 
2 0 min to allow the primers to anneal.
For the sequencing reactions: the ddNTP mixes were dispensed into wells of a microtitie 
plate (Nunc plates are heat resistant). For 4 reactions lOjil of ddNTP mix and Iq l of 
DMSO were mixed together with 2.5pi amounts dispensed per well. The labelling 
mixture (L) was made up by adding, for four reactions, 2pl of labeUiiig mixtui'e, Ip l of 
DMSO and 7pi of water. To each template/primer mix Ip l of O.IM DTT, 0.5pl of 
a^^S[dATP] and 2pl of mixture L was added. The enzyme mixture (S), for 4 reactions, 
was prepared by mixing 10.6pl of enzyme dilution buffer and 1.4pl of Sequenase 
enzyme. 2 pl of this was then dispensed into each template/primer/label mix and 
mcubated at room temperature for 5min. Finally, 3.5pl of the complete mixture was 
dispensed into the 4 corresponding ddNTP wells for each reaction and incubated at 37 °C 
for 5min. 4pl of stop/loading dye was added and mixed before storing at -20°C until 
loading.
2.4.1. Sequencing gel and sample loading.
A BRL SO sequencing gel kit was used for sequencing witli gels being poured the day 
before running and stored at 4°C overnight. A 6 % sequencing gel was prepared 
bymixing 63g of urea, 22.5ml of 40% w/v acrylamide solution, 15ml of 10 x THE 
(900mM Tris-HCl, 900mM boric acid, 25mM EDTA pH8.3) made to 150ml with 
distilled water. 750pl of 10% w/v ammonium persulphate and 125pi of TEMED were 
then added, the solution mixed and poured without degassing.
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The samples were heated to 75-80°C and placed on ice immediately before loading. 3pi 
of sample was loaded per well and the gel run at 40mA for 4 hours or until the 
bromophenol blue reached the base of the gel. After electrophoresis the gel was fixed for 
30min in 2 litres of 10% v/v methanol, 10% v/v acetic acid then tiansfened to a sheet of 
3MM Whatman paper and dried at 80°C under vacuum on a gel drier. An autoradiograph 
was then set up using Hypeifilm MP (Amersham, England) with exposure for around 18 
hours and development using a Kodak X-Omat.
Primer Sequence Location in pMJH702
CHOR 16 CCTGCAGCAAGTATCGTC 2171-2188
CHOR 17 TATGATCGTAAATTAGAT 1854-1872
CHOR 19 GTm TCGCITCATCAAT 1768-1751
CHOR 20 GTCGTAGCGGTGGGTGCA 1562-1580
CHOR 2 2 AGTAATATACATAAACCT 182-200
CHOR 23 AGCATGTGCCGGTCTTGG 1463-1481
CHOR 24 ATCTAATTTACGATCATA 1854-1872
CHOR 25 TGTGCATTCATAAATGTT 1076-1058
CHOR 26 ATTTGCAGGTACACCTTC 1214-1196
CHOR 27 GGAGAATCACATGGACCT 1159-1177
CHOR 28 TGGATAATTGTTTGAAGG 2372-2354
CHOR 29 TGTTTCTCTGGCAGATGA 1555-1537
CHOR 30 GAACACCAAGGTAAACCA 374-392
CHOR 31 AATATACAAGCTATATIT 841-823
CHOR 32 CACGGTTCAGATTCATTA 565-583
CHOR 33 ACCAATTAGATTTCTTTG 281-263
Table 2.4. Sequencing oligonucleotide primers.
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2.5. DNA cloning procedures.
2.5.1. Restriction of S, aureus genomic DNA.
Genomic DNA was generally cut in a 50pl volume with a relatively high number of units 
of restriction enzyme to ensure complete digestion. 2pg of genomic DNA would be cut 
with 10-20U of enzyme for 2 hours at 37 °C in the appropriate buffer before adding a 
fiuther 10-20U of enzyme with incubation for 3 hours. The restriction enzymes were 
inactivated, where possible and when appropriate, by incubation at 65°C for 20min.
2.5.2. Restriction of plasmid DNA.
The two general purpose cloning vectors, pUC18 and pBluescript SKII, were used for 
cloning procedures. For genomic DNA cloning pBluescript was exclusively used. 5pg 
of plasmid DNA was digested in a 50pl volume with 10-20U of restriction enzyme in tlie 
corresponding buffer at 37°C for 1 houi*.
2.5.3. Alkaline phosphatase treatment of cut plasmid.
Calf intestinal alkaline phosphatase (CIAP) was added to the digested plasmid at the 
concenti'ation of l.OU per pmol of 3' or blunt ends and O.IU per pmol of 5' ends. The 
molar amount of plasmid ends was calculated according to the following formula:
g of plasmid x No. of bases / Mr (Mr of a base -660)
The CIAP was added directly to tlie restriction buffer without inactivating the restriction 
enzymes, when possible. CIAP buffer was added and the volume made up to lOOpl and 
incubated at 37°C for 1 hour. All of the enzymes were then subsequently removed using 
a Magic DNA cleanup column (Promega) with elution of the puiifled DNA in water.
2.5.4. Ligation of cut moieties.
Prior to hgation, concentrations of DNA were either measured accurately by 
spectrophotometi’y or by estimation from gel electrophoresis. Generally, several ratios of 
vector DNA and insert DNA were used in separate ligations. The ligations were 
perfoi'med in lOpl volumes with 1-3 Weiss units of T4 DNA ligase and incubated
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ovenüght at 4°C. To facihtate blunt-ended cloning either twice this concenti'ation of T4 
DNA ligase was used or 0,025% v/v Nonidet P-40 was added.
2.6. Preparation of competent ceils and transformation.
Competent cells were made on the day they were required. A single colony of the 
appropriate strain of E. coli was picked from an agar plate or a loop was used to melt a 
small amount of culture from the top of a glycerol stock. This was used to inoculate 
20ml of LB medium wliich was incubated at 37°C overnight with shaking.
30ml of fresh LB medium was inoculated with 600|il of overnight culture and incubated 
at 37°C for ai'ound 2 hours until the ODgoo reached around 0.3. The cells were then spun 
down at 3,000g for 5min and completely resuspended in one half volume of ice-cold 
sterile lOOmM CaCl2 . The cells were left on ice for around 20min followed by 
centrifugation at 3,000g, 4°C for 5min with resuspension in one tenth volume of ice-cold 
lOOmM CaCl2 - The cells were usually left on ice for several hours prior to 
ti'ansfonnation.
For ü'ansformation of the cells, 5pl of hgation mix was diluted with 45pi of sterile, ice- 
cold TNE buffer (50mM Tris-HCl pH7.5, 50mM NaCl, ImM EDTA) on ice and lOOpl 
of competent cells were added. Transformation controls were performed at the same time 
and were made up to an equal volume. The mixture was incubated for 30min ensuring 
the contents were thoroughly mixed. The tubes were then transferred to a 37°C 
waterbath for 90s without agitation then immediately returned to ice for a further 30min. 
1ml of L-broth was added and tlie tubes were incubated for 1-2 hours to aUow expression 
of antibiotic resistance. Suitable aliquots were then plated onto selective plates and 
incubated overnight at 37°C.
2.7. Southern hybridisation.
DNA fi'agments from genomic DNA digests were transferred onto Hybond-N 
(Amersham, England) nylon membranes as described by Southern, (1975) with DNA 
being fixed to the membrane by baking the filter at 80°C for 2 hours. The membranes 
were blocked by incubating the membrane in prehydridisation buffer (50% v/v 
formamide, 6 x SSC, 0.5% w/v SDS, 0.1% w/v NaPPi, 5x Denhardt's ) (50x Denhardt’s 
is 1% w/v Ficoll, 1% w/v polyvinylpyrolidone, 1% w/v bovine serum albumin) for 3-4 
hours at 42°C. The prehybridisation buffer was discarded and changed to hybridisation
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buffer which was the same as prehybridisation buffer but had no Denhardt’s present. 
The radioactive probe was boiled for 5-lOmin to denature it before adding it to the 
hybridisation buffer. The membrane was hybridised at the highest possible stringency 
(42°C for homologous probes) for 12-14 hours. The membrane was then washed at 
room temperature in 2xSSC, 0.5% w/v SDS for 5min followed by a subsequent wash in 
fresh 2xSSC, 0.5% w/v SDS for 15min. The filter was given two subsequent washes in 
2xSSC, 0.5% w/v SDS for 15min followed by a stringent wash, if required (at 65°C in 
O.lxSSC, 0.1% w/v SDS for 1 hour if homologous probe). An autoradiogram was then 
set up using two intensifying screens and left overnight at -70°C.
For heterologous probing experiments, prehybridisation was done in 6 xSSC, 
5xDenhar'dt’s, 0.1% w/v NaPPi, 0.5% w/v SDS at 50°C. Hybridisation was done in the 
same buffer without Denhardt’s. Washes of the membranes were done as above with the 
most stringent wash at 50°C in IxSSC, 0.25% w/v SDS.
2.7.1. Radioactive labelling of DNA.
Specific fragments of DNA that were used as radioactive probes were labelled to high 
specific activity using a Megaprime DNA labeUing kit (Amersham, England). The 
method used was essentially as described in the manufacturers protocol. The subsequent 
labelling reaction was performed after melting the agarose containing the DNA witliout 
fmther purification.
The radioactive probe was purified to remove unincorporated nucleotides using a 
Sephadex-100 mini-column. This was prepared by filhng the base of a 1ml syringe 
barrel, to a depth of roughly 1cm, with siliconised glass wool. The syringe barrel was 
filled with a solution of Sephadex-100 such that the top began to dry. The syringe barrel 
was then centrifuged at 3,000g for 3min and 100|il of TE added before centrifuging at 
3,000g for 3min. Another addition of lOOpl TE was made and the centrifugation 
repeated. The radioactive probe, made up to a volume of lOOql, was added to the 
column and centrifuged for 3min at 3,000g with an Eppendorf tube placed underneath to 
collect the labelled DNA. Iql of the labelled DNA was counted in a scintillation counter.
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2.8. Expression in pTB361.
The expression plasmid pTB361 is a cer, tet^, plasmid which contains a consensus T7 
promoter immediately upstream from a multiple cloning site (Figure 2 .1). The plasmid 
was obtained from Dr. Peter Barth, Zeneca Pharmaceuticals and its use is described in 
Brockbank & Barth (1993).
Ndel
,KpnI
,B g in
,NsiI
/Xhol
BamHI
Clal
EcoRV
pTB361
4453Sail
Figure 2.1. Map of the expression vector pTB361 showing its main 
features. The T7 promoter is located immediately upstream from the Ndel restriction 
site which marks the start of the multiple cloning site.
A number of host E. coli strains were used during studies on the expression of genes 
using the T7 expression plasmids. Initially JM109(DE3) (Promega, USA) was used, 
however, BL21(DE3) and HMS174(DE3) were found to give better expression. These 
latter strains were also used in conjunction with the pLysS and pLysE plasmids.
Materials and Methods 35
The inclusion of die gene for T7 lysozyme (which binds and inhibits T7 RNA 
polymerase) on plasmids pLysS and pLysE provides a means of controlling the basal 
levels of expressed protein prior to induction with IPTG. pLysE provides higher levels 
of T7 lysozyme by virtue of having the T7 lysozyme gene expressed from a tet promoter 
and thus lower basal levels of the target mRNA. The pLysS plasmid has the T7 
lysozyme gene inserted in the inverse direction to the tet promoter producing lower levels 
of enzyme and allowing gieater mRNA production (Studier & Moffat, 1986). These 
plasmids are compatible with pTB361 and confer chloramphenicol resistance. These host 
sti’ains offer a number of advantages over the JM109(DE3) sti'ain, notably BL21(DE3) is 
ompT, Ion and HMS174(DE3) is ompT which may help to circumvent proteolysis during 
purification. The lysozyme produced from the pLysS and pLysE plasmids is sufficient to 
enable lysis with either freeze-thaw or mild Triton treatment.
For expression 20ml of an overnight culture was grown in LB with glucose plus 
antibiotic(s). 50ml of fresh LB with glucose plus antibiotic(s) was then inoculated with 
5ml of overnight culture and grown to an OD^oo of 0.7-1.0 The culture was then made 
0.4mM with respect to IPTG and grown for a further 4-5 hours removing 1ml samples at 
time-points. The ODgoo of the samples were measured and then they were centrifuged at 
full speed for Imin in a microcentrifuge. The cells were resuspended in lOfXl of sample 
buffer for every 0.1 OD unit and boiled for 5min before loading 20pl per well for a large 
gel or 5|il for a mini-gel.
To detennine whether the overexpressed protein was soluble a sample of cultum was 
pelleted by centrifugation and resuspended in a half final volume of TE buffer pH7.2. 
100|ig/ml of lysozyme was added and the cells incubated for 15min at 37°C. An equal 
volume of 2x sample buffer was added before centrifuging for 2min at full speed. The 
supernatant was then caiefuHy removed and set aside and the pellet resuspended in a 
volume equal to the supernatant of sample buffer and both samples were boiled for 5min 
before loading.
2.8.1. Expression for protein purification
Large scale growth of bacteria for subsequent enzyme purification was accomplished by 
glowing 500ml cultuies in 21 flasks in a flat-bed box shaker at 37'’C. Typically 25-50ml 
of overnight culture was inoculated into 500ml of LB containing 0.4% w/v glucose and 
appropriate antibiotics. Growth for 2 hours at 37° C was usually sufficient before 
induction with 0.4mM IPTG and growth for a further 4-5 hours at 37°C was sufficient
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for expression Plasmids were tiansformed into E. coli expression strains prior to 
growth of cells for expression. This was required because of the low stability of the 
plasmids on storage..
2.9. 1DE3 lysogenization of E. coli GLW40.
The site specific integi*ation of the A,DE3 prophage into the chromosome of E. coli 
GLW40 was achieved using a commercially available 1DE3 lysogenization kit (Novagen 
Inc., Madison, WI). The production of GLW40(DE3) obviates the problem of having E. 
coli chorismate synthase present during purification of the S. aureus chorismate synthase 
as the lysogenized host was used to express target genes cloned into the T7 promoter 
vector, pTB361.
Lysogenization was accomplished in a three way infection with XDE3, the helper phage, 
BIO, and the selection phage, B842. A.DE3 cannot integrate into or be excised from the 
chromosome due to a defective int gene. The helper phage provides tlie int function that 
^DE3 lacks but cannot foim a lysogen by itself as it has a defective cl gene. The 
selection phage kills a major class of A.DE3 host range mutants that otherwise would be 
among the surviving cells but can neither integi^ate into susceptible cells (c/") nor kill 
1DE3 lysogens as it has the same immunity.
Specifically, lysogenization was achieved as follows. E. coli GLW40 was grown at 
37°C to an ODgoo of 0.5 in LB supplemented with 0.2% w/v maltose, lOmM MgS04. 
5)0.1 of 1DE3, 3)0.1 of helper phage, and 3)0l of selection phage were mixed with 7)0,1 of E. 
coli GLW40 and incubated at 37°C for 20min to allow the phage to adsorb to the host. 
The cells were then plated onto LB plates and incubated at 37 °C overnight. XDE3 
lysogens were screened by thefr ability to express chorismate synthase from pM3H7EX2.
2.10. Polyacrylamide gel electrophoresis
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was 
peifoiTned essentially as described by Laemmli (1970). 3% stacking and 10% separating 
gels were routinely run in buffer comprising Tris-HCl (3gl'l), Glycine (15gk^), and SDS 
(lgl"l). Samples were denatured by boiling for 5min after dilution in loading buffer 
comprising 60mM Tris-HCl pH6.8, 2% w/v SDS, 20% v/v glycerol, 10% v/v B~ 
mercaptoethanol and 0.0025% w/v bromophenol blue.
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2.10.1. Protein staining.
Protein was visualised on polyacrylamide gels after staining with Coomassie blue. The 
Coomassie reagent was prepared with 0.1% (w/v) Coomassie brilliant blue R-250 in 
10% (v/v) glacial acetic acid, 25% (v/v) methanol. Destaining was performed with 
several changes of a 10% (v/v) glacial acetic acid, 10% (v/v) methanol solution.
2.11. Electroblotting proteins onto FVDF membranes.
A conventional 10% SDS-polyacrylamide gel was poured and 'aged' overnight at 4°C. 
Prior to electrophoresis the top buffer tank was made O.lmM with respect to sodium 
thioglycollate (a free-radical scavenger). Both of these measures were designed to 
reduce the risk of N-terminal blockage of the protein. Proteins were electroblotted by a 
modification of the method of Matsudaira, (1987) onto polyvinylidenefluoride (PVDF).
The gel was trimmed using a scalpel blade and soaked in 400ml of electroblotting 
buffer (lOmM CAPS/KOH pHl l ,  10% v/v methanol) for 30min. The mats and twelve 
pieces of Whatman No,3 paper, of approximately the same size as the mats, were 
soaked in electroblotting buffer. PVDF (Problott, Applied Biosystems) membrane was 
pre-treated by soaking in 100% methanol for a few seconds followed by 50% v/v 
methanol before leaving in electroblotting buffer. A BIO-RAD Trans-Blot 
electrophoresis transfer cell was connected with the cassette prepared as follows:
— cassette /paper /mat /paper/ gel /PVDF /paper /mat /paper /cassette + < —
The gel was electroblotted at lOOV constant voltage for 90min at 4°C. After transfer the 
cassette was dismantled and rinsed with deionised water for 5min followed by methanol 
for a few seconds. The PVDF was stained using Coomassie blue (0.1% w/v Coomassie 
R-250 in 50% v/v methanol) for 30sec and immediately destained in 50% v/v methanol, 
10% v/v acetic acid. Destaining was done for only 3-4min to minimise acid hydrolysis. 
PVDF was rinsed in several changes of distilled water and air dried overnight.
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2.12. Western blotting and immunoblotting.
Samples were separated on a 10% polyacrylamide gel. Afterwards the gel was rinsed in 
distilled water before setting up a blot similar to blotting onto PVDF (described above) 
except blotting onto nitrocellulose membrane (0.45 pM, Schleicher & Scbuell). After 
transfer the nitrocellulose membrane was blocked overnight with BIB (25mM Tris-HCl 
pH7.2, 12.5mM NaCl) and Tween 20 (0.5% v/v)(BIB+T). The nitrocellulose was 
incubated in 100ml of BIB+T containing 1% v/v polyclonal rabbit anti-chorismate 
synthase antibody raised against denatured enzyme and 5% v/v polyclonal donkey 
serum (SAPU) for 90 min at 23“C. This was followed with 4 washes in 100ml of 
BÏB/T then 1 wash in BIB, each for 12min each. The nitrocellulose was then incubated 
in 100ml of 0.5% donkey anti-rabbit horse-radish peroxidase conjugated IgG (SAPU) 
for 90min at 23 °C. This was followed by 4 washes in BIB over 1 hour. The membrane 
was developed with a 5min wash with 1-chloronapthol solution.
2.13. Mutagenesis of chorismate synthase.
The mutation which was to be attempted was the conversion of tyrosine 121 of the S. 
aureus chorismate synthase to either phenylalanine or alanine. Tyrosine 121 
corresponds to tyrosine 130 in the multiple sequence lineup (Figure 3.6).
Primer Sequence Length
CHOR 34 5'g g c a t a t g a g a t a c c t a a c a t c a g g a 3' 26
CHOR 35 5'g GAGATCTTAAAACTCAATATTTAATTG3' 28
CHORY36F 5'g g c g g t a t g a a a t t t a a t c a t c g t g a c t t a c g 3’ 32
CHORY37F 5'c g t a a g t c a c g a t g a t t a a a t t t c a t a c c g c c 3' 32
CHOR Y3 8 A 5'g g c g g t a t g a a a g c t a a t c a t c g t g a c t t a c g 3’ 32
CHORY39A 5'c g t a a g t c a c g a t g a t t a g c t t t c a t a c c g c c 3' 32
Table 2.5. Primers designed for mutagenesis of the aroC gene.
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Figure 2.2. Site-directed mutagenesis strategy using PCR, based on the method of 
Higuchi et al. (1988).
The protocol followed was similar to that described in Higuchi et a l,  (1988). Primary 
PCR reactions were set up as illustrated in Figure 2.2 using Vent polymerase. The 
standard Vent PCR reaction protocol was followed as described in 2.3.2 using 100 
pmol of the primers CHOR 34 + CHOR Y36F, CHOR 35 + CHOR Y37F, CHOR 34 + 
CHOR Y38A or CHOR 35 + CHOR Y39A with 30 cycles at 94°C for Imin, 50°C for 
Imin and 72°C for 50sec. 2mM and 3mM MgSO^ both gave identical results.
The PCR products obtained from the reaction were excised from an LMP gel to remove 
the primers and existing template. The DNA was cleaned up using phenol/chloroform 
extraction and around lOOng of each PCR moiety was added to a second PCR reaction. 
This contained lOOpmol of primers CHOR 34/CHOR 35 and the temperature profile
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used was the same as above except only 20 cycles were performed with an extension 
time of 1.75min.
The final PCR reactions were cleaned up using a Wizard PCR cleanup kit (Promega, 
USA). The purified DNA was digested with Ndel and BglU for 7.5 hours before 
cleaning up the DNA, this time with a Magic DNA cleanup kit. The DNA was finally 
ligated into pTB361 (Figure 2.1).
2.14. Purification of S. aureus chorismate synthase.
E. coli GLW40 pMJH7EX2 (13g wet weight) was thawed passively at room 
temperature and 10ml of buffer A* (20% v/v glycerol, 50mM KCl, 50mM Tris-HCl pH
7.5 at 4°C, ImM Benzamidine, 1.2mM PMSF, l,3mM EDTA, 0.4mM DTT) was 
added. The cell paste was subjected to 2 passes through a French Press at lOOOpsi and 
then made up to 80ml with buffer A*. 0.5mg of DNAsel was added and the mixture 
incubated for 30min at 4°C before spinning at 28,000g for 30min at 4_C.
A 120ml DEAE sephacel (Sigma) column (4cm i.d. x 15cm) was equilibrated with 3 
EC Vs of buffer A*. The column was loaded at 40mlhour~l with the protein and the 
column washed with buffer A* until the OD<0.3. The enzyme was then eluted with a 
gradient of 300ml of buffer A1 (20% v/v glycerol, 50mM KCl, 50mM Tris-HCl pH 7.5 
at 4°C, 1.2mM PMSF, 1.3 mM EDTA, 0.4mM DTT) and 300ml of A2 (A1 with 
500mM KCl) with 10ml fractions being collected. The pooled chorismate synthase 
activity was dialysed against 2 x 21 (3h then overnight) of buffer B1 (20% v/v glycerol, 
lOmM KPi pH6.6 @ 4°C, 0.45mM PMSF, 1.3mM EDTA, 0.4mM DTT).
A 60ml cellulose phosphate (Whatman, England) column (4cm i.d. x 15cm) was 
prepared using NaOH and HCl as instructed in accompanying literature. The cellulose 
phosphate was resuspended in 200ml of 0.5M KPi pH6.6 at 4°C and the pH adjusted 
with KOH. The column was washed with 2ECVs of buffer B1 before loading 
(2 0 m lhour'O ) the dialysed protein and then washed with buffer B1 until OD<0.3. The 
chorismate synthase activity was eluted with a gradient of 200ml of buffer B1 and 250 
ml of buffer B2 (A1 with 400mM KPi) with 5ml fractions being collected.
Chorismate synthase was concentrated using 80% w/v ammonium sulphate with 10% 
glycerol. This was then spun at 28,000g with resuspension in the minimum volume of
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50mM Tris-HCl pH7.5, 0.4mM DTT, 1.2mM PMSF and 50% glycerol for long term 
storage.
2.15. Anaerobic UV Chorismate Synthase Assay.
The assay was performed essentially as described by Ramjee et al. (1994). To begin the 
assay 20ml of buffer, 50mM MOPS, pH 7.5, lOOmM NaCl was sparged with nitrogen 
gas for around one hour. This was done in a small flask stoppered with a No. 37 
Subaseal stopper. A flushing needle (0.8mm i.d. x 70mm) was inserted into one end of 
a 30cm length of Portex tubing (0.5mm i.d.) and to the other end a second needle 
(0.4mm i.d. x 40mm) with a female luer was attached. The tubing allowed the buffer to 
be moved from the gas supply. The flask was vented by using a second needle.
Anhydrous potassium oxalate (COOK)2 [184mg] was weighed out into an eppendorf 
tube and closed with a No. 17 subaseal stopper; the solid was sparged for at least 10 
min. 1ml of the sparged MOPS buffer was added to the potassium oxalate using 
anaerobic teclinique (i.e. syringe flushed with N2 dead space in vial then flushed with 
buffer). Once the (C00K)2 was dissolved 19pl was added to the MOPS buffer.
Standard assay constituents were; 50mM MOPS pH7.5, lOOmM NaCl, ImM Oxalate, 
25pM FMN and 50pM EPSP. These were added separately using gas-tight syringes 
with 7cm needles to a sparged cuvette via a gas tap and Subaseal assembly. The cuvette 
was kept imder a stream of N2 , with venting, by a length of portex tubing which was
attached to a needle with female luer fitting. The other end of the tubing was inserted 
into a needle which was inserted through the Subaseal.
The FMN was photochemically reduced using a Schott LK l 500 microscope lamp at full 
power setting for 3min. The photoreduction of the flavin was calibrated 
spectrophotometrically at 445nm. The cuvette was equilibrated at 25 °C and assays 
were initiated with the addition of enzyme.
2.15.1. Preparation of EPSP from its barium salt.
EPSP was available in the laboratory as the barium salt, Ba2(EPSP).2H20 (Gibson, 
1970). For assays this was converted to the potassium salt by first dissolving the 
barium salt in distilled water and adding an equal volume of lOOmM potassium
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sulphate. After a few minutes the sample was spun at full speed in a microfuge and the 
supernatant collected. The concentration of the substrate was ultimately determined 
spectrophotometrically by enzymatic conversion using 8275-263 OM-i cm-h
2.16. Electrospray mass spectrometry.
Mass spectrometry was performed on a YG platform quadropole mass spectrometer 
fitted with a pneumatically assisted electrospray source and controlled using the VG 
Mass-Lynx software (VG Biotech. Ltd, Altrincham, Cheshire, UK). The carrier solvent 
(1:1 (v/v) acetonitrile/water) infusion was controlled at a flow rate of lOpl/min using a 
Harvard syringe pump (Harvard Apparatus, South Natic, MA, USA). Capillary 
voltages were between 2.8 and 3.2kV, extraction cone voltages 20-30V and the 
focusing cone voltage offset by +10V. The source temperature was set at 65°C and the 
nebulising gas flow at 10 Ihour-f Lens stack voltages were adjusted to give maximum 
ion currents. Before use the instrument was calibrated over the molecular weight range 
of the protein of interest with horse heart myoglobin (Sigma).
Desalting of samples was carried out before analysis using Centricon-10 filtration units 
and HPLC grade water with concentration by centrifugation. For analysis samples were 
diluted with an equal volume of 4% (v/v) formic acid in acetonitrile and 10-20 pi 
aliquots were injected directly into the carrier stream. The MaxEnt deconvolution 
procedure was applied for quantitative analysis of the raw data using 1 .ODa peak width 
and 1 Da/channel resolution,
2.17. Stopped-flow spectrophotometry
Stopped-flow experiments were performed at the University of Sussex, and were 
carried out using a Hi-Tech Scientific SF-51 stopped flow spectrophotometer (Hi-Tech 
Ltd, UK) installed and operated in an anaerobic glove box as described previously 
(Ramjee, 1992). The apparatus was temperature controlled at 25°C using a C-400 
Thermostatted Liquid Circulator (Techne, UK). Spectra of reaction intermediates were 
obtained using a Hi-Tech Scientific MG-6000 rapid-scanning photodiode array coupled 
to the stopped-flow sample handling unit. Rapid scanning experiments were carried out 
using a Xenon lamp with a 20mm slit width and single wavelength experiments were 
carried out using a Tungsten lamp with a 1.8nm slit width. Kinetic data was fitted 
using the Hi-Tech Scientific lS-2 v2.3b0 software.
9/HI
Materials and Methods 43
A lOOpl volume from each syringe was mixed (200[xl final volume) with one syringe 
containing 40pM EPSP in 50mM Mops pH 7.0, lOOmM NaCl and the other syringe 
containing 40pM chorismate synthase, 40pM FMN and either ImM potassium oxalate 
or sodium dithionite in the same buffer. Where potassium oxalate was used as the 
reductant, FMN was reduced photochemically using a Schott LK l 500 for 3min before 
the syringes were loaded. Glycerol concentrations were maintained at equality between 
the two syringes to minimise mixing problems. The glove box was operated and 
maintained at -Ip p m  oxygen concentration using nitrogen gas as described previously 
(Ramjee, 1992).
2,18. Purification of K  coli flavin reductase.
The protocol for purification of E. coli flavin reductase was based upon the procedure 
previously described by Fontecave et al. (1987), with a number of modifications. In 
particular, DEAE-Trisacryl was substituted by DEAE-Sephacel followed by phenyl 
sepharose chromatography. ACA 54 gel filtration chromatography was replaced with 
S-200 gel filtration chromatography and succeeded the phenyl sepharose step. The final 
FPLC protocol was omitted and glycerol was included in all purification buffers.
14g (wet weight) of E. coli BL21(DE3)pLysEpFREX2 was thawed passively at room 
temperature and resuspended in 20ml of ice cold buffer A (20% glycerol, 50mM 
HEPES pH8, 1.3mM EDTA, 0.4mM DTT, 1.2mM PMSF, ImM benzamidine). The 
cells were lysed with three passes through a French press at 1,000 psi. The crude 
extract was made up to 80ml with buffer A before adding 0.5mg of DNAsel and stirring 
on ice for 30min. The extract was clarified by centrifuging at 16,000rpm (Sorvall SS- 
34) for 45 min and the supernatant was loaded at 40mlhour'l onto a 50 ml DEAE 
sephacel (Sigma) column (4cm i.d. x 15cm) pre-equilibrated with buffer A. The 
column was then washed with approximately 12 column volumes of buffer A before 
eluting the protein with a gradient of 300ml each of buffer A and buffer A2 (buffer A 
but 300mM NaCl) with 10ml fractions collected.
The pooled fractions containing flavin reductase were made 0.5M with respect to KCl 
by adding solid KCl. The pool was then loaded at 20mlhour"l onto a 25ml phenyl 
sepharose CL-4B (Sigma) column (4cm i.d. x 15cm) pre-equilibrated with buffer B 
(20% glycerol, 50mM Tris-HCl pH7.5, 0.4mM DTT, 1.3mM EDTA and 1.2mM 
PMSF) containing 0.5M KCl. The column was washed with a gradient of 150 ml each 
of 0.5M-0M KCl buffer B before finally eluting the enzyme with a step of buffer B*
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(lOmM Tris HCl pH7.5, 0.4mM DTT, 1.3mM EDTA and 1.2mM PMSF) with 5ml 
fractions being collected.
The enzyme was precipitated using ammonium sulphate and was then resuspended in 
10% glycerol, 50mM Tris-HCl, 0.4mM DTT. The enzyme was loaded at lOmlhour"^ 
onto a 350ml S-200 gel filtration column (2cm i.d. x 1100cm) previously equilibrated 
with buffer C (10% glycerol, 50mM Tris-HCl pH7.5, 0.5M KCl, 0.4mM DTT). The 
column was run in buffer C and 5ml fractions collected. The enzyme was stored in 
buffer C with the inclusion of glycerol to 50% for long term storage.
2.19. Flavin reductase assay.
E. coli flavin reductase was assayed as described previously by Fontecave et al. (1987) 
except that a unit of activity was changed to correspond to the oxidation of 1 pmol of 
NAD(P)H per min rather than Inmol per min. The amount of activity obtained here 
was several orders of magnitude greater than has previously been obtained. Activity 
was assayed by following the time-dependent disappearance of NAD(P)H absorbance at 
340nm. Assays were performed in a 1ml, 1cm path length cuvette containing 50mM 
Tris-HCl pH7.5, 0.25mM NAD(P)H and 3pM riboflavin. Incubation was made in air 
and at room temperature. Oxidation of NAD(P)H was calculated from the slope of the 
recorded change with one unit of activity corresponding to the oxidation of 1 pmol of 
NADPH (E34o=6200M"icm'i) per min under the above conditions with specific activity
as units per mg of protein.
2.20. BIAcore of E. coli flavin reductase and E. coli chorismate synthase.
Possible interactions between E. coli flavin reductase and E. coli chorismate synthase 
were investigated using a BIAcore 2000 instrument essentially as described in the users 
manual. The BIAcore instrument enables one particular enzyme to be immobilised to a 
sensor chip allowing the interaction of a second enzyme with the first to be measured. 
This is made possible by immobilising the first enzyme to carboxyl groups which have 
been activated in the presence of a mixture of succinimide (NHS) and carbodiimide 
(EDC) to form active esters which react spontaneously with amine groups on the 
enzyme. Interaction of the second enzyme with the first is measured by changes in 
refractive index close to the surface of the sensor chip. These experiments were 
performed in collaboration with Mr. Tino Krell, University of Glasgow.
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For the assay E. coli flavin reductase Avas immobilised onto the pre-activated sensor 
chip in coupling buffer consisting of 50mM NaAc pH4.2. 5 pi of the flavin reductase 
(1.3mgml"l) in 50mM MOPS pH7.5 was mixed with 95pl HBS coupling buffer and 
3 5 pi loaded into the machine at a flow rate of 5plmin"h Interaction was tested using E. 
coli chorismate synthase. 25pi of 7.7mgml“l enzyme in 50mM MOPS pH7.5 was 
diluted in 800pi of HBS coupling buffer and lOpl was loaded with a flow rate of 
5plmin~l- The interaction of chorismate synthase with flavin reductase was also tested 
in the presence of 50pM FAD 50pM EPSP, or 50pM NADH,
The order of the interaction was also altered such that the E. coli chorismate synthase 
was immobilised and interaction of the flavin reductase measured. In this case 50pM 
EPSP and 50pM FAD were included throughout to counteract the problem of 
precipitation.
2.21. Chemical cross-linking.
Cross-linking of chorismate synthase was achieved using dimethyl-suberimidate. 
Typically, 50pl of 2mg/ml enzyme was added to 50pl of freshly prepared cross-linking 
solution. Cross-linking solution was prepared by adding 4ml of 0.5M Triethanolamine 
pH8.0, 800pi of IM  NaOH and 109mg dimethyl-suberimidate made up to 10ml with 
0.4MNaCl.
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CHAPTERS. THE MOLECULAR CLONING AND SEQUENCING 
OF THE AROC  AND THE NDK  GENES, AND EVIDENCE FOR THE 
PRESENCE OF THE GERCC GENES UPSTREAM FROMADÆ
This chapter details the cloning and sequencing strategy used for isolating the aroC 
gene, encoding chorismate synthase, from Staphylococcus aureus. Sequence 
comparisons of the gene and the encoded protein are presented together with details 
of other genes which were isolated during the cloning of the aroC gene.
3.1. Cloning of the aroC gene.
Chromosomal DNA from S. aureus 601055 was digested with a number of 
restriction enzymes and blotted onto Hybond-N membrane. The blot was probed 
with a 350bp EcoBl-HindSi DNA fragment from the plasmid, pCOC102, which 
contains part of the aroC gene. This plasmid also contains the complete aroA and 
aroB genes from S. aureus 8325-4 (O'Connell et a l, 1993). A 5.5kb Clal fragment 
was observed after hybridisation (Figure 3.1) and from examination of the restriction 
map around the aroA region sequenced by O' Connell et al. (1993) was expected to 
contain the complete aroC gene. A plasmid library was therefore prepared by 
ligating Clal digested chromosomal DNA into Clal cut pBluescript.
The 5.5kb Clal restriction fragment was cloned using its ability to complement the 
Aro" phenotype of the aroC strain of E. coli, GLW40. The Clal library was 
transformed into E. coli GLW40 and the cells were plated directly onto minimal 
medium agar containing the appropriate supplements (Table 2.3). 12 colonies were 
obtained after incubation of the plates for 40 hours at 37°C. Small-scale plasmid 
isolations from each of the 12 colonies revealed the presence of plasmid containing a 
5.5kb Clal fragment and which produced identical restriction patterns following 
digestion with EcoBJ/HindlJl. One of the 12 clones was picked and the isolated 
plasmid, pMJH701, used to confirm the presence of the aroC gene by transformmg 
E. coli GLW40 again and plating the cells onto minimal medium agar. As expected, 
many colonies were now visible after incubation for 40 hours at 37°C. The plasmid 
pMJH701 was similarly shown to complement the Aro“ phenotype of the aro A strain 
o f E. coli, AB1321. The complete coding region for aroA, the gene for 5- 
e/2o/pyruvylshikimate 3-phosphate (EPSP) synthase is also contained within the 
5.5kb Clal fragment.
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M 1 2 3 4 5 KB
1.6 -
Lane M: DNA markers. 
Lane 1 : Accl digest 
Lane 2: C/al digest. 
Lane 3: HindlU digest. 
Lane 4: Ndel digest. 
Lane 5: digest.
Lane M 
Lane 1 
Lane 2 
Lane 3 
Lane 4 
Lane 5 
Lane 6 
Lane 7 
Lane 8 
Lane 9
: DNA markers. 
Sacl-Sa/Î digest. 
Sad digest.
Ndel-Accl digest. 
Accl digest. 
AccI-BamHl digest. 
Kpnl-BamHl digest. 
EcoRl-C/al digest. 
Clal digest. 
Clal-BamHI digest.
Figure 3.1. Southern blots of S. aureus 601055 DNA probed with the 350bp 
EcoRI-FfmdlH aroC fragment from S. aureus 8325-4.
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■Accl
Hindin
EcoRV
AcclPMJH701
8.5kb PstI
PstI
EcoRVEcoRI
EcoRV EcoRV
Hindm. EcoRV
AcclClal
Ndeli PstI
EcoRV Hindin
Figure 3.2 Schematic diagram of plasmid pMJH701 showing restriction sites.
3.1.1. Restriction mapping of pMJH701.
Plasmid pMJHTOl was mapped with a number of restriction enzymes. Similarities 
were observed between pMJH701 and pCOC102 with respect to the position of 
many restriction enzyme sites although some differences were observed and are 
likely to be the result of strain differences. The similarities in the maps meant that 
the location of the aroC gene could be deduced with some degree of certainty.
3.1.2. Subcloning of pMJH701.
Plasmid pMJHTOl (Figure 3.2) was subcloned to produce a number of plasmids for 
sequencing with the polylinker sequencing primers SK and KS (Stratagene) and 
primers designed from pUC lS sequence. A 2.5kb Ndel-Clal fragment from 
pMJHTOl was cloned into Ndel-Accl digested pUClS to produce pMJH702 (Figure 
3.4) and a 2.2kb Eco'Rl-Clal fragment from pMJH701 was cloned into EcoBl-Clal 
cut pBluescript producing pMJH703. Plasmid pMJH703 was subcloned further by
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digesting the EcdRl-Clal insert with Dral and four of the resulting fragments were 
purified and cloned into Smal digested pBluescript to produce pMJH706, pMJH707, 
pMJH708 and pMJH709, In addition, 1.4kb EcoRM -Sall and 1.6kb N sil-Sall 
fragments from pMJH701 were cloned into pBluescript and pGEM5, respectively, to 
produce plasmids pMJH710 and pMJH711, The variety of subclones produced may 
be of use for gene replacement work for the aroC gene similar to that performed by 
O'Connell et al. (1993) for the aro A gene.
3.1.3. Sequencing of plasmids and oligonucleotide primers.
The subclones produced were sequenced from each end using the appropriate primer 
derived from vector sequences. From the information generated it was determined 
that the entire aroC  gene would reside completely within the 2.5kb Ndel-Clal 
fragment of pMJH702 and consequently the complete sequence of pMJH702 was 
determined. Synthetic oligonucleotide primers spaced around 250bp apart along the 
template and based on previously sequenced regions were produced to complete the 
sequence of pMJH702 on both strands.
PRVÇ N H  RV H P  A RV Ry N  E A R y  H ÇI I I  I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I
^         ^    ^ . . . .
aroA aroB aroC ndk gerCC
4 ................       — ........ Ill....................................  ►
pMJH7014 ................................       ►
pMJH702
Figure 3.3. Schematic diagram showing the 5.5kb Clal fragment cloned into 
pMJHTOl and the locations of the putative encoded proteins. The locations of 
the aroA and aroB genes are included using the similarity in restriction maps 
generated from pCOC102 (O'Connell et at., 1993) and that of pMJH701. The 
locations of the aroC, ndk and partial gerCC genes were obtained from sequencing. 
Restriction enzymes are abrreviated: A, Accl; C, Clal\ E EcoBJ; RV, EcoRV; H, 
Hindm; N,Ndel; P,Psth
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3.1.4. Sequencing of pMJH702.
The DNA sequence together with the deduced amino acid sequence of the encoded 
proteins is shown in Figure 3.5. Two complete open reading frames (ORFs) were 
located by DNA sequencing. The predicted polypeptide from the larger of the two 
ORFs consisted of 388 amino acids and was 61% identical to the aroF gene product 
of B. suhtilis and 37% identical to the aroC gene product from E, coli. The second 
complete ORF is situated some 500 base pairs upstream from aroC and the predicted 
polypeptide from this consisted of 149 amino acids and had 62% and 45% homology 
with the ndk gene products from B. subtilis and E, coli, respectively.
Hindin
EcoRI
gerCC
PMJH702 
4.9kb
EcoRV
EcoRI
Figure 3.4. Schematic diagram of plasmid pMJH702 showing restriction sites 
and relative locations of genes (gerCC 1-132, ndk 224-673, aroC 1142-2308, aroB 
2343-2501).
Contained within the 2.5kb of DNA sequenced in pMJH702 are two partial ORFs. 
Situated 25bp downstream from the TAA stop codon of aroC is the 5' end of an ORF 
(Figure 3.9) which has similarity with the aioB  gene of B. subtilis. The aroB gene 
of B. subtilis encodes dehydroquinate synthase, the second enzyme of the shikimate
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pathway. The 3' end of the second partial ORF immediately precedes the ndk gene 
and the translated product from this has similarity with the putative gerCC gene 
product from B. subtilis (Figure 3.10).
Immediately upstream from both the aroC and ndk genes are putative promoter 
sequence elements. These regions -66 to -42 ATGAAT (18 bases) T ATT AT and -63 
to -47 TTGAAA (17 bases) TAATAT, respectively are similar to the E. coli 
subtilis (J^ promoter sequence. The codon usage pattern for the sequenced
genes is strongly biased toward A- or U-rich codons, reflecting the relatively low 
G+C content of S. aureus DNA. The value of 33% for the 2.5kb sequenced region 
matches the value of de Ley (1970) for the S. aureus chromosome. Work with E. 
coli and B. subtilis has demonstrated a likely correlation between expression level of 
a gene and its codon usage pattern (Grantham et a l, 1981; Ikemura & Ozeki, 1983). 
More highly expressed genes display a non-random pattern of codon usage, utilising 
a restricted set of codons that are recognised by the major species of isoacceptor 
tRNAs, unlike genes expressed at low levels which display a random codon usage 
pattern. The codon AUA (isoleucine) which is rarely used in highly expressed genes 
in E. coli and B. subtilis is biased against in the ndk gene (0 of 12) but is present in 
aroC (5 o f 35). Fitting in with this data is the fact that Ndk is known to be a highly 
expressed protein in contrast to chorismate synthase. Ignoring methionine (AUG) 
and tryptophan (UGG) for which there are only single codons, an A or U is found in 
the wobble (3 ') position of a codon 84% of the time in the sequenced genes.
3.2. Comparison of chorismate synthases.
Chorismate synthase from S. aureus was compared with the sequences of other 
chorismate synthases using the PILEUP program of the GCG package (Figure 3.6) 
and a consensus sequence was produced. A dendrogram was created using the same 
program (Figure 3.7) and revealed that the chorismate synthase sequences were 
divided into two groups, the first containing the Gram-positive bacterial sequences 
and the second group containing the other bacterial, plant and fungal sequences.
Figure 3.5. Complete nucleotide sequence of pMJH702 and deduced amino acid 
sequence of encoded proteins. The putative promoter -35 and -10 regions, 
ribosome binding sites and protein translations are indicated. Regions of amino acid 
sequence which have been confirmed fi-om protein sequencing experiments are 
imderlined. Nucleotides are numbered fi*om the first base of the Accl/Clal combined 
site of the 2.5kb Ndel-Clal fragment in pMJH702.
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1 ATCGATGAAGCTAAGGCAGTAAGTTCGAAGTATCTAAGTAAAGCTTTGGA 
I D E A K A V S S K Y L S K A L D
51 TTTGATTTCTGAGTTGCCAGATGGACATCCAAAATCACTACTTTTAAGTT 
L I S E L P D G H P K S L L L S L
101 TGACGAAAAAAATGGGGTCAAGAAACACATAGTATTTATGAAAAGTATTG 
T K K M G S R N T  •
   - 1 0 __
151 AAAGCGCTTTACCAACCTGTTAATATATAATAGTAATATACATAAACCTA
____________  n dk
2 01 TTAAACACAGGGGGATACATAAAGTGGAACGTACATTTTTAATGATTAAAM E R T F L M I K
251 CCAGACGCAGTACAAAGAAATCTAATTGGTGAAGTAATTTCAAGAATTGA 
P D A V Q R N L I G E V I S R I E
3 01 AAGAAAAGGACTAAAACTTGTCGGTGGTAAATTAATGCAAGTACCAATGG
R K G L K L V G G K L M Q V P M E
3 51 AACTTGCTGAAACACATTATGGTGAACACCAAGGTAAACCATTTTATAAT 
L A E T H Y G E H Q G K P F Y N
401 GATTTAATTTCATTTATTACATCAGCACCAGTGTTCGCAATGGTAGTTGA 
D L I S F I T S A P V F A M V V E
451 AGGTGAAGATGCAGTTAATGTATCTAGACATATTATTGGCAGCACCAATC 
G E D A V N V S R H I  I G S T N P
501 CTTCAGAAGCTTCACCAGGATCAATTAGAGGTGATTTAGGTTTAACTGTT 
S S A S P G S I R G D L G L T V
551 GGTAGAAATATCATTCACGGTTCAGATTCATTAGAGTCTGCTGAACGTGA 
G R N I I H G S D S L E S A E R E
601 AATTAATTTATGGTTTAATGAAAATGAAATTACTAGCTATGCTTCACCAC 
I N L W F N E N E I T S Y A S P R
651 GTGATGCTTGGTTATACGAATAAAATATAAGCTATAAATCTTTCTGATTT 
D A W L Y E *
7 01 ATAAAAGGAAAAAGGGTTTTGTTATGTGGTTAGTGATTGATGACCATTCA
7 51 TAACAAAGCCCTATTTTTATACGGACTGATTAACTTTATAAAAAATAATC
801 AGTCCATTTTCTTTTATTTAAAGAAATATAGCTTGTATATTATTTATTCG
851 TGGTTAGCTACGATTATATGCGGTATAAGTTGTTCGAATAAATTTTAAAT
9 01 TTTCAAATGGTTGTTTAAACAATCTAACAATATTAGAAATTCATAATACT
951 TTTCTCGTTGTGAATATATTATAATGAATCTTAGTTCGTTTAATATTAAG
1001 ATAATTCTGACATTTAAAAAGAGATATAAATCAATTTCTTAATTGAGCTT
 - 35 ,
1051 GAAAACAAACATTTATGAATGCACAATGAATATGATAAGATTAACAACAT
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-10   aroC
1101 ATTATAATGTTATCGTGGAAGTATGAAAGGAGCGAG'TGTGTATGAGATAC
M R Y
1151 CTAACATCAGGAGAATCACATGGACCTCAATTAACAGTTATTGTTGAAGG 
L T S __G E S H G P O L T V I V E G
1201 TGTACCTGCAAATTTAGAAGTTAAGGTTGAGGATATTAATAAAGAAATGT 
V P A N L E V K  V E D I N K E M F
1251 TTAAGCGTCAAGGCGGTTACGGACGTGGACGTCGTATGCAAATTGAAAAA 
K R Q G G Y G R G R R M Q I E K
13 01 GATACAGTGGAGATTGTTTCGGGTGTAAGAAATGGTTATACATTAGGTAG 
D T V E I V S G V R N G Y T L G S
1351 CCCTATTACAATTGTTGTTACTAATGATGATTTTACACATTGGCGAAAAA 
P I T I V V T N D D F T H W R K I
1401 TTATGGGGCGTGCGCCAATAAGCGACGAAGAACGAGAAAATATGAAACGT 
M G R A P I S D E E R E N  M K R
1451 ACAATTACGAAGCCAAGACCGGGACATGCAGATTTACTTGGCGGTATGAA 
T I T K P R P G H A D L V G G  M K
1501 ATATAATCATCGTGACTTACGAAATGTATTAGAACGTTCATCTGCCAGAG 
Y N H R D L R N V L E R S S A R E
1551 AAACAGCAGCACGTGTAGCGGTCGGTGCACTATGCAAAGTTTTATTAGAA 
T A A R V A V G A L C K V L L E
1601 C AATTAGATATCGAAATATACAGTCGTGTTGTTGAGATAGGTGGCATTAA 
Q L D I E I Y S R V V E I G G I K
1651 AGATAAAGATTTTTATGATTCAGAAACATTTAAAGCAAACCTTGATCGAA 
D K D F Y D S E T F K A N L D R N
17 01 ATGACGTCCGTGTAATTGATGATGGCATCGCACAAGCAATGCGCGATAAA 
D V R V I D D G I A Q A M R D K
17 51 ATTGATGAAGCGAAAAACGATGGTGATTCAATAGGGGGCGTAGTTCAAGT 
I D E A K T D G D S I G G V V Q V
1801 TGTAGTTGAAAATATGCCTGTTGGTGTAGGTAGTTATGTACATTATGATC 
V V E N M P V G V G S Y V H Y D R
1851 GTAAATTAGATGGAAGAATAGCACAGGGTGTCGTTAGTATTAATGCATTT 
K L D G R I A Q G V V S I N A F
1901 AAAGGTGTAAGTTTTGGAGAAGGATTTAAAGCAGCTGAAAAGCCTGGTAG 
K G V S F G E G F K A A E K P G S
1951 CGAAATTCAAGACGAAATTCTCTACAATACTGAATTGGGCTATTATCGTG 
E I Q D E I L Y N T E L G Y Y R G
2 001 GGTCAAATCACTTAGGTGGTTTAGAAGGCGGTATGTCAAATGGAATGCCA 
S N H L G G L E G G M S N G M P
2051 ATTATCGTTAATGGTGTAATGAAACCAATTCCAACGTTATATAAACCATT 
I I V N G V M K P I P T L Y K P L
Molecular Cloning, Sequencing and Mapping 54
2101 AAATTCAGTAGACATTAATACTAAAGAAGACTTTAAAGCAACAATTGAAC 
N S V D I N T K E D F K A T I E R
2151 GTTCTGATAGTTGTGCTGTTCCTGCAGCAAGTATCGTCTGTGAACATGTC 
S D S C A V P A A S I V C E H V
22 01 GTAGCATTTGAAATTGCAAAAGCATTATTGGAAGAATTCCAATCAAATCA V A F A I A K A L L E E P Q S N H
2251 TATTGAGCAACTTAAACAACAAATTATTGAGCGCAGACAATTAAATATTG
  aroB23 01 AGTTTTAACAACAAGAACAATTGAGGTGTAATCATGAAATTACAAACAAC
23 51 ATACCCTTCAAACAATTATCCAATATATGTTGAACACGGTGCAATCAAGT
24 01 ATATAGGCACATATTTAAATCAATTTGACCAAAGTTTCTTGTTAATTGAT
24 51 GAATATGTAAATCAATATTTTGCGAATAAATTTGATGATATTTTATCATA
2501 TG
____________
Figure 3.6. M ultiple alignment of predicted amino acid sequences of chorismate 
synthases. The alignment was created using the GCG PILEUP program (Genetics 
Computer Group, 1991). Gaps were introduced by PILEUP to optimize the 
alignment using the following parameters: gap weight=3; gap length=0.1. Amino 
acids which were completely conserved are highlighted with uppercase letters in the 
row labelled CHOR. Amino acids which occurred in at least 10 of the 12 sequences 
are highlighted with lowercase letters.
bsu Bacillus subtilis
sau Staphylococcus aureus
sty Salmonella typhi
eco Escherichia coli
van Vibrio anguillarum
bin Haemophilus influenzae
les Lycopersicon esculentum
cse Corydalis sempervirens
syn Synechocystis PCC6803
see Saccharomyces cerevisiae
ncr Neurospora crassa
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lesl
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van
hin
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ncrCHOR
bsusau
sty
eco
van
hinles2
lesl
cse
syn
see
ncrCHOR
bsu
sau
sty
ecovan
hin
les2
leslcse
synsee
ncr
CHOR
1
M ........
M ........
MAGNTIGQLF 
.AGNTIGQLF 
MAGNSIGQHF 
MAGNTIGQLF 
.AGSTFGNYF 
.AGNTFGNYF 
.SGSSFGKVP 
M .GNTFGSLF 
M ..STFGKLF 
M ..STFGHYF
51
GHGRGRRMQI 
GYGRGRRMQI 
GTSRYTTQRR 
GTSRYTTQRR 
GTSRYTTQRR 
GTSRYTTPRR 
GQSRITTPRK 
GQSRITTPRK 
GQSRITTPRK 
GQSKITTPRK 
GQSKLSTPRD 
GQSAITTPRD 
G . s , ..t.r.
101
PITEDEEKEM PISDEERENM 
.QRSQDYSA 
.QRSQDYSA 
.QRSTDYSD 
.QRSQDYGD 
.QRGNDYSE .QRGNDYSE 
.QRGNDYSE 
•ARSQDYNE 
.QRPHDYSD 
.QPPKDYGN 
 d y . .
RYLTAGESHG 
RYLTSGESHG 
RVTTFGESHG 
RVTTFGESHG 
RVMTFGESHG 
RVTTFGESHG 
RVTTFGESHG 
RVTTFGESHG 
QVTTYGESHG 
RITTFGESHG 
RVTTYGESHC 
RVTTYGESHC 
r,.T.GESHg
PQLTTIIEGV 
PQLTVIVEGV 
LAVGGIVDGV 
LALGCIVDGV 
lALGCIVDGC 
lALGCIVDGV 
GGVGCIIDGC 
GGVGCIIDGC 
GGVGCVIDGC 
GGVGVIIDGC 
KSVGCIVDGV 
KSVGCIVDGV 
. . . g . i . dG.
PAGLYITEED 
■pANLEVKVED 
PPGIPLTEAD 
PPGÎPLTEAD 
PPGLEITEAD 
PPNLELSEKD 
PPRLPLSESD 
PPRLPLSESD 
PPRFPISEAD 
PPRLEISPEE 
PPGMSLTEAD 
PPGMELTEDD 
Pp.... e. d
50
INFELARRQK INKEMFKRQG 
LQHDLDRRRP 
LQHDLDRRRP 
LQIDLDRRRP 
IQPDLDRRKP 
MQVELDRRRP 
MQVELDRRRP 
IQSDLDRRRP 
IQVDLDRRRP 
IQPQLTRRRP 
IQPQMTRRRP 
.q ..1.rRrp
100
EKDQAKIMSG VRHARTLGSP lALWENNDW KHWTKIMGAA 
EKDTVEIVSG VRNGYTLGSP ITIWTNDDF THWRKIMGRA
EPDQVKILSG VFDGVTTGTS IGLLIENTD...........
EPDQVKILSG VFEGVTTGTS IGLLIENTD...........EADEVKILSG VFEGKTTGTS IGLLIENTD...........
EDDËVQILSG VFEGKTTGTS IGMIIKNGD ..........
ETDTCKÏSSG TADGLTTGSP IKVEVPNTD...........
ETDTCKISSG TADGLTTGSP IKVEVPNTD...........
ETDTCKIYSG VADGFTTGSP IHISVPNTD. .........
EADQCEILSG VFEGKTLGTP lAILVRNKD...........
EKDRVEIQSG TEFGKTLGTP TAMMÎKNED...........
EKDRVIIQSG TEFGVTLGTP IGMLVMNED...........
E.D...I.SG ...g.T.G.. I N.D...........
KRQISRPRPG 
KRTITKPRPG 
..IKDVFRPG 
..IKDVFRPG 
..IKDKFRPG 
..IKDRFRPG 
..MSLAYRPS 
..MSLAYRPS 
..MAKAYRPS 
..MAVKYRPS 
..MDKFPRPS KTMDIYPRPS 
...... RP.
HADLNGAIKY 
HADLVGGMKY 
HADYTYEQKY 
HADYTYEQKY 
HADYTYHQKY 
HADFTYQQKY 
HADATYDPKY HADATYDFKY 
HADATYDFKY 
HADATYEAKY 
HADFTYSEKY 
HADWTYLEKY 
HAD.ty..KY
NHRDMRNVLE 
NHRDLRNVLE 
GLRDYRGG.G 
GLRDYRGG.G 
GIRDYRGG.G 
GIRDYRGG.G 
GVRSVQGG.G 
GVRSVQGG.G 
GVRSVQGG.G 
GIRNWQGG.G 
GIKASSGG.G 
GVKASSGG.G 
g . r...gg.g
150RSSARETTVR 
RSSARETAAR 
RSSARETAMR 
RSSARETAMR 
RSSARETAMR 
RSSARETAMR 
RSSARETIGR RSSARETIGR 
RSSARETIGR 
RSSARETIGR 
RASARETIGR 
RSSARETIGR 
RsSARET..R
151 200
VAAGAVAKKI LSE.LGIKVA GHVLQIGAV...............KAEKTGY
VAVGALCKVL LEQ.LDIEIY SRWEIGGI...............KDK..DF
VAAGAIAKKY LAEKFGIEIR GCLTQMGDIP L..................
VAAGAIAKKY LAEKFGIEIR GCLTQMGDIP L...................
VAAGAIAKKY LKQEFGVEIR AYLSQMGDVC .1..................
VAAGAIAKKY LREHFGIEVR GFLSQIGNIK.I...............APQK
VAAGAVAKKI LKLYSGAEVL AYVSQVHQW L............. PEDLID
VAAGAVAKKI LKLYSGTEIL AYVSQVHNW L ............. PEDLVD
VAAGALAKKI LKAYAGTEVL AYVSQAHKW L............. PEGLVD
VAAGAIAKKI LAQFNGVEIV AYVKSIQDI.................EATVD
VASGAIAEKF LAQNSNVEIV AFVTQIGEIK M ...... NR DSFDPEFQHL
VAAGAIAEKY LKPRYGVEIV AFVSSVGSEH LFPPTAEHPS PSTNPEFLKL 
VAaGA.a.k, L....g.e.................................
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sty
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van
hin
les2
lesl
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syn
see
ncr
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sty
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van
hin
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ncr
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201
TSIEDLQRVT
YDSETFKANL
.EIKDWRQVE
.DIKDWSQVE
.DKVDWNEIE
VGQIDWEKVNHQNVTLEQIE
NQIVTLEQIE
HETLSLEQIE
SNTVTLEQVE
LNTITREKVD
VNSITRETVD
EESPVRCYDE 
DRNDVRVIDD 
LN.PFFCPDA 
QN.PFFCPDP 
NN.AFFCPDA 
SN.PFFCPDE 
SNI.VRCPDP 
SNI.VRCPNP 
SNI.VRCPDS 
SNI.VRCPDE 
SMGPIRCPDA 
SFLPVRCPDA 
.....cpd.
EAGKKMMAAI
GIAQAMRDKI
DKLDALDELM
DKIDALDELM
DKVAAFDQLI
SAVEKFDSLI
EYAEKMIAAI
EYAEKMIGAI
EYAEKMIAAI
ECAEKMIERI
SVAGLMVKEI
EANKRMEDLI
DEAKANGDSI 
DEAKTDGDSI 
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401ALSLGKLQPS LNNSD..... 450
sau AFAIAKALLE EFQSNHIEQL KQQIIERRQL NIEF.....
sty AIVLMDHLLR HRAQNADVKT EIPRW....eco AIVLMDHLLR QRAQNADVKT DIPRW....
van AIVLMDHLLR HRGQNFAVQT ETPKI....
hin AIVLMDHLLR FKAQCK....les2 ALVLVDQLMA QYSQCMMFPI NPELQEPLQS SPESAEVTL.lesl ALVLVDQLMT QYAQCMLFPV NLTLQEPLQP STTKSA....cse ALVLLDQLML QHAQGNLFSI NPALQEPLSE TVSSAAASLQ GV.......syn ALVLCDHLLR FQAQCKTL..
see ALVLADALLI QKARDFSRSV VH.......ncr ALVIMDAVLA HEARVTAKSL LPPLKQTINS GKDTVGNGVS ENVQESDLAQCHOR A.vl.d.l..
to
Figure 3.7. Dendrogram showing similarity among chorismate synthases from 
different organisms. The dendrogram was derived using the PILEUP program of 
the GCG package (Genetics Computer Group, 1991) with the SWISSPROT entries 
for each protein being used.
Figure 3.8. M ultiple alignment of predicted amino acid sequences of nucleoside 
diphosphate kinases. The alignment was created using the GCG PILEUP program 
(Genetics Computer Group, 1991). Gaps were introduced by PILEUP to optimize 
the alignment using the following parameters: gap weight penalty=3; gap length 
penalty=O.L Amino acids which were completely conserved are highlighted with 
uppercase letters in the row labelled NDK. Amino acids which occurred in at least 7 
of 9 of the sequences are highlighted with lowercase letters.
Eco Escherichia coli
Mxa Myxococcus xanthus
Bsu Bacillus subtilis
Sau Staphylococcus aureus
Psa Pisum sativum
Sol Spinacia oleracea
Osa Oryza sativa
See Saccharomyces cerevisiae
Ddi Dictyostelium discoideum
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3.3. Comparison of nucleoside diphosphate kinases.
Nucleoside diphosphate kinase (Ndk) from S. aureus was compared with the 
sequences of other nucleoside diphosphate kinases using the PILEUP program of the 
GCG package (Figure 3.8) and a consensus sequence was produced. The putative 
encoded Ndk from S. aureus shows a high degree of similarity with other Ndks. 
There was no obvious grouping of the Ndk sequences when a dendrogram was 
produced in contrast to chorismate synthase. This may be a consequence of the 
greater degree of conservation between the sequences.
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Eco  MAIER TFSIIKPNAV AKNVIGNIFA RFEAAGFKIV GTKMLHLTVE
Mxa ......AIER TLSIIKPDGL EKGVIGKIIS RFEEKGLKPV AIRLQHLSQA
Bsu......... MMEK TFIMVKPDGV QRQLIGDILS RFERKGLQLA GAKLMRVTEQ
Sau.......... MER TFLMIKPDAV QRNLIGEVIS RIERKGLKLV GGKLMQVPME
Psa......... MAEQ TFIMIKPDGV QRGLVGEIIS RFEKKGFYLK GLKFVNVERA
Sol ...... MEQ TFIMIKPDGV QRGLVGEIIS RFEKKGFSLK ALKFVNVDRP
Osa ...... MEQ SFIMIKPDGV QRGLIGDIIS RFEKKGFYLR GMKFMNVERS
See ...MSSQTER TFIAVKPDGV QRGLVSQILS RFEKKGYKLV AIKLVKADDK
Ddi MSTNKVNKER TPLAVKPDGV ARGLVGEIIA RYEKKGFVLV GLKQLVPTKD
NDK ........ E. tf...KPdgv .r.l.g.i,. R.E.kG..l. ..k......
51 100
Eco QARGFYAEHD GKPFFDGLVE FMTSGPIWS VLEGENAVQR HRDLLGATNP
Mxa QAEGFYAVHK ARPFFKDLVQ FMISGPWLM VLEGENAVLA NRDIMGATNP
Bsu MAEKHYAEHQ GKPFFGELVE FITSGPVFAM VWEGENVIEV TRQLIGKTNP
Sau LAETHYGEHQ GKPFYNDLIS FITSAPVFAM WEGEDAVNV SRHIIGSTNP
Psa FAEKHYADLS AKPFFSGLVD YIISGPWAM IWEGKNWTT GRKIIGATNP
Sol FAEKHYADLS AKPFFNGLVE YIVSGPWAM VWEGKGWAT GRKLIGATNP
Osa FAQQHYADLS DKPFFPGLVE YIISGPWAM VWEGKDWAT GRRIIGATRP
See LLEQHYAEHV GKPFFPKMVS FMKSGPILAT VWEGKDWRQ GRTILGATNP
Ddi LAESHYAEHK ERPFFGGLVS FITSGPWAM VFEGKGWAS ARLMIGVTNP
NDK .a..hYa... .kPFf...v. ...SgPv.am v.EG...v.. .R ..iG.TnP
101 150
Eco ANALAGTLRA DYADSLTENG THGSDSVESA AREIAYFFGE GEV. .CPRTR
Mxa AQAAEGTIRK DFATSIDKNT VHGSDSLENA KIEIAYFFRE TEIHSYPYQK
Bsu KEALPGTIRG DYGMFVGKNI IHGSDSLESA EREINIFFKN EELVSYQQLM
Sau SEASPGSIRG DLGLTVGRNI IHGSDSLESA EREINLWFNE NEITSYASPR
Psa AQSEPGTIRG DFAIDIGRNV IHGSDAVESA NKEIALWF.P EGAANWESSL
Sol LASEPGTIRG DFAIDIGRNV IHGSDAVDSA TKEIALWF.P DGWHWQSSL
Osa WEAAPGTIRA DYAVEVGRNV IHGSDSVDNG KKEIALWP.P EGLAEWRSNL
See LGSAPGTIRG DFGIDLGRNV CHGSDSVDSA EREINLWFKK EELVDWESNQ
Ddi LASAPGSIRG DFGVDVGRNI IHGSDSVESA NREIALWFKP EELLT.EVKP
NDK  GtiR. D g.N. . HGSDS......El...F............
151
Bsu AGWIY..
Sau DAWLYE
Psa HSWIYE
Sol HSWIYE.
Osa HPWIYESSee AKWIYE.
Ddi NPNLYE.
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3.4. Comparison of the N-terminal 3-dehydroquinate synthase fragment with 
sequences within the Swissprot database.
The aroB fragment located downstream from aroC was translated and compared 
with other 3-dehydroquinate synthase sequences in the Swissprot database. The 
degree of identity was found to be low. The N-terminal region of this protein would 
appear to be poorly conserved among the sequences examined. There is no doubt, 
however, that the protein is a 3-dehydroquinate synthase as the 3 ’ end of the aroB 
gene has been sequenced and shows identity with other 3-dehydroquinate synthases 
and, furthermore, a plasmid containing the region 5 ' of aroA  and 3 ' of a ro C  
complements the aroB mutation of E. coli AB2847 (O’Connell et al., 1993). The N- 
teiminal region of the S. aureus 3-dehydroquinate synthase is shown aligned with B. 
subtilis 3-dehydroquinate synthase in Figure 3.9.
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Bsu MKTLHVQTAS SSYPVFIGQG IRKKACELLT SLNRPLTRIM FVTDEEVDRL YGDEMLHLLQE
I I I  I l l * * * l  I *1 ' I I I  * '  I
Sau MK.LQTTYPS NNYPIYVEHG AIKYIGTYLN QFDQS....F LLIDSYVNQY PANKFDDILSY
Figure. 3.9. The translated product of the partial 5. aureus aroB gene aligned 
with the N-terminal region of B, subtilis 3-dehydroquinate synthase. The symbol 
(I) indicates identical amino acids and (•) indicates conserved amino acids.
3.5 Comparison of GerCC with related sequences from the Swissprot database.
The partial gerCC  gene of S. aureus was identified by vntue of its homology with 
the 5 . subtilis gerCC gene and an ORF from stearothermophilus (Figure 3.10). 
Although only a small portion of the 5. aureus gerCC gene sequence was known a 
significant level of identity was observed (39%) with each of the Bacillus genes. A 
comparison of the protein sequence matches obtained from a search of the Swissprot 
database with the partial S. aureus sequence revealed identity with a broad family of 
proteins including geranylgeranyl pyrophosphate synthetases and hexa- and 
heptaprenyl pyrophosphate synthetases (Table 3.1).
Molecular Cloning, Sequencing and Mapping 60
BsugerCC
SaugerCC
BstORFS
lEASMAVSEM YLQKAFQKLN TLPRGRARSS LAAIAKYIGK RKF 
I * I I I  I I I I * I I I  I I I I I
IDEAKAVSSK YLSKALDLIS ELPDGHPKSL LLSLTKKMGS RNT 
I * 1 1 * 1 1 1 1 1 1  II * 1 1  I I I
lERSYALSDR YLDKALHLLD GLPMNAERGL LRDLALYIGK RDY
Figure 3.10. The translated product of the partial 5. aureus gerCC  gene aligned 
with the translated product of the B. subtilis gerCC  gene and the B, 
stearothermophilus ORF3 protein. The symbol (I) indicates identical amino acids 
and (*) indicates conserved amino acids.
The B. stearothermophilus ORF3 gene has recently been demonstrated to encode one 
subunit of a heterodimeric heptaprenyl pyrophosphate synthetase (Koike-Takeshita 
et al., 1995). The ORF3 gene has 65% identity with theB. subtilis gerCC gene such 
that the gerCC  gene of B. subtilis is likely to similaiiy encode a heptaprenyl 
pyrophosphate synthetase. Heptaprenyl pyrophosphate synthetase functions to 
produce the polyprenyl side-chain precursor of the respiratory quinone in B. subtilis 
and B, stearothermophilus (Takahashi et al., 1980). The respiratory quinone in 
Gram-positive organisms is menaquinone which is produced via a post-chorismate 
pathway. The primary biosynthetic precursors of menaquinones are shown in Figure
3.11.
Shikimate
Prenyl
Me
Me
S-Adenosylmethionine
Figure 3.11. The primary biosynthetic precursors o f menaquinones.
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Sequence Protein Organism Accession
number
%
ident.
%
simil.
SauGerCC Putative heptaprenyl Staphylococcus U31979 - -
pyrophosphate synthetase aureus
BsuGerCC Putative heptaprenyl Bacillus M80245 38.6 59.1
pyrophosphate synthetase subtilis
BSIORF3 Heptaprenyl pyrophosphate Bacillus stearo­ D49976 38.6 53.0
synthetase thermophilus
NciGGPP Geranylgeranyl pyrophosphate Neurospora p24322 18.2 52.3
synthetase crassa
EcoGGPs Hypothetical geranylgeranyl Escherichia coli pl9641 18.6 39.5
pyrophosphate synthetase
SceHPs Hexaprenyl pyrophosphate Saccharomyces pl8900 32.6 48.8
synthetase cerevisiae
CpaGGPs Geranylgeranyl pyrophosphate Cyanophora p31171 20.9 44.2
synthetase panophora
RcaGGPs Geranylgeranyl pyrophosphate Rhodobacter p 17060 20.5 40.9
synthetase capsulatus
EcoGTT Geranyl transtransferase Escherichia coli p22939 18.6 46.5
EurGGPs Geranylgeranyl pyrophosphate Erwinia p21684 28.9 55.3
synthetase uredovora
Table 3.1. Comparison of the translated product from the partial 5. aureus 
gerC C  gene with sequences obtained from the GenEMBL and Swissprot 
databases. Values for percentage identity and similarity between the sequences 
were obtained using the GAP program of the GCG package (Genetics Computer 
Group, 1991).
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3.6. Mapping of the gerC genes in S. aureus.
To examine the possibility that the gerCA  and gerCB genes immediately precede 
gerC C , as is observed in B. subtilis, and to confirm that the partial V  ORF in 
pMJH702 was gerCC, S. aureus DNA was hybridized against selected radioactively 
labelled fragments from pMAY l (Figure 3.12) using reduced stringency conditions. 
The plasmid pM AYl, which contains the complete coding sequences for the gerC 
genes from Bacillus subtilis, was obtained from Dr. Anne Moir, University of 
Sheffield. Southern blots of S. aureus DNA were probed using a number of different 
restriction fragments from pMAY l as detailed in Table 3.2 and shown in Figure
3.12.
Invwvvsvvww
gerCA gerCB gerCC
gerCAl
get CAB 1 ^
gerC A B l^
gerCABCl 4 "
gerC C l
5 0 0 b p
Figure 3.12. Map of the gerC genes from B. subtilis showing the regions of DNA 
in pM AYl used for probing S. aureus genomic DNA.
Examination of the Southern blots generated using the gerC A B l, gerCCI and 
gerCABCl probes (Figures 3.14, 3.15, 3.16) demonstrated that the gerC  genes were 
likely to be present in some form in S. aureus. The heterologous probes bound with 
differing efficiency but did mostly reveal discrete bands. The pattern of restriction 
fragments generated using the gerCCI probe was compared with the restriction 
pattern generated previously using the aroC probe (Figure 3.1 and Figure 3.14) and 
was found to match closely with these blots and with the restriction map generated 
previously for the aroC and ndk genes (Figure 3.3). This agreement between the 
restriction patterns allowed a restriction map to be produced for the region 5" to the
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ndk gene and encompassing the region where the gerCA and gerCB genes might be 
expected to reside if their location matched that observed in B. subtilis.
Fragment from pMAY l Restriction sites length (bp)
gerCAgerCBgerCC H indm -H inm i 2,252
gerCAgerCB Hindm-'Sspl 1,215
gerCAgerCB Ddel-Hindm 906
gerCA H inm i-N sil 452
gerCC Dral-Hindm 843
Table 3.2, Summary of gerC restriction fragments generated from pM AYl and 
used as heterologous probes for Southern blots of S. aureus 601055 DNA.
I -...I.11....   miimiMiiiBimr^ i^i.I  ..   ii    " — ™ — «#»#««
aroB aroC ndk gerCC gerCB gerCA 0.7kb
Figure 3.13. Schematic map showing the predicted positions of the gerC  genes 
relative to the aroy ndk  region of the S, aureus chromosome. The positions of the 
gerC genes are shown by dashed lines indicating approximate locations based on the 
hybridisation data presented here and using the sizes of the genes from B. subtilis. 
The restriction endonucleases are abbreviated: A, AccI; C, C lal\ E, EcoRI; RV, 
EcoRV; H, //m dlll; N, Ndel\ P, Pstl.
Comparison of the restriction patterns produced with the gerCABl and gcrCAECl 
probes with the restriction patterns produced using the aroC  and gerCC  probes 
enabled the mapping of the gerCA and gerCB genes in the region 5  ^to the aroC and 
ndk genes (Figures 3.15 & 3.16 cf. Figures 3.14 & 3.1). The gerCAgerCBgerCC 
genes are likely to reside almost exclusively on a 4.5kb Clal fragment; the 3" end of 
gerCC resides on the 5.5kb Clal fragment which constitutes pMJH701 (Figure 3.13).
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M J . 2 3 A 5 6 9,
Lane M: 
Lane 1 
Lane 2 
Lane 3 
Lane 4 
Lane 5 
Lane 6 
Lane 7 
Lane 8 
Lane 9 
Lane 10
DNA markers. 
Accl digest. 
BamHI digest. 
Bg/ll digest. 
C/al digest. 
EcoRI digest. 
Hindi digest. 
Hindlll digest. 
Kpnl digest. 
Ndel digest.
•: Pstl digest.
Lane M; DNA markers. 
Lane 1 : Sad-Sa/I digest 
Lane 2 : Sad  digest.
Lane 3: Ndel-AccJl digest. 
Lane 4: A cd  digest.
Lane 5: Acd-BamRl digest. 
Lane 6 : Kpnl-BamHl digest. 
Lane 7: EcoRI-C/nl digest. 
Lane 8 : Clal digest.
Lane 9: BamHl-Clal digest.
Figure 3.14. Southern blots of S. aureus 601055 DNA probed 
with an 843bp DraI-/fi/idIII fragment {gerCCl) from pMAYl.
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Lane M: 
Lane 1 
Lane 2 
Lane 3 
Lane 4 
Lane 5 
Lane 6 
Lane 7 
Lane 8 
Lane 9 
Lane 10
DNA markers. 
Accl digest 
BamHI digest. 
Bglll digest. 
Cial digest. 
EcoRI digest. 
HincU digest. 
ffm dlll digest. 
Kpnl digest. 
Ndel digest. 
Pstl digest.
Lane M: DNA markers. 
Lane 1 : Accl digest. 
Lane 2: C/al digest. 
Lane 3: Hindlll digest. 
Lane 4: Nc/el digest. 
Lane 5: Pstl digest.
Figure 3.15. Southern blots of S. aureus 601055 DNA probed 
with a l,215bp iTi/idlll-Ys/^I fragment (gerCABl) from pMAYl.
■iüia iaiÉoiàÉiaéri TU...,.
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M 1 2 3 4 5  6 7 8  9 10
Lane M 
Lane 1 
Lane 2 
Lane 3 
Lane 4 
Lane 5 
Lane 6 
Lane 7 
Lane 8 
Lane 9
: DNA markers. 
Sacl-SaR digest 
Sad  digest. 
Ndel-AccR digest. 
A cd  digest. 
Acd-BamHl digest. 
Kpnl-BamHl digest. 
EcoRl-Clal digest. 
Clal digest. 
BamHl-Clal digest.
Lane M 
Lane 1: 
Lane 2 
Lane 3 
Lane 4 
Lane 5 
Lane 6 
Lane 7 
Lane 8 
Lane 9 
Lane 10
: DNA markers. 
A cd  digest. 
BamHI digest. 
Bglll digest. 
Clal digest. 
EcoRI digest. 
H indi digest. 
Hindlll digest. 
Kpnl digest. 
Ndel digest.
•: Pstl digest.
Figure 3.16. Southern blots of S. aureus 601055 DNA probed with a 
2,252bp ^i/fdIII-/7i/fdIII fragment (gerCARCV) from pMAYl.
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3.6. Chapter summary.
The aroC gene encoding chorismate synthase was cloned from Staphylococcus 
aureus by complementation of an aroC  strain of Escherichia coli. Sequencing 
upsti'eam of the cloned gene revealed a putative promoter sequence indicating that 
the aroC  gene may form an operon with the downstream aroB and aroA  genes 
identified previously (O’Connell et a l, 1993). A comparison of the S. aureus 
chorismate synthase sequence with other known chorismate synthase sequences 
demonstrated that the enzymes from S, aureus and Bacillus subtilis form a sequence 
group which is distinct from that formed by the other bacterial, plant and fungal 
enzymes.
Sequencing upstream from the aroC gene of S. aureus revealed the presence of the 
complete ndk gene encoding nucleoside diphosphate kinase. The encoded protein 
had a high level of sequence similarity with other known Ndks. Sequencing of the 
plasmid containing the aroC gene also revealed partial open reading frames 
encoding the 5 ’ end of the aroB gene, encoding 3-dehydroquinate synthase, and the 
3 ’ end of a gerC C  homologue. The N-terminal region of the S. aureus 3- 
dehydroquinate synthase had a low level of sequence identity to other 3 - 
dehydi'oquinate synthases. The gerCC gene fromE. subtilis is believed to encode a 
heptaprenyl pyrophosphate synthetase by virtue of its high degree of similarity with 
the ORF3 gene from Bacillus stearothermophilus which encodes a heptaprenyl 
pyrophosphate synthetase involved in menaquinone biosynthesis.
In B. subtilis the gerCC gene is the final gene in an operon with gerCB and gerCA. 
Similaiiy the ORF3 gene of B. stearothermophilus resides in a three gene operon 
which has a high degree of identity with the B. subtilis gerC genes. Southern 
hybridisation experiments were performed using fragments of the gerC genes from 
B. subtilis to probe for the S. aureus gerC genes. This revealed that the gerCB and 
g er CA  genes were similarly situated upstream from g e r C C  in S. aureus. 
Furthermore it demonshated that the gerC genes were linked to the aroBaroA genes 
in both S. aureus m d B .  subtilis.
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CHAPTER 4. OVEREXPRESSION ANALYSIS OF S. A UREUS 
CHORISMATE SYNTHASE AND NUCLEOSIDE DIPHOSPHATE 
KINASE AND E. COLI FLAVIN REDUCTASE.
This chapter describes the maximal overexpression of S. aureus chorismate synthase and 
its verification by N-terminal sequencing. In addition the overexpression of an E. coli 
flavin reductase is detailed. This enzyme was overexpressed to examine possible 
interactions between this flavin reductase and E. coli chorismate synthase.
4.1. Overexpression of S. aureus ehorismate synthase.
Expression analysis of the plasmids pMJH701 and pMJH702 suggested that chorismate 
synthase was expressed from its native promoter in E. coli DH5a (Figure 4.4). 
However, the level of expression was relatively low and to maximise expression the 
aroC gene was cloned downstream from a strong promoter and ribosome binding site.
The S. aureus aroC gene was amplified using PGR with oligonucleotide primers. The 
oligonucleotide CHOR 34 5’GGCATAIGAGATACCTAACATCAGGA3’ had nnN del 
restriction site (underlined) incorporated to facilitate cloning, and this was followed by 
the 5’ end of the aroC gene sequence. Similarly, the oligonucleotide CHOR 35 
5'GGAGATCTTAAAACTCAATATTTAATTG3' had a Bglll restriction site 
incorporated and this was followed by the 3’ end of the aroC gene sequence. The aroC 
gene was amplified using the proofreading, thermostable enzyme Vent polymerase and 
the number of cycles of PCR was minimised to reduce the likelihood of 
misincorporation during the reaction. The amplified aroC gene product was cloned into 
the T7 promoter containing vector, pTB361, producing the plasmid pMJH7EX2, which 
was sequenced and found to match the template sequence.
The plasmid pMJH7EX2 was transformed into E. coli BL21(DE3) and HMS174(DE3) 
and expression was monitored over time before and after induction with 0.4mM IPTG 
(Figure 4.1). Chorismate synthase was'' observed to accumulate to levels around 50% of 
total protein (using gel scanning densitometry) after a period of 5 hours post induction. 
The protein was also shown to be soluble by lysing the cells with lysozyme and 
separating the soluble material from insoluble material by centrifugation. PAGE revealed 
chorismate synthase to be located in the soluble (supernatant) fraction.
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Lane M: Molecular weight markers.
Lane 1: BL21(DE3)pTB361.
Lanes 2-4: BL21(DE3)pMJH7EX2 - 0 , 4 , 5  hours.
Lanes 5-7: BL21(DE3)pLysSpMJH7EX2 - 0 , 4 , 5  hours.
Lanes 8-10: HMS174(DE3)pMJH7EX2 - 0 , 4 , 5  hours.
Lanes 11-13: HMS174(DE3)pLysSpMJH7EX2 - 0 , 4 , 5  hours.
Figure 4.1. SDS-PAGE showing a time course of protein expression from the aroC 
overexpression clone pMJH7EX2 in two E, coli host strains after induction with 
IPTG.
In addition to the 43kD band expected for S. aureus chorismate synthase, a second band 
of 33kD was observed on the gel. The presence of this band was thought to arise from 
the larger expressed protein and to confirm this a gel with the overexpressed proteins 
was blotted onto polyvinylidenefluoride (PVDF). N-terminal sequencing, by Edman 
degradation, was used to obtain the sequence of both the main 43kD species and the 
33kD sub-species (Table 4.1). The 43kD species matched the N-terminal amino acid
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sequence predicted from translation of the aroC gene sequence including the initiating |
methionine. The sequence of the 33kD band matched an internal region of chorismate i
synthase and also began with a methionine. Examination of the DNA sequence ;
immediately upstream from this methionine revealed the presence of a potential, weak 
ribosome binding site. The 33kDa band thus appears to be due to translational start ^
events were occurring within the aroC mRNA. This was presumably a result of the 
large amounts of mRNA present when expression to such high levels was initiated. t
Cycle
43kD band 
Amino acid pmol
33kD band 
Amino acid pmol
1 M 72.85 M 22.72
2 R 72.53 K 21.3
3 Y 68.19 R 39.69
4 L 65.18 T 11.52
5 T 41 I 17.66
6 S 22.1 T 10.23
7 G 45.5 K 16.5
8 E 39.1 P 13.16
9 S 15.2 R 29.68
10 H 20.4 P 11.17
11 G 26.7 G 13.05
12 P 26.4 H 17.71
13 Q 20.9 A 10.93
14 L 22.9 D 15.23
15 T 12.8 L 11.36
16 V 20.9 V 11.6
17 I 19.6 G 11.16
18 V 15.6 G 2.2
19 R 10.4
20 G 14.7
21 V 16.3
22 P 17.9
23 A 30.8
24 N 27.5
25 L 15.6
26 E 5.84
27 V 19.3
28 K 9.4
Table 4.1. N-terminal sequeneing data from overexpressed 
S. aureus chorismate synthase.
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4.1.1. Lysogenization of E. coli GLW40 for expression.
The lysogenization of E. coli GLW40 with the XDE3 prophage to produce an 
expression system which would be free from endogenous contaminating chorismate 
synthases was thought to be advantageous since the E. coli chorismate synthase 
purification protocol would be the starting point for subsequent enzyme purification. 
Consequently, E. coli GLW40 was lysogenized with ÀDE3 and a suitable lysogen was 
selected by virtue of its ability to direct the overexpression of chorismate synthase.
KD M
31 # #
22 ^  \
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Lane M: Molecular weight markers.
Lane 1: GLW40(DE3).
Lanes 2-4: GLW40(DE3)pMJH7EX2 - 0 , 4 , 5  hours.
Figure 4.2. SDS-PAGE showing a time course of protein expression from the aroC 
overexpression clone pMJH7EX2 in E. coli GLW40(DE3) after induction with IPTG.
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The level of overexpression using E. coli GLW40(DE3) was less than that observed 
with E. coli BL21(DE3). This contrasts with the expression of E. coli EPSP synthase 
where levels of overexpression were comparably high in both E. coli AB2849(DE3) and 
E. coli BL21(DE3) (Shuttleworth et a l, 1992). However, the level of overexpression 
was sufficiently high to warrant using the aroC lysogen strain to obviate the problem of 
E. coli chorismate synthase contaminating the S. aureus preparation.
4.2. Immunological analysis of S. aureus chorismate synthase.
Crude extracts of S. aureus 601055, E. coli BL21(DE3)pMJH7EX2, E. coli 
AB2849pGM605, and E. coli AB2849 were separated by SDS-PAGE. The gel was 
then blotted onto nitrocellulose membrane and the membrane incubated with polyclonal 
rabbit anti-E. coli chorismate synthase antibodies generated against denatured enzyme.
Lane 1 
Lane 2 
Lane 3 
Lane 4
E. coli AB2849.
E. coli AB2849pGM605.
S. aureus 601055.
E. coli BL21(DE3)pMJH7EX2.
Figure 4.3. Western blot of chorismate synthase from E. coli and S. aureus 
using rabbit anti-E. coli chorismate synthase antibodies.
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Development of the nitrocellulose membrane revealed that the antibodies had bound to 
two main proteins in both of the E. coli AB2849 lanes, the larger of the two proteins 
being E. coli chorismate synthase (Figure 4.3). The lane containing S. aureus 601055 
revealed no band at the molecular weight of the E. coli enzyme, as expected. 
Furthermore, the lane containing the overexpressed S. aureus chorismate synthase 
showed only a faint band corresponding to E. coli chorismate synthase but no band at 
the molecular weight corresponding to the S. aureus enzyme. This lack of 
immunological cross-reactivity provides evidence for structural differences between S. 
aureus chorismate synthase and E. coli chorismate synthase.
■CS
14
Lane M; Molecular weight markers.
Lane 1 : E. coli DH5a.
Lane 2: E. coli DH5apMJH702.
Lane 3: E. coli DH5apMJH701.
Figure 4.4. Protein expression from plasmids pMJH702 and pMJH701 in E. coli 
DHSa with arrows showing expression of chorismate synthase and nucleoside 
diphosphate kinase.
4.3. Overexpression of S. aureus nucleoside diphosphate kinase.
Examination of protein expression from the plasmids pMJH701 and pMJH702 revealed 
the presence of a second protein in addition to chorismate synthase (Figure 4.4). This 
protein had an estimated molecular weight from SDS-PAGE of 16.5kD. The molecular
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weight of nucleoside diphosphate kinase (Ndk) from translation of its gene sequence is 
16.6kD. Confirmation that the protein was Ndk by N-terminal sequencing was not 
possible due to extremely poor blotting of the protein onto PVDF. The presence 
immediately upstream from the ndk gene of what would appear to be a strong ribosome 
binding site supports the proposal that the second expressed protein is Ndk. The level 
of expression was unaffected by the addition of IPTG to growing cells harbouring the 
plasmids as judged by SDS-PAGE.
4.4. Overexpression of E, coli flavin reductase.
The E. coli jre  gene, encoding flavin oxidoreductase, was amplified from E. coli K-12 
genomic DNA using PGR with oligonucleotide primers based upon the gene sequence 
published previously by Spryou et al, 1991. The oligonucleotide FLRDl 
5’GAGAAAGCATATGACAACCTTAAGCTGTAAA3’ had an Ndel restriction site 
(underlined) incorporated to facilitate cloning, and this was followed by the 5’ end of 
the fre  gene sequence. Similarly, the oligonucleotide FLRD2
5’TCTCCAGA1CITATCAGATAAATGCAAACGCATC3’ had a Bglil restriction site 
incorporated and this was followed by the 3’ end of the fre  gene sequence with an extra 
stop codon TAA placed after the TGA stop codon. The fre  gene was amplified using 
the proofreading thermostable enzyme Vent polymerase as described for the aroC gene 
and required 4mM MgSO^ for extension. The amplified fre  gene product was cloned 
into the T7 promoter containing vector, pTB361, producing the plasmid pFREX2, 
which was sequenced and found to match the published sequence.
The plasmid pFREX2 was transformed into E. coli BL21(DE3) and BL21(DE3)pLysS 
to examine expression of the flavin reductase. The growth of the strains on L-agar was 
observed to be significantly retarded, especially BL21(DE3)pFREX2 which grew 
extremely slowly. Growth in L-broth was similarly poor and the strains grew around 2- 
3 times slower compared with the expression of chorismate synthase. Protein 
expression was monitored after induction with IPTG by SDS-PAGE (Figure 4.5).
'
The level of expression of the flavin reductase was observed to be high and a notable 
feature of the cells obtained was their distinctly pale colour, presumably a consequence 
of flavins in the cell mostly being reduced.
I
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Lane M: Molecular weight markers.
Lane 1 : BL21(DE3)pTB361.
Lanes 2-5: BL21(DE3)pFREX2 - 0, 2, 3, 4 hours.
Lanes 6-9: BL21(DE3)pLysSpFREX2 - 0, 2, 3 ,4  hours.
Figure 4.5. SDS-PAGE showing a time course of protein expression from the fre  
overexpression clone pFREX2 after induction with IPTG.
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4.5. Chapter summary.
Chorismate synthase from S. aureus was maximally overexpressed by placing the 
coding region of the aroC gene optimally spaced downstream of a T7 promoter. 
Expression was performed using both the E, coli strain BL21(DE3) and by lysogenising 
GLW40, an aroC strain of E. coli. Lysogénisation of GLW40 was performed to remove 
the presence of contaminating endogenous E. coli chorismate synthase during the 
purification of the S. aureus enzyme. Antibodies previously generated against E. coli 
chorismate synthase were found not to cross-react with the S. aureus enzyme. This 
highlights further the differences between the Gram-positive chorismate synthases and 
the enzymes from other bacteria, plant and fungi which show strong inter-species cross- 
reactivity.
Overexpression from the aroC overexpression clone pMJH7EX2 revealed two bands 
after SDS-PAGE. The N- terminal sequence of the main band matched that predicted to 
be the N-terminus of the protein. The N-terminal sequence of the second, minor band 
revealed that an internal start event had occurred during overexpression. S. aureus 
nucleoside diphosphate kinase was found to overexpress presumably from its native 
promoter in pMJH701 and pMJH702.
The flavin reductase from E. coli encoded by the fre  gene was maximally overexpressed 
with the same vector system used for S. aureus chorismate synthase. The E. coli flavin 
reductase was overexpressed to allow the investigation of possible interactions with E. 
coli chorismate synthase which are detailed in chapter 7.
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CHAPTER 5. PURIFICATION AND CHARACTERISATION OF 
S. AUREUS CHORISMATE SYNTHASE.
■ ÎSÏ
This chapter describes the purification of S. aureus chorismate synthase to near 
homogeneity. In addition details of the enzyme with respect to its subunit molecular mass, 
its native structure and its kinetic properties are presented.
5.1. Purification of S. aureus chorismate synthase.
S. aureus chorismate synthase was purified from 13g (wet weight) ofE.  coli GLW40(DE3) 
pMJH7EX2 using two chiomatographic steps of DEAE-Sephacel and cellulose phosphate, 
principally as described by White et a l, 1988 and incoiporating some minor alterations 
(Ramjee, 1992). The purification yielded around lOOmg of enzyme with a purity of 95% as 
judged by SDS-PAGE. The chromatographic profiles of the enzyme on the two columns 
are shown in Figures 5.1 and 5.2 and Table 5.1 summarises the purification.
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Figure 5.1. Elution profile of S. aureus chorismate synthase from DEAE-Sephacel. 
OD280 (*), enzyme activity(o).
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Figure 5,2. Elution profile of S. aureus chorismate synthase from cellulose 
phosphate. OD280 (*), Activity(o).
Step
Total
protein
(mg)
Total
activity
(U)
Specific 
activity 
(U mg-l)
Yield
(%)
Purification
(-fold)
Crude extract 1 2 1 0 416 0.34 10 0 1
DEAE-Sephacel 592 317 0.54 76 1.6
Cellulose phosphate 98.5 248 2.5 60 7.4
Table 5.1 Summary of the purification of S. aureus chorismate synthase from 
E. coli GLW40(DE3)pMJH7EX2.
t i
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S, aureus chorismate synthase was ultimately resuspended in the minimum volume 
of 50mM Mops pH7.0, 0.4 mM DTT, 1.2mM PMSF, 50% glycerol after ammonium 
sulphate precipitation and was stored at -20°C. The enzyme was concentrated greatly 
using this procedure with the most concentrated sample produced being around 
40mgml‘h The stability of S. aureus chorismate synthase in this buffer was good 
with no obvious loss of activity after six months as judged by UV assay. The 
specific activity of chorismate synthase from S. aureus was significantly lower than 
that from E. coli such that purification of the enzyme using the UV assay was made 
more difficult. The volume of sample being added was above the optimum for the 
UV assay meaning that significant amounts of oxygen were added to the system 
resulting in the underestimation of specific activity. A significantly higher specific 
activity was obtained after DEAE-Sephacel chromatography when the flavin on the 
enzyme was photoreduced for 1 min in the absence of oxalate before addition to the 
assay.
5.2. Protein concentration determination using the extinction coefficient of 
chorismate synthase.
The concentration of chorismate synthase was determined spectrophotometrically at 
280nm using the method described by Gill and Von Hippel, 1989. The extinction 
coefficient was calculated using the number of tyrosine, tryptophan and cysteine 
residues present and determining the absorbance of the protein in water and 6 M 
guanidine hydrochloride. SM.Nat the calculated extinction coefficient for chorismate
synthase in water was determined to be 23,100 M-^cm'f
5.3. Molecular weight and subunit structure of chorismate synthase.
The subunit molecular weight (Mr) of S. aureus chorismate synthase was measured 
by electrospray mass spectrometry as 43,024 ± 3.8 (Figure 5.3), consistent with the 
migration position observed with SDS-PAGE. The predicted mass of the enzyme 
from translation of the DNA sequence was 43,027 which is in good agreement with 
the mass determined by electro spray mass spectrometry.
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Figure 5.3. Electrospray mass spectrum of S. aureus chorismate synthase. The
spectrum over the Mr range shown (42,000-44,000) was obtained using the MaxEnt 
deconvolution programme on the raw data, top.
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The native (M J was determined using gel filtration chromatography, with reference 
to several standard proteins of known Mf. Active chorismate synthase eluted 
between catalase (Mj- 232,000) and haemoglobin (Mr 68,000) with an apparent Mr of 
186,800 ± 7,000 (Figure 5.4). Chemical cross-linking of the subunits of chorismate 
synthase was achieved using dimethyl-suberimidate. A gel of the crosslinked 
enzyme (Figure 5.5) suggests that chorismate synthase is a homotetramer with a 
molecular weight of 182,400 ± 12,500, which is similar to the mass obtained by gel 
filtration.
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Figure 5.4. Estimation of the native Mr of chorismate synthase. The native Mr of 
active chorismate synthase was estimated by gel filtration using a superose-12 FPLC 
column with reference to standard proteins of known Mr. Ve - Elution volume, Vo - 
Void volume.
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Lane M: Molecular weight markers.
Lanes 1, 2: S. aureus chorismate synthase (18, 27pg).
Lanes 3, 4: E. coli chorismate synthase (8 , 12pg)
Figure 5.5. Dimethyl-suberimidate cross-linked chorismate synthase from S. 
aureus and E. call 5% SDS polyacrylamide gel stained with Coomassie blue.
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5.4. pH optimum.
The pH optimum for the chorismate synthase reaction catalysed by the S. aureus 
enzyme was determined by measuring activity using the UV assay, with substrate 
levels as in the standard assay, in 50mM MOPS, lOOmM NaCl with the pH adjusted 
between 6.5 and 8.5 with KOH. Initial experiments revealed a slight curvature in the 
traces when FMN was at a concentration of lOpM. This was eliminated when the 
FMN concentration was increased to 25 pM. Maximal activity in MOPS buffer was 
observed between pH 6.0 and pH 7.25, however, increasing pH above 7.25 resulted 
in a progressive loss of activity up to pH 8.5, where only 8% of activity remained 
(Figure. 5.6).
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Figure 5.6. Determination of the pH optimum of S, aureus chorismate 
synthase. Graph shows the change in specific activity with changing pH in 50mM 
MOPS, lOOmMNaCl buffer.
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5.5. Buffer optimum.
The optimum buffer for the chorismate synthase reaction catalysed by the S. aureus 
enzyme was determined by measuring activity with substrate and FMN levels as in 
the standard assay, in 50mM buffer pH7.5, lOOmM NaCl. MOPS buffer was found 
to give maximum activity while only 26% of maximal activity was observed in Tris- 
HCl buffer (Table 5.3).
Buffer Relative
activity
MOPS 1.0
Tricine 0.82
Triethanolamine 0.46
KPi 0.34
Tris-HCl 0.26
1.0 corresponds to 29.27U; 7.3fxg of enzyme per assay
Table 5.3. Relative activity of chorismate synthase in different buffers.
5.6 Specific activity with different flavins.
Chorismate synthase from different organisms has been shown to utilise FMN, FAD 
and riboflavin as cofactor with a pronounced preference for FMN. S. aureus 
chorismate synthase was assayed using the standard assay with each of the three 
flavins at 25pM. The highest specific activity was obtained when FMN was the 
cofactor with a value of 4.01 pmolesmin-^mg-i (100%) ; FAD gave a specific activity 
of 0.52 pmolesmin-fing-i (13%) ; and riboflavin gave a specific activity of 0.10 
pmolesmim^mg-i (2.4%).
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5.7. Dependence of chorismate synthase activity on the EPSP and FMN 
concentration.
Apparent Km values were determined from steady-state kinetic analyses using SOmM 
MOPS pH 7.0, lOOmM NaCl buffer. Km values were calculated from double 
reciprocal plots as shown in Figures 5.7 and 5.8.
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Figure 5.8. Determination of apparent for EPSP. A double reciprocal plot 
showing the dependence of chorismate synthase activity on the EPSP concentration . 
Standard assays were performed as described in ‘Materials and Methods’ with 
varying EPSP concentration in 50mM MOPS pH7.0, lOOmM NaCl. Assays were 
initiated with 0.2pl (7.3 pg) of enzyme.
Linear regression of the data gave the equation y -  0.7109x + 0.0558 and a value for 
r, the correlation coefficient, of 0.9623. The appai'ent K^ for EPSP was 12.7 ± 0.5
pM a value in accordance with most of the other chorismate synthases studied.
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Figure 5.8. Determination of apparent Km for FMN. A double reciprocal plot 
showing the dependence of chorismate synthase activity on the FMN concentration . 
Standard assays were performed as described in ‘Materials and Methods’ with 
varying FMN concentration in 50mM MOPS pH7.0, lOOmM NaCl. Assays were 
initiated with 0.2pi (7.3pg) of enzyme.
Linear regression of the data gave the equation y = 1.0221x + 0.2125 and a value for 
r, the correlation coefficient, of 0.9741. The apparent for FMN was 4.8 ± 0.5 pM 
which is approximately two orders of magnitude greater than other chorismate 
synthases studied.
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5.8. Pre-steady state kinetics of S, aureus chorismate synthase.
A series of experiments investigating the transient absorbance changes during the S. 
aureus chorismate synthase reaction were performed at the University of Sussex, 
Brighton in collaboration with Dr. Stephen Bornemann.
Single turnover experiments with rapid scanning stopped-flow spectrophotometry 
were used to observe the difference spectrum of any intermediate(s) formed during 
the S. aureus chorismate synthase reaction. The FMN cofactor provides a convenient 
chromophore for stopped flow spectrophotometry with its three oxidation states 
having distinct spectra. The difference spectrum obtained for the reaction 
intermediate(s) was then used to select a single wavelength for the analysis of the 
chorismate synthase reaction during multiple turnover experiments. The reaction of 
the enzyme with (6 S)-6 -F-EPSP and possible kinetic isotope effects using (6 R)- 
[62HJ-EPSP and (6S)-[62H]-EPSP were also investigated .
5.8.1 Rapid scanning stopped-flow spectrophotometry.
Figure 5.9. shows the difference spectrum between 350nm and 700nm of the 
transient flavin intermediate formed during single turnover of chorismate synthase. 
The spectrum was produced by subtraction of a spectrum of reduced flavoenzyme 
with no substrate. The spectral features of the intermediate observed consists of a 
maximum at 390nm with a secondary maximum at 450nm separated by a trough 
which has a minimum at 425nm. An isosbestic point exists at 355nm. The flavin 
intermediate is formed extremely rapidly and decays more slowly as detailed in 
Figure 5.11. Analysis of the spectrum shovm in Figure 5.9 at 390nm was used to 
produce first order rate constants to describe the rate of formation and decay of the 
flavin intermediate (Figure 5.11). This gave values of 12.Is-^ for ki and 6.0s-* for 
k2 .
In addition to photochemically reducing FMN in the presence of oxalate, dithionite 
mediated reduction of the cofactor was performed as a comparison, where 50pM 
sodium dithionite replaced potassium oxalate, in a stopped-flow experiment set up 
essentially as indicated above. Dithionite mediated reduction obviates the problem 
of small amounts of dissolved oxygen remaining in the solutions, however, the 
dithionite ion absorbs strongly in the UV region of the spectrum and consequently 
spectra produced were less smooth. A difference spectrum was generated against a
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control of enzyme, dithionite and FMN in buffer (Figure 5.10) and gave rate 
constants describing the formation and decay of the intermediate which closely 
matched those obtained when FMN was reduced photochemically with values of 
1 2 .6 s"i for ki and 6,4s-i for k^.
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Figure 5.9. The difference spectrum observed during the chorismate synthase 
reaction. Syringe A contained 40pM FMN, 40pM chorismate synthase and ImM 
(C0 0 K )2 in 50mM Mops pH7.0, lOOmM NaCl. Syringe B contained 40pM EPSP and 
trace FMN in 50mM Mops pH7.0, lOOmM NaCl. The run time of the experiment was 1.92 
sec.
ay
#
f.
Purification and Characterisation of Chorismate Synthase 89
tY=OJ003
0J0175
A»s
OJOl
OJ0O25
340 SIS
VkickmgÜk ( u ) iX=35
Figure 5.10. The difference spectrum observed during the chorismate synthase 
reaction. Syringe A contained 40pM FMN, 40|iM chorismate synthase and ImM sodium 
dithionite in 50mM Mops pH7.0, lOOmM NaCl. Syringe B contained 40pM EPSP in 
50mM Mops pH7.0, lOOmM NaCl. The run time of the experiment was 9.6 sec.
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Figure 5.11. Formation and decay of the flavin intermediate during single turnover 
rapid scanning stopped-flovy spectrophotometry. Two exponentials were fitted to the 
data obtained at 390nm to obtain the rate constants k l and k2 .
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5.8.2. Single wavelength stopped-flow experiments.
Single wavelength (390nm) stopped flow experiments were performed to obtain a more 
accurate measurement for the kinetics of flavin intermediate formation during turnover with 
EPSP. The kinetics of the intermediate were further investigated with respect to the 
substrate analogues (6 S)-[6 %]-EPSP, (6R)-[62H]-EPSP and (6 S)-6 F-EPSP.
iY=OJ003
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Figure 5.12. Single wavelength stopped-flow titration of EPSP against enzyme.
Syringe A: chorismate synthase 40pM, FMN 40pM and dithionite ImM in 50mM Mops 
pH7.0, lOOmM NaCl. Syringe B: EPSP at (1) lOpM, (2) 20pM, (3) 30.8|JiM, (4) 80pM 
and (5) 160pM in 50mM Mops pH7.0, lOOmM NaCl. 25 C, 1.8nm slit width, tungsten 
lamp, kl for (1) 72s“i (2) 106s'i (3) 122s-i (4) 186s-i (5) 313s“i. kz for (1) 6 .6 s-i (2) 6 .6 s~‘ 
(3) 6.3s'^ (4) 6 .6 s'i (5) 6.5s'k The errors for ki and k% were calculated to be ±10% and 
±0 .1s '^  respectively.
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EPSP was titrated against enzyme and the kinetics of flavin intermediate formation 
were determined from one quarter to four times turnover of the enzyme (Figure 
5.12). When EPSP concentration was increased an increase in the rate of formation 
of the flavin intermediate was observed (Figure 5.13). This contrasts with E. coli 
chorismate synthase where the rate of flavin intermediate formation is independent of 
substrate concentration. Furthermore, it was not possible to fit two exponentials to 
describe the rates of formation and decay of the intermediate above one quarter to 
one half times turnover. The latter part of flavin intermediate decay did fit to an 
exponential for each of the substrate concentrations and revealed a similar rate of 
decay at each concentration.
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Figure 5.13. The increase in ki with increasing substrate concentration.
Derived from Figure 5.12.
Further stopped-flow kinetic analysis of chorismate synthase was performed using 
the substrate analogues (6 S)-[6 %]-EPSP and (6 R)-[6 ^H]-EPSP to determine whether 
there were kinetic isotope effects (KIE) on either the pro-S or pro-R hydrogen bonds 
during the S. aureus chorismate synthase reaction i.e. establish if  C-H bond cleavage
.il-
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was rate-limiting during catalysis. The error in fitting two exponentials to the data as 
demonstrated above meant that the pre-steady state analysis of a KIE produced an 
unacceptably large error. This was a problem for what appeared to be a very small 
KIE; instead steady-state kinetic analysis was used to investigate a possible kinetic 
isotope effect.
5.9 Steady state analysis of EPSP analogues.
Steady-state assays with deutero- and fiuoro-substituted EPSP were performed using 
the standard anaerobic assay containing 25pM FMN, 50pM EPSP and 7.3pg S. 
aureus chorismate synthase (36.5pg for (6 S)-6 F-EPSP and its control assay) in 
50mM Mops pH 7.0, lOOmM NaCl. Assays were carried out using a Shimadzu 
MPS2000 multipurpose recording spectrophotometer. Vmax was determined for 
each of the analogues as detailed in Table 5.3. The kinetic isotope effect at the pro-i? 
hydrogen was determined to be 1.02±0.06 and 1.00±0.09 at the pro-^ hydrogen. It 
was observed, however, that there was a great deal of curvature in the traces during 
the deutero analogue assays and consequently the very beginning of the traces were 
used to calculate the rates.
The rate of product formation was judged to be approximately 130 times slower for 
the fluoro analogue when compared to EPSP. However, pronounced curvature of the 
trace was observed initially with the rate apparently increasing before remaining 
linear for the majority of the assay.
Substrate Vmax (Umg-l) Error
EPSP 4.22 ±0 .1 0
(6R)-[62H]-EPSP 4.15 ±0.17
(6S)-[62H]-EPSP 4.20 ±0.28
EPSP 4.45 ±0 .1 0
(6 S)-6F-EPSP 0.034 ±.007
Table 5.3. Observed Vmax for EPSP compared to deutero- and fluoro 
analogues of EPSP.
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5.10. Preliminary investigation of flavin interaction with S. aureus chorismate 
synthase.
Experiments designed to investigate the interaction of the flavin cofactor with 
chorismate synthase were done at the University of Sussex, Brighton in collaboration 
with Dr. Peter Macheroux. Spectrophotometry was done using an HP 8452A diode 
array spectrophotometer linked to a Vectra 386/33N PC.
5.10.1. Titration of chorismate synthase with EPSP.
A spectrum of FMN, 14pM in 50mM MOPS, lOOmM NaCl pH 7.0, was taken prior 
to and after the addition of S. aureus chorismate synthase to ISpM. Further spectra 
were then taken after additions of 3, 6 , 9, 12, 15,18 and 27p,M EPSP (Figure 5.14).
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Figure 5.14. Changes to the spectrum of FMN after addition of enzyme 
followed by the addition of EPSP. A large change in the spectrum is observed 
upon addition of enzyme (largest change in spectrum is in the region 300-400nm). 
Each addition of EPSP changes the spectrum slightly (reduction in the spectrum in 
the region 300-480nm and increase in the spectrum between 480 and 520nm)
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Figure 5.15. Titration of chorismate synthase with EPSP. Graph generated from 
data obtained from Figure 5.14.
Values obtained from changes in the FMN spectrum at 444nm before and after the 
addition of EPSP were plotted (Figure 5.15). Extrapolation of the curve to obtain the 
concentration of EPSP where there was essentially no further change in the flavin 
spectrum at 444nm gave a value around 15pM. This matched the concentration of 
enzyme present in the titration and indicated stoichiometric binding of the EPSP to S. 
aureus chorismate synthase. Figure 5.14 shows the spectra obtained during the 
titration. A large change in the FMN spectrum between 300 and 400nm was 
observed when enzyme was added to the FMN displaying that the enzyme was 
binding the oxidised FMN and shifting its spectrum. This contrasts with the E. coli 
enzyme where no change to the flavin spectrum is observed upon addition of the 
enzyme to the FMN (P. Macheroux, personal communication). Further changes in 
the spectrum were then observed as EPSP was added suggesting conformational 
changes to the enzyme-flavin complex.
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5.10.2. Flavosemiquinone formation with 6R-6F-EPSP.
The following two experiments were performed using a quartz cuvette which had a 
side-arm in the neck and which could be stoppered with a Subaseal stopper to allow 
an anaerobic environment to be produced by cycles of vacuum and nitrogen. After a 
baseline was recorded for buffer (50mM MOPS pH7.0, lOOmM NaCl) the spectrum 
of 14pM FMN, 15pM S. aureus chorismate synthase and 30pM 6 R-6 F-EPSP in 
buffer was recorded. 2mM oxalate was then added to the other components by 
mixing the contents of the cuvette with the side arm. After photoreduction of the 
oxalate for 10s using a Schott LK1500 lamp at full power setting a spectrum was 
taken. Further spectra were then recorded after 10, 20, 35, 50, 70, 130, 430s.
Examination of the spectra produced (Figure 5.16) revealed photoreduction of the 
flavin, as evinced by a decrease in the maxima at 360nm and 444nm, furthermore, 
there was evidence for the formation of a flavosemiquinone (radical) [broad peak 
between 500 and 650 mn with a maximum of 594nm]. The flavosemiquinone was 
formed extremely rapidly, however, complete reduction of the FMN 
(flavosemiquinone to hydroquinone) was very slow.
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Figure 5.16. Flavosemiquinone formation in the presence of 6R-6F-EPSP.
Photoreduction of the flavin is shown by decrease in the maxima at 360nm and 
444nm from the spectrum of FMN+enzyme+6 R-6F-EPSP. Flavosemiquinone 
formation, 500 to 600nm, was rapid and was followed by its slow disappearance with 
further photoreduction to produce hydroquinone.
Purification and Characterisation of Chorismate Synthase 97
5.10.3. Flavosemiquinone formation with EPSP.
This experiment was performed in a similar way to the above experiment. A 
baseline of buffer was taken before recording a spectrum of 15p,M FMN, 15pM 
enzyme and 2mM oxalate in 50mM MOPS pH7.0, lOOmM NaCl. The FMN was 
then photoreduced for 5, 15, 35, 55, 115 and 175s with spectra taken at each time- 
point. EPSP was added via the side arm, 150pM final concentration, and spectra 
were recorded after 15, 90 and 210s (Figure 5.17).
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Figure 5.17. Flavosemiquinone formation in the presence of EPSP. The spectra 
reveal photoreduction of the FMN with decreases in the maxima at 360 and 444nm. 
Flavosemiquinone formation shovm by the broad peak between 500 and 650nm 
occurred after addition of EPSP; the addition of a small amount of oxygen at the 
same time resulted in oxidation of some flavin with a concomitant increase in the 
spectrum. Chorismate formation is noted by the dramatic increase in absorbance at 
the 300nm region for several of the spectra.
Flavosemiquinone was formed in the presence of chorismate with a shift in the 
maximum to 610nm, compared to the maximum of 594nm, observed for (6 R)-6F- 
EPSP. The same spectral shift was observed for E. coli chorismate synthase (P. 
Macheroux, personal communication) and is thought to result from chorismate not
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being released from the enzyme-flavin complex. Chorismate is more hydrophobic 
than EPSP, due to loss of the phosphate group, and would create a more apolar 
environment around the flavin perturbing the flavosemiquinone spectrum. 
Furthermore, the spectrum is characteristic of the anionic reduced form of FMN 
(Muller e/a/., 1972)
5.10.4. Dissociation constant for oxidised flavin.
The dissociation constant, for oxidised FMN (FMNqx) was calculated after 
incubating 5. aureus chorismate synthase, 15pM, with FMN, 14pM, in 50mM 
MOPS pH7.0, lOOmM NaCl and separating free flavin from enzyme bound flavin 
using a centricon-10 concentrator. The OD444 was calculated for the free flavin in
the eluate and for the enzyme bound flavin in the concentrated protein fraction. The 
Kd was then obtained from the following equation:
Kd == [FMNJfree • [EnzymeJpREE / [Enzyme~FMN]
The Kd for FMNqx in the presence of EPSP was similarly calculated with 50pM 
EPSP added after incubation of the enzyme with FMN. The values obtained for Kd 
FMNqx were 7.15qM without EPSP and 2.42qM in the presence of 50pM EPSP. 
These values indicate that oxidised flavin is bound tightly by the enzyme in contrast 
to the E. coli enzyme which has a Kd for FMNqx of >100pM. It also shows that 
oxidised flavin is bound more strongly when EPSP is present. This has implications 
for crystallography where the FMN can be retained on the enzyme in the presence of 
EPSP to produce holoenzyme.
1
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5.11. Chapter summary.
Chorismate synthase was purified to near homogeneity producing nearly lOOmg of 
enzyme from 13g (wet weight) of E. coli GLW40(DE3)pMJH7EX2, The enzyme 
was judged to be a homotetramer using cross-linking with dimethyl-suberimidate. 
The subunit molecular mass was determined to be 43,024 by electrospray mass 
spectrometry and this closely matched the value of 43,027 determined from 
translation of the gene sequence.
The pH optimum of the enzyme was found to be non-symmetrical in MOPS buffer 
with an optimum of activity around pH 7.0. The apparent Km for EPSP of the S. 
aureus enzyme was calculated to be 12.7pM and the apparent Km for FMN was 
calculated to be 4.8pM.
S. aureus chorismate synthase was further investigated using stopped-flow methods 
to examine the pre-steady state kinetics of the enzyme. A flavin intermediate was 
observed during turnover with a difference spectrum which resembled that obtained 
previously with the E. coli enzyme. The spectral characteristics of the S. aureus 
flavin intermediate were different, however, with respect to its maxima, minima and 
overall shape. The rate of decay (6.5s“l) of the intermediate was eight times slower 
than that observed previously for the E.coli enzyme (52s"l) and this compared well 
with a seven fold lower Vmax-
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CHAPTER 6. SITE-DIRECTED MUTAGENESIS OF S, AUREUS 
CHORISMATE SYNTHASE.
The mutagenesis of S. aureus chorismate synthase was attempted without structural 
information for the enzyme. The mutagenesis of tyrosine 121 (130 in multiple lineup, 
Figure 3.6) in the S. aureus sequence was based upon the premise that tyrosine 
residues are known to be important for flavin binding in a variety of flavin-cofactor 
requiring enzymes and that a lineup of the chorismate synthase sequences knovm to 
date revealed only one tyrosine residue which was completely conserved.
6.1. Construction and overexpression of site-directed mutants.
The tyrosine residue was substituted by phenylalanine and by alanine in S. aureus 
chorismate synthase using the PCR method of Higuchi et al. (1988) as described in 
section 2.17. The final mutagenised PCR products were cloned into pTB361 and 
when sequenced were found to match the original template except for the desired 
mutations. The two resulting plasmids pMJHY121F and pMJHY121A were 
transformed into E. coli GLW40(DE3)pLysS and protein expression monitored over 
time (Figure 6.1). The host strains containing the two mutant plasmids were observed 
to grow more slowly than the ‘wild type’, pMJH7EX2 containing host strain but did 
produce large amounts of overexpressed enzyme. Expression of the mutants in E. 
coli BL21(DE3) or GLW40(DE3) when the pLysS plasmid was absent was poor and 
cell growth was significantly retarded. The reason for this is not at all clear but 
suggested that the mutations had produced some change which was detrimental to the 
cell.
6.2 Functional test of mutants using complementation.
The chorismate synthase free background of the host strain E. coli GLW40(DE3) was 
used to express the tyrosine mutants with growth on minimal medium. The ability to 
complement the Aro" phenotype of this strain has been shown to be a sensitive 
procedure for cloning aroC genes (this study, Millar et a l, 1988), testing deletion 
mutants for chorismate synthase activity (Henstrand et a l, 1995b) and should by the 
same argument provide a sensitive test for the activity of site-directed mutants of 
chorismate synthases.
Mutagenesis of Chorismate Synthase 101
s .:z :
§ i
# #  W
sI a#
^  a  #a
lamp mmmmm
Lane M: Molecular weight markers
Lanes 1,7: E. coli GLW40(DE3)pLysS
Lanes 2 -6 : E. coli GLW40(DE3)pLysSpY121F 0 , 2 , 3 , 4 , 14 hr
Lanes 8 - 1 2 : E. coli GLW40(DE3)pLysSpY121A 0 , 2 , 3 , 4 , 14 hr
Figure 6.1. SDS-PAGE showing a time course of protein expression from the 
aroC clones pY121F and pY121A in E, coli GLW40(DE3) pLysS after induction 
with IPTG. The 10% SDS gel was stained with Coomassie blue.
Plasmids in E  co/z MM MM+ MM+TET MM+ MM+TET+
GLW40(DE3) TET +CAM SUPPS CAM+SUPPS
pMJH7EX2
pMJHY121F
pMJHY121A
pLysSpMJH7EX2 
pLysSpMJHY121F 
pLysSpM JHY121A
Table 6.1. Complementation test of ‘wild-type’ and mutants on minimal 
medium. +++ indicates strong growth, ++ indicates medium growth, + indicates poor 
growth and - indicates no growth after 60 hours. MM minimal medium, TET 
tetracycline [12.5|agml'i], CAM chloramphenicol [17pgml-i], SUPPS [tyrosine 
(200mgl"i), tryptophan (200mgF0, phenylalanine (400mgF^), para-aminohenzoate 
(320pgl"0, para-hydroxybenzoate (320pgl-i), thiamine-HCl (3mgl-i)]. 
Chloramphenicol was included in plates when the pLysS plasmid was present.
The ‘wild-type’, pMJH7EX2, produced a positive control with growth on minimal 
medium with or without antibiotics and/or aromatic supplements. The phenylalanine 
mutant was capable of growth on minimal medium suggesting a functional 
chorismate synthase. However, the alanine mutant was particularly distinctive using 
the complementation test due to its inability to grow on minimal medium with or 
without the appropriate antibiotics. It was capable of growth on supplemented 
minimal medium indicating that the plasmids were present and the host strain was 
viable.
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The plasmids pMJH7EX2, pMJHY121F and pMJHY121A were each transformed 
into GLW40(DE3) and GLW40(DE3)pLysS and plated onto LB plates containing 
antibiotics where appropriate. Following growth on rich medium for 12 hours, 
minimal medium plates containing antibiotics and supplements where appropriate 
were streaked. The minimal medium plates were then incubated for 24 hours and 
checked for growth with a further check for growth after 60 hours. The results are 
summarised in Table 6 .1 and a number of the plates are shown in Figure 6.2.
3
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W.T. is E. coli GLW40(DE3)pMJH7EX2.
Y121F is E. coli GLW40(DE3)pMJHY121F.
Y121A is E. coli GLW40(DE3)pMJHY121 A.
Figure 6.2. Functional tests of mutants and ‘wild-type’ using complementation 
on minimal medium. MM indicates minimal medium, TET+CAM indicates the 
inclusion of tetracycline (12.5pgml-l) and chloramphenicol (ITpgmF^). SUPPS 
indicates the inclusion of aromatic supplements as detailed in the legend for Table 6.1. 
CAM was added to plates when pLysS was present with pMJH plasmids.
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6.3. Specific activities of the crude extracts for the mutants.
Unsuccessful attempts were made to purify both of the mutant S. aureus chorismate 
synthases. The purification of ‘wild-type’ chorismate synthases, generally, is made 
more difficult by the reduced solubility of the apoenzyme. Flavin dissociates from the 
enzyme during purification (Kd for oxidised flavin with EPSP absent is 7.15pM for 
the S. aureus enzyme) and the flavin is completely removed during absorption of the 
enzyme to cellulose phosphate in the final affinity chromatography step of 
purification. The enzyme can be stabilised during purification by the addition of 
glycerol as a co-solvent.
The crude extract of the alanine mutant was noticeably less yellow than the crude 
extracts of the phenylalanine mutant and the ‘wild-type’. Furthermore during 
purification the pool of ehorismate synthase activity obtained after DEAE-Sephacel 
eliromatography was colourless compared to the light yellow coloured enzyme pool 
obtained with the phenylalanine mutant and the more obviously yellow coloured pool 
obtained with the ‘wild-type’. Enzyme activity was lost dramatically upon dialysis of 
the DEAE-Sephacel pool from the alanine mutant in lOmM KPi buffer, pH6 .6  due to 
precipitation of the enzyme. Millar, (1988) observed that during the attempted 
purification of E. coli chorismate synthase from a strong overprodueer at least 90% of 
activity was lost during the dialysis, a problem overcome by Ramjee, (1992) with the 
inclusion of glycerol.
Plasmid
Volume
(ml)
Protein
(mg)
Activity
(U)
Specific activity 
(Umg-i)
pMJH7EX2 80 1 2 1 0 416 0.34
pMJHY121F 80 748 23.2 0.031
pMJHY121A 70 1390 2.94 2.12 X 10-3
Table 6.2. Specific activities of chorismate synthase mutants and ‘wild-type’ 
from attempted purifications. Specific activities were determined using the 
standard assay and values were also examined by adding enzyme before the 
photoreducing step to avoid the addition of large volumes of sample and thus 
dissolved oxygen.
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As a consequence o f these problems, the S. aureus mutants were not successfully 
purified past eliromatography on DEAE-Sephacel. The mutants were compared 
instead by examining the specific activity of crude extracts as detailed in Table 6.2. 
The spécifié activity of the alanine mutant was at least 150 fold less than the ‘wild- 
type’ while that of the phenylalanine mutant was around 10 fold less. The mutant 
enzymes were known to be soluble in the crude extracts as evinced by their presence 
in the soluble supernatant fraction after lysis with lysozyme.
6.4. Chapter summary.
Tyrosine 121 of aureus chorismate synthase was changed to either phenylalanine or 
alanine using the PCR mutagenesis strategy of Higuchi et aL (1988). The two mutant 
enzymes were expressed to high levels, however, the levels of expression achieved 
were observed to be lower than those observed for the wild-type S. aureus chorismate 
synthase.
Activity of the two mutants was determined by their ability to complement the Aro" 
phenotype of E. coli GLW40. While both the wild-type and phenylalanine mutant 
enzymes were able to complement the aroC mutation the alanine mutant was not. 
Changes to the activity of the mutant chorismate synthases was confirmed by an 
observed reduction in the specific activities of the mutant enzymes compared to wild- 
type enzyme when assayed in crude extracts.
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CHAPTER 7. PURIFICATION AND CHARACTERISATION 
OF E. COLI FLAVIN REDUCTASE.
This chapter describes the purification and characterisation of a flavin reductase from 
E. coli. This enzyme was purified to analyse possible interactions between E. coli 
chorismate synthase and flavin reductase.
7.1. Purification oiE . coli flavin reductase.
E. coli flavin reductase was purified from 14g (wet weight) of E. coli 
BL21(DE3)pLysEpFREX2 using three chromatographic steps of DEAE-Sephacel, 
phenyl sepharose and S-200 gel filtration. The protocol was similar to the method 
previously published by Fontecave et a l (1987) for purification from wild-type E. coli 
C600 but included a number of changes as detailed in section 2.23. The purification 
yielded around 2 0 mg of enzyme which was apparently homogeneous as judged by 
Coomassie-stained SDS-PAGE. The chromatographic profiles of the enzyme on the 
two columns are detailed in Figures 7.1, 7.2 and 7.3 while Table 7.1 summarises the 
purification.
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Figure 7.1. Elution profile of E. coli flavin reductase from DEAE-Sephacel.
0^280 (•), Activity (o).
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The pLysE plasmid was incorporated into the expression system for the expression of 
E. coli flavin reductase to relieve the problem of extremely slow cell growth. This 
may be a consequence of the possibly detrimental reduction of most of the free flavins 
within the cell and/or NAD(P)H being shunted through the flavin reductase reaction 
depleting cellular ‘energy’ reserves. In addition, NAD(P)H:flavin reductase has been 
demonstrated to be a selective superoxide radical generator under aerobic conditions 
(Gaudu et a/., 1994) and it may be the toxicity of this which was retarding growth. 
Cells after overexpression were observed to be very pale in colour in contrast to the 
usual golden colour.
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Figure 7.2. Elution profile of E. coli flavin reductase from phenyl sepharose.
Arrow indicates elution of the enzyme using a step of lOmM Tris-HCl pH7.5 from 
50mM TriS“HCl pH7.5. OD280 (*), Activity (o).
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Step
Total
protein
......
Total
activity
(U)
Specific 
activity 
(U mg-i)
Yield
(%)
Pui’ification
(-fold)
Crude extract 987 1,612 1.63 1 0 0 1
DEAE-Sephacel 192 4,322 23.74 268 14.6
Phenyl sepharose 79.5 6,378 80.2 396 49.2
S-200 19.2 3,513 183 218 112.3
Table 7.1 Summary of the purification of E. coli flavin reductase from E, coli 
GLW40(DE3)pLysEpFREX2. Assays for activity were performed as per standard 
assay (section 2.19) with riboflavin as substrate and NADPH as cofactor.
300 c3
40 45 50 55 60 65 70 75
Fraction number
Figure 7,3. Chromatography of E, coli flavin reductase using S-200 gel 
filtration. OD280 (•), Activity (o).
:
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E. coli flavin reductase was ultimately resuspended in the minimum volume of 50mM 
Tris-HCl pH7.5, 0.4mM DTT, 1.2mM PMSF, 50% glycerol after ammonium sulphate 
precipitation and stored at -20°C. The purification of E. coli flavin reductase yielded 
around 2 0 mg of apparently pure enzyme and this was despite expression being 
minimised with the inclusion of the pLysE plasmid. The use of the pLysS plasmid 
would be more useful for obtaining large yields of enzyme for more detailed kinetic 
analysis or crystallography.
Î
7.2. Protein concentration determination using the extinction coefficient of 
flavin reductase.
The concentration of flavin reductase was determined spectrophotometrically at 
280nm using the method described by Gill & Von Hippel, (1989). The extinction 
coefficient was calculated using the number of tyrosine, tryptophan and cysteine 
residues present and determining the optical density of the protein in water and 6 M 
guanidine hydrochloride. SM.Nat the extinction coefficient of flavin reductase in water
was calculated to be 23,800 M'^cm-f
7.3. Dependence of flavin reductase activity on the concentration of riboflavin, 
FMN, FAD, NADPH and NADH.
■i
Although the aim of purifying the flavin reductase was to investigate possible 
interactions with E. coli chorismate synthase a re-evaluation of the steady-state 
kinetics was thought to be necessary since earlier work with the enzyme was done 
using enzyme which was only 25% pure. The dependence of flavin reductase activity 
on the concentration of the substrates, riboflavin, FMN or FAD and on the 
concentration of cofactor, NADPH or NADH is shown in Figures 7.4, 7.5 and 7.6. 
The Vmax of the enzyme with each of the flavins and cofactors was also determined. 
The purity of the enzyme in the previous study had been too low to permit these 
calculations. Comparison of the apparent K^s obtained in this study with those of the 
previous study were in broad agreement but generally lower overall. The V^ax of the 
enzyme was considerably greater than had been suggested in the earlier study as 
shown in Table 7.2 and reveals the enzyme to have a very high value for kcat/Km, the 
measure of catalytic efficiency.
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Figure 7.4. Determination of apparent for flavins with NADPH as reductant.
A double reciprocal plot showing the dependence of flavin reductase activity on the 
flavin concentration with 0.25mM NADPH. Standard assays were performed as 
described in ‘Materials and Methods’ with varying riboflavin (■) or FMN(A) 
concentration in 50mM Tris-HCl pH7.5. Assays were initiated with 0.13pg and 
6.356pg of enzyme, respectively.
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Figure 7.5. Determination of apparent Km for flavins with NADH as cofactor. A
double reciprocal plot showing the dependence of flavin reductase activity on the 
flavin concentration with 0.25mM NADH. Standard assays were performed with 
varying riboflavin (o), FMN(*) or FAD(A) concentration in 50mM Tris-HCl pH7.5. 
Assays were initiated with 0.13pg, 0.32|ag and 0.64pg of enzyme, respectively.
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Figure 7.6. Determination of apparent for NADPH and NADH with 
riboflavin as substrate. A double reciprocal plot showing the dependence of flavin 
reductase activity on the NADPH (o) or NADH (•) concentration with 0.3pM 
riboflavin. Standard assays were performed as described in ‘Materials and Methods’ 
with varying NADPH or NADH concentration in 50mM Tris-HCl pH7.5. Assays 
were initiated with 0.095 pg of enzyme.
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Substrate Second
substrate
Apparent 
Km (pM)
k^ cat
(s-1)
kcat/Km
(M-^s-l)
^max
(Umg"l)
Riboflavin NADH 0.23 42.1 1.8 X 108 96.4
FMN NADH 0.51 25.5 5 X 10^ 58.4
FAD NADH 0.67 17.0 2.5x107 38,9
Riboflavin NADPH 0.96 76.5 7.97 X 107 175.2
FMN NADPH 1.89 9.4 4.97x106 21.6
FAD NADPH - - - -
NADH Riboflavin 19.9 nd nd nd
NADPH Riboflavin 28.4 nd nd nd
Table 7.2. Kinetic parameters for flavins and pyridine nucleotides for E. coli 
flavin reductase, nd indicates not determined.
7.4. Molecular weight determination of flavin reductase.
The molecular weight (Mr) of E. coli flavin reductase was measured by electrospray 
mass spectrometry as 26,115.00 ± 0.82 (Figure 7.7), consistent with the migration 
position observed with SDS-PAGE. The predicted Mr of the enzyme from translation 
of the DNA sequence with the N-terminal methionine removed is 26,113. The N- 
terminal methionine was shown to be removed from the protein in the previous study 
ofSpryoue/a/. (1991).
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Figure 7.7. Electrospray mass spectrum of E, coli flavin reductase. The lower 
spectrum over the Mr range shown (25,500-26,500) was obtained using the MaxEnt 
deconvolution programme on the raw data (upper spectrum).
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Figure 7.8. BIAcore analysis. Flavin reductase binding to the sensor chip with a 
corresponding increase in refractive units (RU) from 13,500 to 23,721.
7.5. Investigation for an interaction between flavin reductase and chorismate 
synthase.
E. coli flavin reductase was immobilised to the sensor chip using coupling buffer, 
sodium acetate pH 4.2, followed by washing of the chip with the same buffer (Figure
7.8). The final amount of enzyme that was bound corresponded to an increase of 
10,221 refractive units. E. coli chorismate synthase was tested for binding (Figure
7.9) in the absence of any other ligand and in the presence of FMN, EPSP or NADH. 
The experiment was also repeated with chorismate synthase first immobilised onto the 
sensor chip and binding tested with flavin reductase. This reversed order produced 
essentially the same result. The lack of an increase in the number of refractive units 
after each addition of enzyme/and ligand (large increase in RU) and washing (drops 
back to start point) of the chip demonstrated the lack of any binding between the two 
enzymes. 1
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Figure 7.9. BIAcore analysis. Chorismate synthase (SOjaM) was tested for binding 
to immobilised flavin reductase (50|uM) in the absence of any other ligands (1) and in 
the presence of stoichiometric amounts of FMN (2), EPSP (3) or NADH (4) relative 
to chorismate synthase.
7.6. C hapter summary.
E. coli flavin reductase encoded by the fre  gene was purified to homogeneity in tliree 
steps. Nearly 20mg of enzyme was obtained with a specific acivity of 183 Umg-^ in 
the standard assay. This value was higher than that previously estimated for the 
enzyme from a partially pure preparation (Fontecave et a l, 1987). The Km of the
enzyme for riboflavin, FMN and FAD were very similar to those demonstrated in the 
same study. The subunit molecular mass of the enzyme was determined to be 26,115, 
which is consistent with a predicted mass of 26,113 from translation of the gene with 
the N-terminal methionine having been removed.
Biacore analysis was used to demonstrate that E, coli chorismate synthase does not 
interact intimately with the E. coli flavin reductase encoded by the fre  gene. This 
confirms that E. coli chorismate synthase does not require intimate contact with this, 
the main, flavin reductase to obtain reduced flavins.
I
#
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CH A PTER 8 . GENERAL DISCUSSION.
The aim of this project was to clone the gene encoding chorismate syntliase from the 
pathogen Staphylococcus aureus and subsequently express the encoded protein to high 
levels for purification. Thereafter the enzyme would be investigated kinetically with both 
steady-state and pre-steady-state techniques in order to compare the pure enzyme with 
other chorismate synthases studied to date. As detailed in the preceding chapters the 
gene encoding chorismate synthase was cloned together with the gene encoding 
nucleoside diphosphate kinase and two partial open reading frames encoding regions of 
3-dehydi'oquinate synthase and a heptaprenyl pyrophosphate synthetase. Chorismate 
synthase was successfully purified to near homogeneity and was studied kinetically in 
some detail.
The aroC gene encoding chorismate synthase and the ndk gene encoding nucleoside 
diphosphate kinase were cloned from a chnical isolate of Staphylococcus aureus by 
complementation of the Aro" phenotype of the aroC E. coli strain, GLW40. The genes 
were isolated on a 5.5kb Clal restriction fragment forming plasmid pMJH701. This 
plasmid was also found to complement the Aro" phenotype of die aroA E. coli strain 
AB1321. Subsequent restriction mapping of pMJH701 and its compaiison witli 
pCOC102 demonstrated that it contained the complete aroC gene and the complete aroA 
and aroB genes which had been identified previously (O'Connell et aL, 1993). A 2.5kb 
McI-C/tzI restriction fragment from pMJH701 which was expected to contain the aroC 
gene was cloned to form pMJH702 and the complete nucleotide sequence of this was 
determined.
Sequencing of pMJH702 confirmed the presence of the complete coding sequence for 
chorismate synthase and revealed tliat the complete open reading frame for nucleoside 
diphosphate kinase was located around 500bp upstream from the aroC gene. In addition 
two partial open reading frames (ORFs) were contained within pMJH702. The 5 ' end of 
an ORE which had similarity with the aroB gene, encoding 3-dehydroquinate synthase, 
of B. subtilis was located immediately downstream of the aroC gene. Immediately 
upstream from the ndk gene was the 3' end of a second partial ORE, the translated 
product of which had similarity with the putative gerCC gene product from B. subtilis.
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The low G+C content of the sequenced DNA was consistent with the value of 33% 
determined for the S. aureus chromosome (de Ley, 1970) and the codon usage pattern of 
the aroC and ndk genes was also consistent with the low G+C content. The codon 
usage further supported observations made with E. coli andB. subtilis. In these bacteria 
more highly expressed genes are observed to display a non-random pattern of codon 
usage, utilising a restricted set of codons that are recognised by the major species of 
isoacceptor tRNAs, whereas genes expressed at low levels display a random codon 
usage pattern (Grantham et aL, 1981; Ikemura & Ozeki, 1983). The AUA codon 
(isoleucine) is rarely used in highly expressed genes in E. coli and B. subtilis. The gene 
encoding nucleoside diphosphate kinase is known to be highly expressed in the 
organisms in which it has been studied and the S. aureus ndk gene contains no AUA 
codons (0 of 12) while aroC contains 5 (of 35) AUA isoleucine codons. The gene 
encoding chorismate synthase belongs to the group of lowly expressed genes.
Pr omoter region -35 -1 0
pTlSlrepC ATTAGA TGTTAT
pT181-cr TCTTGA TTTAAT
pTlSlprc TATTAA TAGACT
pTlSUc^ AGCGAA AACAAA
agr-Fl TAATGA TCGTAT
p llS m a Z TTGACA TATTAT
spa TTGCAA TATGAT
hla TTGATT TATTTT
aroC ATGAAT TATTAT
ndk TTGAAA TAATAT
E. coli consensus TTGACA TATAAT
B. subtilis consensus TTGACA TATAAT
Taken from Novick (1990).
T ab le  8.1, Staphylococcus aureus  p rom oter regions.
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Putative promoter sequence elements and ribosome binding sites were located upstream 
from both the aroC and ndk genes. Novick, (1990) reported a variety of sequences 
corresponding to -35 and -10 promoter regions for S. aureus. Many of these were from 
plasmid encoded genes with few being chromosomally encoded. The putative promoter 
sequence elements identified in this study matched more closely those obtained for 
cliromosomally encoded genes and were also similar to the -35 and -10 consensus 
regions of E, coli and B. subtilis promoters (Table 8.1).
In S. aureus the aroC gene is likely to form the first gene in an operon which includes 
the aroB and aroA genes. Evidence to support this includes, firstly, the demonstration 
by O'Connell et aL, (1993) that temperature sensitive plasmids which were forced to 
integmte into the chromosome 5" to aroA produced an Aro" phenotype. Secondly, in 
this study a putative consensus promoter was identified 5 ' to the aroC gene while no 
such sequences were observed 5" to the aroB gene (this study) or the aroA gene 
(O'Connell et aL, 1993), A further piece of evidence which may support an 
aroCaroBaroA operon in S. aureus comes from a compaiison with the gene organisation 
of theB. subtilis chromosome. In B. subtilis the aroF, aroB and aroH genes encoding 
chorismate synthase, dehydioquinate synthase and chorismate mutase, respectively, 
form the start of an aro-trp-aro ‘supraoperon’ of thirteen genes concerned with the 
biosynthesis and transport of aromatic amino acids. In the absence of tryptophan the 
aroFaroBaroH genes are transcribed as a unit (Henner & Yanofsky, 1993). This atv 
operon is preceded by the cheR and ndk genes and the gerCAgerCBgerCC operon. In 
this study the ndk gene and the gerC genes of S. aureus were located upstream from the 
aroC, aroB and aroA genes. As shown in Figui'e 8.1 there are obvious similarities in 
gene organisation in these regions of the S. aureus and B. subtilis chromosomes. This 
similarity in gene organisation between the two organisms may also extend to 
tianscription of the genes such that the S. aureus aro genes are also transcribed as a unit.
Physical mapping experiments with S. aureus have shown that aroA (and thus aroB and 
aroC) aie linked to tyrB (O'Connell et aL, 1993) while the tip operon is linked to tyrA 
which maps some distance from tyrB (Pattee, 1981). The cheR gene which is situated 
between ndk and aroF in B. subtilis was not observed in S. aureus. The cheR gene 
encodes a receptor-methylating enzyme involved in motility and transfers methyl groups 
from S-adenosylmetliionme (SAM) to the méthylation chemotaxis proteins. S. aureus is 
a non-mo tile organism and the absence of the cheR gene is likely to reflect this.
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Although there is no similar aro-trp~aro ‘supraoperon’ in S. aureus it has been 
demonstrated in this study that the ndk genes and the gerCAgerCBgerCC genes are 
situated upstream from the aroCaroB genes as is observed m B. subtilis,
aroR aroB aroF cheR ndk gerCC gerCB gerCA
B. subtilis
aroA aroB aroC ndk gerCC gerCB gerCA
S. aureus
aroA aroB aroC ndk gcrCC gerCB gerCA 0.7kb 
►pMravoi
4 " "  ^
pMIH702
Figure 8.1. Schematic diagram  representing a map of the gerC, ndk, aro region of 
the S. aureus chromosome. The positions of the ndk and the aro genes were 
determined from the DNA sequencing data obtained in this study and from the 
previous work of O'Connell et al. (1993). The positions of the gerC  genes are shown 
by dashed arrows indicating approximate locations based on hybridisation analysis data 
obtained in this study and using the sizes of the B. subtilis genes (Henner et al., 1986). 
The map also indicates the positions of the inserts of pMJH701 and pMJH702. The 
restriction enzymes are abbreviated as follows: A, Accl; C, CM ; E, BcoRI; RV, 
EcoBN\ H, Hwcffll; N, Ndel\ P, Pst I.
The observed linkage between the gerC and the aro genes in S. aureus and B. subtilis 
may have a functional explanation. The gerCC gene of B. subtilis has 65% identity 
with an open reading frame (0RF3) in Bacillus stearothermophilus which encodes 
heptaprenyl pyrophosphate synthetase (Koike-Takeshita et aL, 1995). This heptaprenyl 
pyrophosphate synthetase has been demonstrated to be involved in the synthesis of the 
polyprenyl side-chain of menaquinone in this organism (Koike-Takeshita et aL, 1995; 
Takahashi et aL, 1980). The high level of identity observed between the genes from B. 
subtilis and B. stearothermophilus suggests that the gerCC gene of B. subtilis similarly 
encodes the heptaprenyl pyrophosphate synthetase involved in menaquinone
II
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biosynthesis. Since menaquinone biosynthesis is a post-chorismate pathway the close 
Ihikage of the gerC genes and the aro genes may reflect the greater clustering of aromatic 
pathway genes in these organisms. It would be of interest to determine whether the gerC 
genes of B. stearothermophilus ar e located upstream of aro genes.
The S. aureus ndk gene encodes a protein with a liigh level of identity to other known 
Ndk sequences. The ndk gene belongs to the class of highly biased genes in E. coli and 
is highly expressed in aU of the bacteria in which it has been studied. It is the only 
enzyme responsible for the phosphorylation of nucleotides other than ATP in Salmonella 
typhimurium (Ginther & Ingraham, 1974). The initiating metliionine codon of the 5 . 
aureus ndk gene was found to be GUG. In E. coli the use of a non-AUG codon serves 
to limit expression of a gene at the translational level. However, this situation does not 
appear to be reflected in B. subtilis and other clostridial branch Gram-positive organisms 
where nearly 30% of genes have non-AUG initiation codons. Instead it has been 
suggested that translational efficiency is controlled more by the strength of the Shine- 
Dalgarno (SD) sequence and as strength of the SD sequence increases differences 
between AUG, GUG and UUG in terms of translational efficiency is moderated 
(Vellanoweth, 1993). Consequently the ribosome binding site of the S. aureus ndk gene 
may be of more importance to translational efficiency than the GUG codon.
Nucleoside diphosphate (NDP) kinases ai'e ubiquitous enzymes that catalyse the transfer of 
the y-phosphate of nucleoside triphosphates to nucleoside diphosphates. These enzymes 
show very little specificity for the base and the sugar*. Any ribonucleotide triphosphate 
(NTP), deoxyribonucleotide triphosphate, ribonucleotide diphosphate (NDP) or 
deoxyribonucleotide diphosphate can be used as a substrate. The reaction is reversible and 
occurs in two steps (ping-pong mechanism), with the formation of a phosphoenzyme 
intermediate (Par'ks & Agarwal, 1973; Almaula et aL, 1995).
-j'j.
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The primary role of NDP kinase m the cell has been suggested to be the maintenance of a 
pool of nucleotide triphosphates for the synthesis of DNA and RNA. Furthermore, NDP 
kinase has been reported to be the only enzyme responsible for catalysing this reaction in 
Salmonella typhimurium (Ginther & Ingraham, 1974) and has also been found to be 
essential in Myxococcus xanthus (Munoz-Dorado et aL, 1990a,b). The Drosophila awd 
gene involved in larval development encodes an NDP kinase (Rosengard et aL, 1989).
$
General Discussion. 122
The enzyme has been imphcated as a tumour suppressor candidate in studies of 
prohferating malignant human cells. NDP kinases have been reported to be associated 
witli protein complexes in vivo and aie believed to participate in the DNA replication 
machineiy. NDP kinase has been found to be present in highly purified bacterial DNA 
polymerase preparations (Miller & Wells, 1971) and was reported to associate with 
ribonucleotide reductase (Allen et al., 1983). NDP kinase has also been proposed as a 
novel protein kinase without sequence similarities to die classical protein serine-threonine 
kinases (Hanks et al, 1988).
The ciystal structure of Myxococcus xanthus nucleoside diphosphate kinase has been 
deteimined (Williams et al., 1993) and would allow modeUing of the S. aureus 
sequence. The E. coli enzyme has been modelled based on the M. xanthus structure and 
utilising die high identity that exists between Ndk enzymes (Almaula et a i, 1995).
The original observation diat aro mutants of sahnonellae were avirulent and confened 
protection against challenge with a virulent strain has led to the production of aro mutants 
in a variety of bacterial species which are attenuated and stimulate protective immunity. 
To date these include: Salmonella typhimurium (Hoiseth & Stocker, 1981), Salmonella 
typhi (O'Callaghan et al., 1988), Salmonella choleraesuis (Nnalue & Stocker, 1987), 
Shigella flexneri (Verma & Lindberg, 1991), Bordetellapertussis (Roberts et a i ,  1990), 
Yersinia enterocolitica (Bowe et al., 1989) Aeromonas salmonicida (Vaughan et al., 
1993) mà. Bacillus anthracis (Ivins et a l, 1990).
The production of an aro mutant of Staphylococcus aureus which was attenuated and 
which stimulated protection against challenge with a virulent str ain would have obvious 
commercial benefit. The ever increasing problem of methicdlin resistant Staphylococcus 
aureus (MRSA) strains in hospitals has significandy added to the spread of antibiotic 
resistance and reduced the number of antibiotics which can be used to successfully treat 
infected patients. In addition, the problem of staphylococcal mastitis is of concern to the 
dairy industry and efforts to produce a vaccine could significantly reduce the problem.
O’ Connel et a i  (1993) isolated S. aureus aroAvl^c  ^insertion mutants in air attempt to 
obtain attenuation of strain 8325-4. They succeeded in isolating an allelic replacement 
mutant which required aromatic amino acids for growth, however, the strain was able to 
grow in the absence of PABA. Integration of aroA deletion plasmids into the 
chromosome of strain 8325-4 produced a PABA and aromatic amino acid dependent
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phenotype. These strains were unsuitable for in vivo virulence and growth experiments 
and were very unstable reverting at high frequency. Tire authors suggested that the 
inabihty to isolate stable replacement mutants which were PABA and aromatic amino 
acid dependent was possibly the result of such an insertion mutant being lethal. This is 
unprecedented to date for the pre-chorismate pathway. However, there is the possibility 
that some uncharacterised essential metabolic pathway that is requhed for growth 
branches from chorismate in S. aureus.
The characterisation of the aroC gene in this study, wliich is likely to form the first gene 
in an operon with aroB and aroA, would allow a further study of the abüity to produce 
attenuation of S. aureus using aro mutants. It would be of very great interest to 
determine if the failure of O'Connell et al. (1993) to obtain stable PABA and aromatic 
amino acid dependent mutants was a consequence of an uncharacteiised essential 
metabolic pathway or merely the instability of the integration mutants produced. There 
would now also be the possibility of producing integration mutants in multiple atv genes 
albeit at the same locus.
The S. aureus aroC gene was found to be expressed in E. coli presumably from a 
promoter on the inserts of both pMJH701 and pMJH702. Since the level of expression 
was poor the gene was amplified using the polymerase chain reaction (PCR) to facilitate 
its cloning, optimally spaced, downstream from the T7 promoter on pTB361. The aroC 
strain of E. coli was successfully lysogenized with the XDE3 phage to produce a 
chorismate synthase free background for expression. This expression system resulted in 
the accumulation of veiy high levels of soluble S. aureus chorismate synthase. The N- 
teiminus and an internal region of the enzyme were sequenced and found to match that 
predicted from the gene sequence. Chorismate synthase from S. aureus was purified to 
near homogeneity, producing lOOmg of enzyme from 13g of cells. This quantity of 
enzyme was necessary for its analysis using steady-state and pre-steady-state kinetics 
and has allowed initial but as yet unsuccessful attempts at crystallising the enzyme.
The sequenced S. aureus aroC gene was found to encode a polypeptide of 388 amino 
acids with a predicted Mr of 43,027 as calculated by the PEPTIDESORT program of the 
GCG package, similar to the Mr of 43,024 ± 3.8 deteimined for overexpressed 
chorismate synthase by electrospray mass spectiomehy. The amino acid sequence of S . 
aureus chorismate synthase was found to have 61% identity (78% similarity) with the 
putative aroF gene product from B. subtilis and 37% identity (57% similaiity) witli 
chorismate synthase from E. coli. Little attention has been paid to the sequence fr om B.
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subtilis previously due to its lower identity when compared with other chorismate 
synthases (excluding S. aureus) which typically share upwards of 50% identity (70% 
similaiity) with each other.
Compaiison of the B. subtilis and S. aureus sequences with the other chorismate 
synthases suggested that these two species may forni a different sequence group, 
iHustiated by the dendrogram produced from the PBLEUP progiam of the GCG package 
(Figure 3.7), The formation of a separate sequence group was also supported using 
immunological analysis. Antibodies raised against chorismate synthase from E. coli 
and/or Corydalis sempervirens have been shown to possess strong inter-species cross­
reactivity with chorismate synthases from higher plants, fungi and bacteria (Schaller et 
al., 1990, 1991a,b; Schmidt et a i, 1993: Hensüand et al., 1995b). This immunological 
cross-reactivity between the chorismate synthases has been reasoned to indicate that 
antigenic déterminants of these enzymes were liighly conserved during evolution 
(Schaller gf a/., 1991a). This study, in contrast, has demonstrated that there was no 
detectable immunological cross-reactivity between S. aureus chorismate synthase and 
antibodies raised against E. coli chorismate synthase. Whüe this indicates that there are 
structural differences between tlie chorismate synthases from S. aureus and E. coli the 
two enzymes must share essential functional identity since the aroC gene from S. aureus 
was cloned using its ability to complement an aroC strain of E. coli.
The subunit structure of S. aureus chorismate synthase was determined using both gel 
filtration and cross-linking with dimethyl-suberimidate. Both of these techniques 
demonstrated that the enzyme exists as a homoteti'amer. This subunit structure was also 
observed for the monofunctional E. coli chorismate synthase and the bifunctional N . 
crassa chorismate synthase (White et a l, 1988). Both the B. subtilis (Hasan & Nester, 
1978b) and the E. gracilis enzymes (Schaller et al., 1991a) have been suggested to be 
tiimers with associated flavin reductase activity (not bifunctional) although in the latter 
case this has yet to be confirmed. Chorismate synthase from Corydalis sempervirens 
has been obseiwed to be a homodimer, and it was suggested Üiat this may be a 
consequence of interaction between chorismate synthase and a putative flavin reductase 
present in tlie plastid (Henstrand et al., 1995a). This subject will be discussed further 
later.
The pH optimum deteimined for S. aureus chorismate synthase was found to be non- 
symmetiical in MOPS buffer witli an optimum of activity around pH 7.0. Other 
chorismate synthases studied to date have been shown to have a pH optimum around
I
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pH8 (Table 8,2) and their more symmetrical bell shaped profile taken as evidence that 
catalysis was not dependent on a single ionisable group (Fersht, 1985; Ramjee, 1992). 
This experiment with S. aureus chorismate synthase was designed merely to determine 
the optimum pH for activity and was not aimed at identifying possible groups involved 
in catalysis. Nevertheless, it is interesting to note the profile obtained and if time had 
permitted tlie V^ax values for the enzyme across the pH range shown could have been 
deteimined with the aim of trying to measure the pK^ value of the amino-acid side 
chain(s) involved in catalysis. The pKa of MOPS buffer is 7.15 at 25°C and as such this 
buffer solution only has useful buffer action in a range of one pH unit on either side of 
this value. A more detailed study would have typically involved a combination of 
buffers or tlie use of buffers of constant ionic strength to minimise possible buffer 
effects.
It should be noted that the pH dependence observed for 5. aureus chorismate synthase 
activity may reflect the partial or complete ionisation of either the substrate or cofactor at 
the various pH values (Fersht, 1985). The interaction between the enzyme and 
substrate/cofactor might then have been altered such that this was the effect being 
obseiwed.
5'. aureus chorisruate synthase was observed to exhibit maximum activity with reduced 
FMN as cofactor. FAD and riboflavin were capable of substituting FMN as cofactor but 
produced lower levels of activity than FMN, 13% and 2.4% respectively. This 
preference is common to all of the chorismate synthases which have been studied to date 
and in N. crassa and B. subtilis may reflect the properties of the associated flavin 
reductase. The S. aureus enzyme, while similar to otlier chorismate synthases with 
regaid to its prefeiTed flavin, exhibited considerably lower levels of activity with FAD 
and riboflavin. A comparison of the E. gracilis, N. crassa, C. sempervirens and E, coli 
chorismate synthases revealed activities for FAD and riboflavin relative to FMN of 73- 
84% and 14-39%, respectively when dithionite was used as reductant (Schaller et a i ,  
1991a). These values are around 6 times greater than the S. aureus enzyme.
I
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Property E. gracilis JV. crassa C. sempervirens E. coli B. subtilis^ S. aureus^
Apparent
(EPSP)
27|lM 2J]xM 53pM l.SpM^ nd 12.7|xM
Apparent
(FMN)
76nM 66nM 37nM “ 12.5pM 4.8^iM
Cofactor
specificity FMN>FAD FMN>FAD FMN>FAD FMN>FAD FMN>FAD FMN>FAD
Flavin reductase Present Present Absent Absent Present Absent
Apparent
(NADPH)
7.4pM 21.4pM - - 78.5pM -
Mr (native) 110-138kD 198kD SO.lkD 162ko3 nd 182-186kD
Mr (subunit) 41.7kD 46.4kD4 41.9kD 39.0kD3 39.9kD 43.0kD
No. of subunits nd 4 2 4 3 4
isoelectric point 5.5 4.9 5.0 6.453 5.5 5.9
pH optimum 8.2 8.1 8.0 7.5-8.03 nd 7.0
nd, not determined.
Table 8.2. Comparison of the properties of chorismate synthases studied  
to date.5
The apparent Km for EPSP of the S. aureus enzyme in MOPS buffer pH 7.0 was 
determined to be 12.7 ± 0.5pM. This value is in accordance with the other chorismate 
synthases studied (see Table 8.2). The enzyme may also be substrate inhibited as 
evinced by tlie slight curvature in the points of the Lineweaver-Burke plot at low values 
of 1/S (Figui'e 5.8). This effect was also observed with the C. sempervirens and E. 
gracilis enzymes (Schaller et aL, 1991a). The apparent Km for FMN of the S. aureus 
enzyme in the same buffer was calculated to be 4.8 ± 0.5jiM. This contrasts with 
apparent Km values for FMN of 76nM, 66nM, and 37nM for the E. gracilis, N. crassa 
and C. sempetyirens enzymes, respectively. These are two orders of magnitude lower 
than the S. aureus enzyme.
 ^ Hasan & Nester, 1978a,b.
^ This study.
 ^Ramjee, 1992.
Henstrand et aL, 1995b.
 ^Taken from Schaller et aL, 1991
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Chorismate synthase from E. coli has been studied using pre-steady-state kinetics in an 
effort to obtain more information about the rates of individual steps on the enzyme 
reaction pathway and to detect transient intermediates.. Kinetic studies under steady- 
state conditions reveal only very hmited information and give an idea of rate constants 
for the slowest step only (Fersht, 1985). S. aureus chorismate synthase was 
investigated using pre-steady state kinetics. This work was not aimed at producing an 
in-depth analysis of the pre-steady state kinetics of the S. aureus enzyme but was instead 
more of a compaiative exercise.
A feature of the work performed previously witli E. coli chorismate synthase was the 
identification of transient absorbance changes during turnover. A difference spectrum of 
an enzyme-bound intermediate during the conversion of EPSP to chorismate was 
determined (Figure 1.4)(Ramjee e ta l ,  1991). The changes in tlie absorbance spectrum 
of FMNH2 were reasoned to be consistent with the formation of a flavin-C4 adduct and 
a charge transfer complex. This was the first demonstration of the intimate involvement 
of the flavin cofactor in the catalytic cycle of a chorismate synthase although the exact 
nature of the intermediate is still unclear".
The S. aureus chorismate synthase reaction was investigated using rapid-scanning 
stopped-flow spectrophotometry to determine if similar transient absorbance changes 
were obser-ved during EPSP turnover. A flavin intermediate was observed during 
turnover and the difference spectrum of this resembled tliat obtained with the E. coli 
enzyme. The spectral characteristics of the S. aureus flavin intermediate were different 
with respect to its maxima, minima and its overall shape (cf. Figures 1.4 & 5.9), 
However, in agreement with the E. coli enzyme was the absence of an increase in the 
amplitude at 580nm confirming that FMN semiquinone was not formed at detectable 
levels during turnover.
Single wavelength (390nm) stopped-flow experiments were carried out to more 
accmately measure tlie kinetics of the intermediate for comparison with the E. coli 
enzyme. This was complicated with the finding that the rate of formation of the 
intermediate was dependent on the substrate concentration (Figures 5.11, 5.12). 
Consequently, the rates of formation and decay could not be simply described by fitting 
two exponentials to tlie data without the introduction of large errors in the rate values. 
However, it was found that the latter part of flavin intermediate decay could be fitted to 
an exponential. This gave a rate (6.5s'l) (Figure 5.11) which was eight times slower
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than that observed for the E. coli enzyme (52s'l) (Bomemann et aL, 1995) and this 
compares well with a 7 fold lower Vmax-
A further comparison of the kinetics of the 5. aureus enzyme with the E. coli enzyme 
was carried out using analogues of EPSP under steady-state conditions and monitoring 
the formation of the product diene. As a means of investigating the reaction 
mechanism o f both the N. crassa chorismate synthase and the E. coli chorismate 
synthase deuterated analogues of EPSP have been used.
2-O3PO'' " y  " O ' 'c o g -  
OH
(6R)-[6 %]EPSP
Primary kinetic isotope effects, which result from the cleavage of the bond to the atom 
which has been isotopically substituted, have been observed with both enzymes using 
(6R)-[6^H]EPSP. The presence of this primary kinetic isotope effect indicates that 
cleavage of the C-(6^roR)H bond of EPSP is rate limiting. A moderate primary kinetic 
isotope effect of 6proR^HV=2.7± 0.2 for the N. crassa enzyme (Balasubramanian et aL, 
1990) and a small and insignificant, primary kinetic isotope effect of 6proR2HV“ 113±
0.03 for the E. coli enzyme (Bomemann et aL, 1995) have been detected. The S. 
aureus enzyme was investigated with quadruplicate assays and a very small kinetic 
isotope effect of 6proR^HV=1.02± 0.06 was obtained. Further assays would be required
to confirm this value given the error associated with the isotope effect. However, it 
would appear that there is no significant primary kinetic isotope effect associated with 
the S. aureus enzyme indicating that C(6)-H bond-breaking is not rate-limiting. The 
large value, by comparison, associated with the N. crassa enzyme may be a 
consequence o f the bifunctional nature of this enzyme and may indicate that C-H bond 
breaking at the C-6 position is rate limiting with this particular enzyme.
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The S. aureus enzyme was titrated with EPSP in the presence of approximately 
stoichiometric amounts of oxidised flavin and was found to bind one molecule of EPSP 
per subunit. Furthermore, the enzyme was observed to bind oxidised flavin both in the 
presence and absence of EPSP. The spectral characteristics of oxidised flavin were 
altered upon binding by the S aureus enzyme. This contrasts with the E. coli enzyme 
which does not bind oxidised flavin as judged by the absence of spectral changes to the 
flavin upon addition of enzyme. As a consequence of the S. aureus chorismate synthase 
binding oxidised flavin the Kd for FMNqx was calculated, A value of KpPMNox =
7.15|aM was determined and in the presence of 50|aM EPSP this was reduced to 
2.42|iM. The presence of EPSP thus enhances the binding of FMN to the enzyme.
Further comparisons of S. aureus chorismate synthase with the E. coli enzyme were 
caiTied out with respect to flavosemiquinone formation. FMN bound to the E. coli 
enzyme has been observed to form a radical under conditions where EPSP was added to 
enzyme with reduced flavin bound. Similarly, a flavosemiquinone is formed under 
conditions where FMN is photoreduced when bound to the enzyme in the presence of 
(6R)-6F-EPSP (P. Macheroux, unpublished). A flavin radical was coiTespondingly 
detected when each of these experiments were performed using the S. aureus enzyme. 
There is as yet no explanation for the observation of this radical with EPSP and 6R-6F- 
EPSP other than the fact that the ligand is perturbing the FMN redox potential. In the 
case of EPSP it is not known whether tlie radical would be formed in vivo. Although 
the flavin radical can not yet be explained its observation during experiments with both 
the E. coli and the S. aureus enzymes suggests that it may be a feature of all chorismate 
synthases.
The chorismate synthase reaction is unusual due to its absolute requirement for a reduced 
flavin cofactor despite the absence of an overall change in redox state. As a means of 
further investigating the binding of reduced flavin to the S. aureus chorismate synthase 
site-directed mutagenesis was used. The possibility of using site-directed mutagenesis to 
analyse the enzyme was limited by the lack of structural information. However, 
examination of a number of flavoproteins using both crystallography and site-directed 
mutagenesis has demonstrated the involvement of residues, which are usually 
hydrophobic and often aromatic, in the binding of FMN (Shen et aL, 1989; Porter, 
1991; Klein & Fulco, 1993; Oster et al, 1991). These residues which are located above 
and below the isoalloxazine ring, help to maintain a hydrophobic environment for the 
flavin and may participate in stacking interactions with the isoalloxazine ring. In rat hver 
NADPH cytochrome P-450 oxidoreductase two tyrosine residues are involved in
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binding of FMN to the protein (Shen et a i,  1989). The replacement of Tyr-148 in this 
enzyme with aspartate completely abolished FMN binding and cytochrome c activity. 
Replacement of Tyr-148 with the conservative replacement, phenylalanine did not 
substantially affect activity. Shnilarty crystallographic analysis of Desulfovibrio vulgaris 
flavodoxin has demonstrated the involvement of both tyrosine and tryptophan residues in 
binding FMN (Porter & Kasper, 1985).
The mutagenesis of tyrosine 121 of S. aureus chorismate synthase (130 in multiple 
sequence lineup, Figm*e 3.6) was therefore based upon the premise that tyrosine residues 
are known to be important for flavin binding in a number of flavin-cofactor requiring 
enzymes. Furthermore, a comparison of the chorismate synthase sequences known to 
date revealed only one completely conserved tyrosine residue. There are no tryptophan 
residues in S. aureus chorismate synthase. The conserved tyrosine was replaced with 
phenylalanine or alanine, using PCR, producing the two mutants Y121F and Y 121 A. 
The purification of these two mutants was hampered by precipitation after fractionation 
on DEAE-sephacel and their successful purification may ultimately requhe a different 
strategy from that of tlie wild-type. However, the enzymes were observed to be present 
in the soluble, supernatant fraction during crude extract preparation and this allowed tlie 
specific activities of tlie mutant enzymes to be demonstrated in an unpur ified state. The 
phenylalanine mutant, Y121F was found to have around 10% activity compared to the 
‘wild-type’ wliile the specific activity of tlie alanine mutant proved very difficult to 
measure in crude extracts but was detennined to be at most 1% that of the ‘wild-type’. A 
feature of the Y 121A mutant was the dramatically less-yellow colour of the cnrde extract 
when compared to the ‘wild-type’ possibly indicating that less flavin was bound to the 
this mutant enzyme. The Y121F mutant crude extract was not visibly less yellow than 
the ‘wild-type’ although no absolute values for flavin absorbance were obtained for any 
of these enzymes.
I
While it may appear’ tliat the mutagenesis of tyrosine-121 of S. aureus chorismate 
synthase has altered flavin binding it is stressed that a more thorough analysis of these 
mutants would be required before such claims could be confirmed. There was an 
obvious effect on the activity of the enzyme, however, and techniques such as chcular 
dichroism may be required to help establish that disturbance of the protein fold and 
structural characteristics of the enzyme have not resulted from the mutagenesis. The 
amino acid substitutions made have been suggested to be “safe” in site-directed 
mutagenesis (Bordo & Argos, 1991). However, the absence of confor-mational changes 
would need to be confirmed.
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Another of the interesting features of chorismate synthase is its often intimate 
relationship with NAD(P)H-dependent flavin oxidoreductase activity. The B. subtilis 
and tlie E. gracilis chorismate synthases are isolated in complex form with separable 
flavin reductase activities while the N. crassa would appear to have flavin reductase 
activity embedded within the chorismate synthase sequence (Henstrand et aL, 1995b). 
The relationship of the monofunctional chorismate synthases with flavin reductase 
activity remains unexplored and it is often suggested that ‘endogenous’ flavin reductase 
activity is responsible for providing the reduced flavin cofactor required for catalysis. It 
is interesting to note that some chorismate synthases have become associated intiinsically 
or otherwise with flavin reductase activity duiing evolution while others have not.
Previous research with luciferase from Vibrio harveyi and Photobacterium fischeri has 
demonstrated tliat the kinetics of the luciferase were altered in the presence of flavin 
reductase activity (Duane & Hastings, 1975; Jablonski & DeLuca, 1978). For example, 
when luciferase was present in the flavin reductase assay the apparent values for 
NADH, NADPH and FMN were lowered. The kinetic pattern of the NADPH-specific 
reductase was found to change from a ping-pong mechanism to a sequential mechanism. 
This was suggested to be evidence that the flavin reductase was an important source of 
reduced FMN to luciferase and that the transfer of reduced flavin from the reductase to 
luciferase occurs via a complex rather than diffusion of tlie reduced flavin through 
solvent (Duane & Hastings, 1975; Jablonski & DeLuca, 1978). However, the 
mechanism of transfer of the reduced flavin has not been unambiguously determined. 
The Vibrio haiyeyi NADPH:FMN oxidoreductase has been crystallised and this may 
help determine whether complex formation occurs (Tanner et aL, 1994).
As a means of investigating possible interactions between a monofunctional chorismate 
synthase and a flavin reductase the fre  gene encoding flavin reductase in E. coli, as 
published previously (Spryou et aL, 1991), was amphfied by PCR and cloned into die 
expression vector pTB361. The enzyme was tlien purified to homogeneity using a 
modified procedure of Fontecave et al. (1987). The DNA sequence of the amphfied 
gene was checked by sequencing and the purified enzyme had a mass of 26,115 ± 0 .8 2  
similar to that of the translated gene sequence (26,113) with the N-terminal methionine 
removed as calculated by the PEPTIDESORT program of the GCG package. The 
kinetics of the flavin reductase were re-evaluated since the previous study of Fontecave 
et al. (1987) had used enzyme with a purity of around 25% and further analysis would 
requhe accurate determinations of the kinetic parameters of the enzyme.
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The kinetic parameters of the purified E. coli flavin reductase were observed to be 
different from those published previously most likely as a result of the increased purity 
of the preparation. However, relative properties with regard to different flavins as 
substrates were the same. Maximal activity of the enzyme was observed with riboflavin 
as subsnate followed by FMN then FAD and NADPH was preferred over NADH as the 
reduced pyiidine nucleotide cofactor. As reported previously the enzyme was unable to 
utilise FAD as substrate when NADPH was cofactor and tliis was suggested to be a 
result of steric hindrance (Fontecave et al,, 1987). The Km of the enzyme with respect 
to the flavin substrates and the reduced nucleotide cofactor were found to be lower than 
reported previously by Fontecave et al. The catalytic efficiency of the enzyme as judged 
by the value of Kcat/Km was observed to be high when riboflavin was the substi’ate (1.8 
X 10^ M'^S"^ and 7.97 x 1Q7 M"1S’1 for NADH and NADPH as cofactor, respectively).
In order to replicate some of the kinetic experiments of the luciferase/flavin reductase 
system with chorismate synthase and flavin reductase a dh^ct assay of flavin reductase 
activity in the presence of chorismate synthase and a chorismate synthase assay in the 
presence of flavin reductase was attempted. The presence of E. coli chorismate 
synthase, at stoichiometric levels, in the flavin reductase assay was observed to result in 
no change to the Km of riboflavin or FMN when NADPH was reduced cofactor. An 
attempt to couple chorismate synthase activity with the flavin reductase activity proved 
unsuccessful. Chorismate formation observed at 275nm was obscured by the oxidation 
of NADPH—>NADP+ preventing a determination of whether chorismate formation was 
occurrmg and whetlier the Km of flavin was changing.
One important feature of this coupled assay was the observation that oxidation of 
NADPH contributed to the absorbance change at 275nm when monitoring chorismate 
formation. The N. crassa enzyme which utilises NADPH as cofactor is assayed at 
275nm and presumably this assay would also measure NADPH oxidation. The Vmax of 
the N. crassa enzyme was deteimined using this assay to be 32.1 U/mg (White et al., 
1988) which is larger than E. coli chorismate synthase and substantially larger than the 
otlier chorismate synthases. It remains to be determined whether this assay is suitable 
for bifunctional chorismate synthases as an accurate measurement of Vmax-
The failure to obseive a change in the Km value for FMN with E. coli flavin reductase in 
the presence of E. coli chorismate synthase led to the examination of complex formation 
using BIAcore. The technique of BIAcore involves the immobiUsation of one of the 
proteins of interest onto a sensor chip which is coated with a metal film and which is
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illuminated witli light. The binding of a second enzyme to the immobilised enzyme will 
produce a change in the refractive index close to the surface of the sensor chip and 
binding can be followed in terms of the change to the refractive index. In order to 
determine whether there was any interaction between the E, coli flavin reductase and the 
E, coli chorismate synthase the flavin reductase was immobilised to the sensor chip and 
binding of the chorismate synthase tested. No binding of the chorismate synthase to the 
flavin reductase was observed. When the order of the reaction was changed such that 
chorismate synthase was immobilised and the flavin reductase tested for binding a 
similar result was obtained. Therefore, using this system and with results of the limited 
kinetic work it is likely that E. coli flavin reductase encoded by the fre  gene does not 
interact with E. coli chorismate synthase.
The flavin reductase (FRE) encoded by the fre  gene in E. coli is known to be an essential 
component of a complex multiprotein system that catalyses the transformation of an 
inactive form of ribonucleotide reductase into an active enzyme. The function of the 
flavin reductase is to reduce the non-heme fenic centre of ribonucleotide reductase and 
may provide a mechanism for regulating ribonucleotide reductase. This flavin reductase 
is also proposed to play a role in non metabolism in E, coli. It was not possible to 
determine in this study whether FRE provides the reduced flavin for the chorismate 
synthase reaction, however, if it does so it would appear that no complex forms between 
the two proteins. It should be noted that there are other flavin reductase activities in E. 
coli and these may also supply reduced flavin for the chorismate synthase reaction. The 
chorismate synthase reaction may easily obtain enough reduced flavin in vivo without 
complex formation in organisms such as E. coli where there are monofunctional 
chorismate synthases. Other organisms which have lower levels of endogenous flavin 
reductase activity may have compensated with the formation of complexes or 
bifunctional proteins.
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Future work.
There are a number of areas which could be further investigated following tlie work 
presented in this thesis. The unambiguous determination that the aroC, aroB and aro A 
genes of S. aureus form an operon could be simply done using northern blot techniques. 
In addition, the confirmation that the geiif genes are present in their entirety and that they 
are expressed in S. aureus would be impoitant together with the ability to ascribe a 
function to these genes in botli B. subtilis and S. aureus. Further molecular biological 
work could involve extended analysis of the intriguing situation that the aro genes have 
been suggested to be essential in S. aureus (O’Connell et al., 1993). This could be 
confirmed with tlie production of more integration mutants in the aroC and aroB genes 
and an analysis as to whether stable attenuated strains could be obtained.
The pH dependence of the S. aureus chorismate synthase could be further investigated to 
detennine whether there is a single ionisable group involved in catalysis. This may lead 
to further study of the enzyme using chemical modification reagents to determine 
essential residues for catalysis and substrate/cofactor binding. The identification of such 
residues using chemical modification and subsequent peptide mapping techniques would 
allow for a more rational mutagenesis regime to be followed for the enzyme. The 
tyrosine mutants produced during this study definitely warrant further study to 
unambiguously determine whether the tyrosine residue is essential for catalysis and if it 
has a role in flavin binding to the enzyme.
The crystalhsation of chorismate synthase from S. aureus, E. coli or N. crassa would 
provide a wealtli of information on the enzyme and would facilitate a further study of the 
enzyme using site-directed mutagenesis. The availability of large quantities of 
chorismate synthase from S. aureus provides another source of the enzyme for attempts 
at crystallisation.
References 135
r e f e r e n c e s .
Allen, J.R., Lasser, G.W., Goldman, D.A., Booth, J.W. & Mathews, C.K. 1983. 
T4 phage deoxyribonucleotide-synthesizing enzyme complex. J. Biol. Chem. 258: 
5746-5753.
Almaula, N., Lu, Q., Delgado, J,, Belkin, S. & Inouye, M. 1995. Nucleoside 
diphosphate kinase from Escherichia coli.. J. Bacteriol. 177: 2524-2529.
Amrhein, N. Deus, B., Gehrke, P. &  Steinrucken, H.C. 1980. The site of 
Inhibition o f the shikimate pathway. H. Interference with chorismate formation in 
vivo and in vitro. Plant Physiol. 66: 823-829.
Anagnostopoulos, C., Piggot, P.J. & Hoch, J.A. 1993. The genetic map of Bacillus 
subtilis. In Bacillus subtilis and other Gram-positive bacteria. pp425-462. Edited by 
A. Sonenshein, J.A. Hoch, R. Losick. American Society for Microbiology, 
Washmgton, D.C.
Anton, I.A. & Coggins, JR . 1988. Sequencing and overexpression of the 
Escherichia coli aroE gene encoding shikimate dehydrogenase. Biochem. J. 249: 
319-326.
Azevedo, V., Sorokin, A., Ehrlich, D. & Serror, P. 1993. The transcriptional 
organization of the Bacillus subtilis 168 chromosome region between the spoVAF and 
serA genetic loci. Mol. Microbiol. 10: 397-405.
Bacon, G.A., Burrows, T.W. & Yates, M. 1951. The effects of biochemical 
mutation on the virulence of Bacterium typhosum. The loss o f virulence of certain 
mutants. Br. J. Exp. Pathol. 382: 85-96.
Balasubramanian, S., Abell, C. & Coggins, J R. 1990. Observation of an isotope 
effect in the chorismate synthase reaction. J. Am. Chem. Soc. 112; 8581-8583.
Balasubramanian, S., Davies, G.M. Coggins, J R. & Abell, C. 1991. Inliibition of 
chorismate synthase by {6R)- and (65)-6-Fluoro-5-e«o/pyruvylshikimate 3-phosphate. 
J. Am. Chem. Soc. 113: 8945-8946.
. â
.........................   ■ ‘ ■; 3-,
References 136
Balasubramanian, S., Coggins, J R. & Abell, C. 1995. Observation of a secondary 
tritium isotope effect in the chorismate synthase reaction. Biochem. 34: 341-348.
Banerji, S., Wakefield, A.E., Allen, A.G., Maskell, D., Peters, S.E. & Hopkin,
J.M. 1993. The cloning and characterisation of the arom gene of Pneumocystsis 
carinii. J. Gen. Microbiol. 139: 2901-2914.
Bartlett, P.A., Maitra, U. & Chouinard, P.M. 1986. Synthesis of “Iso-EPSP” and 
evaluation of its interaction with chorismate synthase. J. Am. Chem. Soc. 108: 8068- 
8071.
Bentley. R. 1990. The shikimate pathway-a metabolic tree with many branches. 
Crit. Rev. Biochem. Mol. Biol. 25: 307-384,
Berlyn, M B. & Giles, N.H. 1969. Organisation of enzymes in the polyaromatic 
synthetic pathway: separability in bacteria. J. Bacteriol. 99: 222-230.
Biggs, J., Tripoulas, N., Hersperger, E., Dearolf, C. & Shearn, A. Analysis of the 
lethal interaction between the prune and killer o f prune mutations of Drosophila. 
Genes Dev. 2: 1333-1343.
Bolotin, A., Khazak, V., Stoynova, N., Ratmanova, K., Yomantas, Y. & Kozlov,
Y. 1995. Identical amino acid sequences o f the AroA(G) gene products of Bacillus 
subtilis 168 and B. subtilis Marburg strain. Microbiology 141: 2219-2222.
Boocock, M. 1983. Ph.D. Thesis. University of Glasgow, Glasgow.
Bordo, D. & Argos, P. 1991. Suggestions for “safe” residue substitutions in site- 
directed mutagenesis. J. Mol. Biol. 217: 721-729.
Bomemann, S., Ramjee, M.N., Lowe, D.J., Thorneley, R.N.F., Coggins, JR ., 
Abell, C., Nichols, W.W. & Davies, G.M. Studies on Escherichia coli chorismate 
synthase. In Proceedings of the Eleventh International Conference on Flavins and 
Flavoproteins. Edited by K. Yagi. 1993. Walter de Gruyter, Berlin.
Bomemann, S., Balasubramanian, S., Coggins, JR ., Abell, C., Lowe, D.J. & 
Thorneley, R.N.F. 1995. Escherichia coli chorismate synthase: a deuterium kinetic- 
isotope effect under single-tumover conditions shows that a flavin intermediate farms 
before the C-(6j!?roR)-H bond is cleaved. Biochem. J. 305: 707-710.
References 137
Bowe, F., O’Gaora, P., Maskell, D., Cafferkey, M. & Dougan, G. 1989. 
Virulence, persistence, and immunogenicity of Yersinia enterocolitica 0:8 aroA 
mutants. Infect. Immun. 57: 3234-3236.
Brockbank, S.M.V. & Barth, P.T. 1993. Cloning, sequencing and expression of 
the DNA gyrase genes from Staphylococcus aureus , J. Bacteriol. 175: 3269-3277.
Cease, K.B., Potcova, C.A., Lohff, C.J. & Zeigler, M.E. 1994. Optimized PCR 
using Vent polymerase. PCR Meth. Appl. 3:298-300.
Charles, I.G., Lamb, H.K., Pickard, D., Dougan, G. & Hawkins, A.R. 1990. 
Isolation, characterization and nucleotide sequences of the aroC genes encoding 
chorismate synthase from Salmonella typhi and Escherichia coli. J. Gen. Micro. 136: 
253-258.
Chatfïeld, S., Li, J.L., Sydenham, M., Douce, G., Dougan, G. 1992a. Salmonella 
genetics and vaccine development. In Molecular Biology of Bacterial Infection, pp 
299-312. Edited by C. E. Hormaeche, C.W. Penn, C.J. Smyth Society for General 
Microbiology. Symposium 49. Cambridge University Press.
Chatfield,S.N., Fairweather, N., Charles, I., Pickard, D., Levine, M., Hone, D., 
Posada, M., Strugnell, R.A. & Dougan, G. 1992b. Construction of a genetically 
defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering o f a candidate 
oral typhoid-tetanus vaccine. Vaccine 10: 53-60.
Chaudhuri, S. & Coggins, J.R. 1985. The purification of shikimate dehydrogenase 
from Escherichia coli. Biochem. J. 226: 227-231.
Chen, Q., Actis, L.A., Tolmasky, M E. & Crosa, J.H. 1994. Chromosome- 
mediated 2,3-dihydroxybenzoic acid is a precursor in the biosynthesis o f plasmid- 
mediated siderophore anguibactin in Vibrio anguillarum. J. Bacteriol. 176: 4226- 
4234.
Coggins, J.R. & Boocock, M R . The arom multifunctional enzyme. In 
Multidomain Proteins. Edited by D.G. Hardie and J.R. Coggins. 1986. Elsevier 
Science Publishers, Amsterdam.
References 138
Coggins, J R., Boocock, M R., Campbell, M.S., Chaudhuri, S., Lambert, J.M., 
Lewendon, A., Mousdale, D M., Smith, D.D.S. 1985. Biochem Soc. Trans. 13:
Cooper, G.L., Venables, L.M., Nicholas, R.A.J., Cullen, G.A & Hormaeche, C.E.
1992. Vaccination of chickens with chicken-derived Salmonella enteritidis phage 
type 4 aroA live oral salmonella vaccines. Vaccine 10: 247-254.
299-303.
Coggins, J R., Duncan, K., Anton, LA., Boocock, M R., Chaudhuri, S., Lambert, 
J.M., Lewendon, A., Millar, G., Mousdale, D M., Smith, D.D.S. 1987. Biochem 
Soc. Trans. 15: 754-759. 'Mî i ’îl
%
Davies, G.M., Barrett-Bee, K.J., Jude, D.A., Lehan, M., Nichols, W.W., Pinder, 
P.E., Thain, J.L., Watkins, W.J. & Wilson, R.G. 1994. (6iS)-6-fluoroshikimic 
acid, an antibacterial agent acting on the aromatic biosynthetic pathway. Antimicrob. 
Agents Chemother. 38: 403-406.
Davis, B.D. 1955. Intermediates in amino acid biosynthesis. Adv. Enzymol. 
16:287-295.
Defeyter, R.C. & Pittard, A.J. 1986. Genetic and molecular analysis of aroL, the 
gene for shikimate kmase II in Escherichia coli K-12. J. Bacteriol. 165: 226-232.
Deka, R.K., Anton, I.A., Dunbar, B. & Coggins, J.R. 1994. The characterisation 
of the shikimate pathway enzyme dehydroquinase from Pisum sativum. FEBS Lett.
349: 397-402. ■
Dougan, G., Maskell, D., Pickard, D. & Hormaeche, C. 1987. Isolation of stable 
aroA mutants of Salmonella typhi Ty2: properties and preliminary characterisation in 
mice. Mol. Gen. Genet. 207: 402-405.
Duane, W. & Hastings, J.W. 1975. Flavin mononucleotide reductase of luminous 
bacteria. Mol. Cell. Biochem. 6:53-64
Duncan, K., Lewendon, A. & Coggins, J.R. 1984. Uie purification of 5- 
e«o/pyruvylshikimate 3-phosphate synthase from an overproducmg strain of 
Escherichia coli. FEBS Lett. 165: 121-126.
References 139
Duncan, K., Edw ards, R.M. & Coggins, J.R . 1987. The pentafunctional arom 
enzyme of Saccharomyces cerevisiae is a mosaic of monofunctional domains. 
Biochem. J. 246: 375-386.
Ew art, C.D.C., Jude, D.A., Thain, J.L . & Nichols, W.W. 1995. Frequency and 
mechanism of resistance to antibacterial action of ZM 240401, (6S)-6-fluoro-shikimic 
acid. Antimicrob. Agents Chemother. 39: 87-93.
Fersht, A. 1985. Enzyme Structure and Function. W.H. Freeman & Co., New York.
Floss, H.G., Onderka, D.K. & C arro l, M. 1972. Stereochemistry of the 3-Deoxy- 
D-arabino-heptulosonate 7-phosphate synthetase reaction and the chorismate 
synthetase reaction. J. Biol. Chem. 247: 736-744.
Fontecave, M., Eliasson, R. & Reichard, P. 1987. NAD(P)H:flavin oxidoreductase 
of Escherichia coli. J. Biol. Chem. 262: 12325-12331.
Fontecave, M., Eliasson, R. & Reichard, P. 1989. Enzymatic regulation of the 
radical content of the small subunit o f Escherichia coli ribonucleotide reductase 
involving reduction o f its redox centers. J. Biol. Chem. 264: 9164-9170.
Fontecave, M., Coves, J. & Pierre, J.L . 1994. Ferric reductases of flavin 
reductases? Biometals. 7: 3-8.
Frost, J.W ., Bender, J.L., Kadonga, J.T . & Knowles, J.R. 1984. Dehydroquinate 
synthase from Escherichia coli". purification, cloning and construction of 
overproducers o f the enzyme. Biochem. 23: 4470-4475.
Ganem, B. 1978. From glucose to aromatics: recent developments in natural 
products of the shikimic acid pathway. Tetrahedron Report. 34: 3353-3383.
G aertner F.H. & K.W. Cole. 1973. Properties of chorismate synthase in 
Neurospora crassa. J. Biol. Chem. 248: 4602-4909.
G aertner F.H. & K.W. Cole. 1977. A cluster gene: evidence for one gene, one 
polypeptide, five enzymes. Biochem. Biophys. Res. Comm. 75: 259-264.
Duncan, K., C haudhuri, S., Campbell, M.S. & Coggins, J.R . 1986. The 
expression and complete amino acid sequence of Escherichia coli 3-dehydroquinase. 
Biochem J. 238:475-481.
s i
References 140
Gaudu, P., Touati, D., Niviere, V. & Fontecave, M. 1994. The NAD(P)H:flavin 
oxidoreductase from Escherichia coli as a source of superoxide radicals. J. Biol. 
Chem. 269: 8182-8188.
Ghisla, S. & Massey, V. 1986. New flavins for old: artificial flavins as active site 
probes for flavoproteins. Biochem. J. 239: 1-12.
Ghisla, S. & Massey, V. 1989. Mechanisms of flavoprotein-catalyzed reactions. 
Eur. J. Biochem. 181: 1-17.
Gibson, F. 1970. Preparation of chorismic acid. Methods Enzymol. 17:362-364.
Gill, S.C. & von Hippel, P.H. 1989. Calculation of protein extinction coefficients 
from amino acid sequence data. Anal. Biochem. 182: 319-326.
Ginther, C.L. & Ingraham, J.L. 1974. Cold-sensitive mutant of Salmonella 
lyp/H'mwnMm defective in nucleosidediphoshokinase. J. Bacteriol. 118: 1020-1026.
Gorlach, J., Schmid, J. & Amrhein, N. 1993. Differential expression of tomato 
{Lycopersicon esculentum L.) genes encodmg shikimate pathway enzymes. II. 
Chorismate synthase. Plant Mol. Biol. 23: 707-716.
Grantham, R., Gautier, € ., Gouy., Mercier, R. & Pave, A. 1981. Codon catalog 
usage and the genome hypothesis. Nucleic Acids. Res. 8: 49-53.
Griffin, H.G. & Barrow, P.A. 1993. Construction of an aroA mutant of Salmonella 
serotype Gallinarum: its effectiveness in immunization against experimental fowl 
typhoid. Vaccine 11: 457-461.
Halle, F. & Meyer, J-M. 1992. F err isiderophore reductases o f Pseudomonas: 
purification, properties and cellular location of the Pseudomonas aeruginosa 
ferripyoverdine reductase. Eur. J. Biochem. 209: 613-620.
Hama, H., Almaula, N., Lerner, C.G., Inouye, S. & Inouye, M. 1991. Nucleoside 
diphosphate kinase from Escherichia coli its overproduction and sequence 
comparison with eukaryotic enzymes. Gene 105:31-36.
Hanks, S.K., Quinn, A.M. & Hunter, T. 1988. The protein kinase 
family:conserved features and deduced phylogeny of the catalytic domains. Science 
241: 4342-4352.
References 141
H arris, J., Kleanthous, C., Coggins, J.R ., Hawkins, A.R. & Abell, C. 1993. 
Different mechanistic and stereochemical courses for the reactions catalysed by type I 
and type II dehydroquinases. J. Chem. Scoc., Chem. Commun. 1080-1081.
Hasan, N. & Nester, E.W. 1978a. Purification and characterisation of NADPH- 
dependent flavin reductase; an enzyme required for the activation of chorismate 
^ynfh2iSQmBacillus subtilis. J. Biol. Chem. 253: 4987-4992.
H asan, N. & Nester, E.W. 1978b. Purification and properties of chorismate 
synthase from Bacillus subtilis. J. Biol. Chem. 253: 4993-4998.
Hasan, N. & Nester, E.W. 1978c. Dehydroquinate synthase in Bacillus subtilis; an 
enzyme associated with chorismate synthase and flavin reductase J. Biol. Chem. 
253: 4987-4992.
Haslam, E. 1993. Shikimic Acid: Metabolism and Metabolites. John Wiley & sons, 
Chichester, England.
Hastings, J.W ., Potrikus, C.J., Gupta, S.C., Kurfust, M. & Makenson, J.C. 1985. 
Biochemistry and physiology of bioluminescent bacteria. Adv. Microb. Physiology. 
26: 235-291.
Hawkes, T.R., Lewis, T., Coggins, J  R., Mousdale, D M., Lowe D.J. &  Thorneley, 
R.N.F. 1990. Chorismate synthase; pre-steady-state kinetics of phosphate release 
from 5-gMo/pyruvylshikimate 3-phosphate. Biochem. J. 265: 899-902.
Henner, D. (1991). Unpublished sequence data. gerCAgerCBgerCC, ndk, cheR, 
aroFaroBaroHnuclQotidQ sequence. Genbank accession No. M80245.
Henner, D .J., Band, L., Flaggs, G. & Chen, E. 1986. The organization and 
nucleotide sequence of the Bacillus subtilis hisH, tyrA, aroE genes. Gene 49: 147- 
152.
Henner, D.J., Gollnick, P. & Moir, A. 1990. Analysis of an 18 kilobase pair region 
of the Bacillus subtilis chromosome containing the mtr and gerC opérons and the aro- 
trp-aro supraoperon. In 6th International Symposium on Genetics of Industrial 
Microorganisms p657-665. Edited by H. Heslot, J. Davies, J. Florent, L. Bobichon, 
G. Durand, L. Penasse. Société Française de Microbiologie, Strasbourg, France.
References 142
Henner, D. & Yanofsky, C. 1993. Biosynthesis of aromatic amino acids. In 
Bacillus subtilis and other Gram-positive bacteria. pp269-280. Edited by A. 
Sonenshein, J.A. Hoch, R. Losick. American Society for Microbiology, Washington,
D.C.
H enstrand, J . M., Amrhein, N. & Schmid, J. 1995a. Cloning and characterization 
of a heterologously expressed bifunctional chorismate synthase/flavin reductase from 
Neurospora crassa. J. Biol. Chem. 270: 20447-20452.
H enstrand, J. M., Schmid, J. & Amrhein, N. 1995b. Only the mature form of the 
plastidic chorismate synthase is enzymatically active. Plant Physiol. 108;
Higuchi, R., Krummel, B. & Saiki, R.K. 1988. A general method of in vitro 
preparation and specific mutagenesis of DNA fragments: study of protein:DNA 
interactions. Nucleic Acids Res. 208: 7351-7383.
Hill, R.K. & Bock, M.G. 1978 Stereochemistry of 1,4-conjugate elimination 
reactions. J. Am. Chem. Soc. 100; 637-639.
Hill, R.K. & Newkome, G.R. 1969. Stereochemistry of chorismic acid biosynthesis. 
J. Am. Chem. Soc. 91: 5893-5894.
Hoiseth, S.K. & Stocker, B A D . 1981. Aromatic-dependent Salmonella 
typhimurium are non-virulent and are effective live vaccines. Nature 241: 238-239.
Homchampa, P., Strugnell, R.A. & B. Adler. 1992. Molecular analysis of the aroA 
gene of Pasteurella multocida and vaccine potential of a constructed aroA mutant. 
Mol. Microbiol. 6: 3585-3593.
Huang, L., Montoya, A.L. & Nester, E.W. 1974a. Characterization of the 
functional activities of the subunits of 3-deoxy-D-arabinoheptulosonate 7-phosphate 
synthase-chorismate mutase from Bacillus subtilis 168. J. Biol. Chem. 249: 4473- 
4479.
Huang, L., Nakatsukasa, W.M. & Nester, E.W. 1974b. Regulation of aromatic 
biosynthesis in Bacillus subtilis 168. J. Biol. Chem. 249: 4473-4479.
Huang, L., Montoya, A.L. & Nester, E.W. 1975. Purification and characterization 
of shikimate kinase enzyme activity in Bacillus subtilis 168. J. Biol. Chem. 250: 
7675-7681.
References 143
Ikem ura, T. & Ozeki, H. 1983. Codon usage and transfer RNA contents: organism 
specific codon-choice patterns in reference to the isoacceptor contents. Cold Spring 
Harbor Symp. Quant. Biol. 47: 1087-1097.
Ivins, B E., Welkos, S.L., Knudson, G.B. & Little, S.F. 1990. Immunization 
against anthrax with aromatic compound-dependent (Aro^) mutants of Bacillus 
anthracis and with recombinant strains of Bacillus subtilis that produce anthrax 
protective antigen. Infect. Immun. 58: 303-308.
Jablonski, E. & DeLuca, M. 1978. Studies of the control luminescence in Beneckea 
harveyi: properties o f the NADH and NADPH:FMN oxidoreductases. Biochem. 17: 
672-678.
Jensen, R. A. & Nester, E.W. 1965. The regulatory significance o f intermediary 
metabolites: control of aromatic acid biosynthesis by feedback inhibition in Bacillus 
subtilis. J. Mol. Biol. 12: 468-481.
Jensen, R. A., Nasser, D.S. & Nester, E.W. 1967. Comparative control of a 
branch-point enzyme in microorganisms. J. Bacteriol. 94: 1582-1593.
Jensen, R.A. & Nester, E.W. 1966. Regulatory enzymes of aromatic acid 
biosynthesis in Bacillus subtilis. I. Purification and properties of 3-deoxy-D-«raômo- 
heptulosonate 7-phosphate synthetase. J. Biol, Chem. 241: 3365-3371.
Jones, D.G.L., Reusser, U. & Braus, G.H. 1991. Molecular cloning, 
characterization and analysis of the regulation of the AR02 gene, encoding chorismate 
synthase, of Saccharomyces cerevisiae. Mol. Microbiol. 5: 2143-2152.
Jones, P.W., Dougan, G., Haywood, € ., Mackensie, N., Collins, P. & Chatfield, S. 
N. 1991. Oral vaccination o f calves against experimental salmonellosis using a 
do\M.o aro muiemi of Salmonella typhimurium. Vaccine 9,29-33.
Jude, D.A., Ew art, C.D.C, Thain, J.L., Davies, G.M. & Nichols, W.W. Transport 
of the antibacterial agent (6iS)-6-fluoroshikimate and other shikimate analogues by the 
shikimate transport system of Escherichia coli. In press.
Karnell, A., Cam, P.D., Verma, N. & Lindberg, A.A. 1993. AroD deletion 
attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral 
vaccine in monkeys. Vaccine 11:830-836.
References 144
Kleanthous, C., Deka, R., Davis, K., Kelly, S.M., Cooper, A., Harding, S.E., 
Price, N.C., Hawkins, A.R. & Coggins, J.R. 1992. A comparison of the 
enzymological and biophysical properties of two distinct classes of dehydroquinase 
enzymes. Biochem. J. 282: 687-695.
K lein, M.L. & Fulco, A.J. 1993. Critical residues involved in FMN binding and 
catalytic activity in cytochrome P450bm-3. J- Biol. Chem. 268: 7553-7561.
Koike-Takehita, A., Koyama, T., Obata, S., Ogura, K. 1995. Molecular cloning 
and nucleotide sequence of the genes for two essenial proteins constituting a novel 
enzyme system for heptaprenyl diphosphate synthesis. J. Biol. Chem. 270; 18396- 
18400.
Koshiba, T. 1978. Purification of two forms of the associated 3-dehydroquinate 
hydro-lyase and shikimate:NADP+ oxidoreductase in Phaseolus mungo seedlings. 
Biochim. Biophys. Acta 522: 10-18.
Lacombe, M., W allet, V., Troll, H. & Veron, M. 1990. Functional cloning of a 
nucleoside diphosphate kinase from Dictyostelium discoideum. J. Biol. Chem. 265: 
10012-10018.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature 227: 680-685.
Lauhon, C.T. & Bartlett, P.A. 1994. Substrate analogues as mechanistic probes for 
the bifunctional chorismate synthase from Neurospora crassa. Biochem. 33: 14100- 
14108.
Lei, B., Liu, M., Huang, S. & Tu, S. 1994. Vibrio harveyi NADPH-flavin 
oxidoreductase: cloning, sequencing and overexpression of the gene and purification 
and characterization of the cloned enzyme. J. Biol. Chem. 176: 3552-3558.
De Ley, J. 1970. Reexamination of the association between melting point, buoyant 
density, and chemical base composition of deoxyribonucleic acid. J. Bacteriol. 101: 
738-754.
Llewellyn, D.J., Daday, A. & Smith, G.D. 1980. Evidence for an artificially 
evolved bifunctional 3-deoxy-D-arabinoheptulosonate 7-phosphate synthase-
chorismate mutase in Bacillus subtilis. J. Biol. Chem. 255: 2077-2084.
References 145
Lo, H-S. & Reeves, R.E. 1980. Purification and properties of NADPH: flavin 
oxidoreductase from Entamoeba histolytica. Mol. Biol. Parasitol. 2: 23-30.
Luckner, M. 1990. Secondary metabolism in microorganisms, plants and animals. 
Springer-Verlag, Berlin.
Lumsden, J. & Coggins, J.R. 1977. The subunit structure of the arom multienzyme 
complex of Neurospora crassa: a possible pentafunctional polypeptide chain. 
Biochem. J. 161: 599-607.
Lumsden, J. & Coggins, J.R. 1978. The subunit structure of the arom multienzyme 
complex 0 Î Neurospora crassa: Evidence from peptide ‘maps’ for the identity of the 
subunits. Biochem. J. 169: 441-444.
Macheroux, P., Petersen, J., Bomemann, S., Lowe, D.J., Thorneley, R.N.F. 1995. 
Binding o f the oxidized, reduced and radical flavinsemiquinone species to chorismate 
synthase; an investigation by spectrophotometry, fluorimetry, EPR, and ENDOR 
spectroscopy. Unpublished.
Majumder, K., Selvapandiyan, A., Fattah, F.A., Arora, N., Ahmad, S. & 
Bhatnagar, R.K. 1995. 5-e«o/pyruvylshikimate 3-phosphate synthase of Bacillus 
subtilis is an allosteric enzyme. Eur. J. Biochem. 229: 99-106.
Matsudaira, P. 1987. Sequence from picomole quantities of proteins electroblotted 
onto polyvinylidene difluoride membranes. J. Biol. Chem. 262: 10035-38.
Millar, G. 1988. PhD Thesis. University of Glasgow, Glasgow.
Millar, G., Lewendon, A., Hunter, M.G. & Coggins, J.R. 1986. The cloning and 
expression of the aroL gene from Escherichia coli K12. Biochem. J. 237: 427-437.
Miller, L.K. & Wells, R.D. 1971. Nucleoside diphosphokinase activity associated 
with DNA polymerases. Proc. Natl. Acad. Sci. 68: 2298-2302.
Moffat, B.A. & Studier, F.W. 1987. T7 lysozyme inhibits transcription by T7 RNA 
polymerase. Cell 49: 221-227.
Mousdale, D M. & Coggins, J.R. 1986. Detection and subcellular localization of a 
higher plant chorismate synthase. FEBS Lett. 205: 328-332.
References 146
M uller, F., Brustlein, M., Hemmerich, P., Massey, V. & W alker, W.H. 1972. 
Light-absorption studies on neutral flavin radicals. Eur. J. Biochem. 25: 573-580.
M unoz-Dorado, J., Inouye, M. & Inouye, S. 1990. Nucleoside diphosphate kinase 
from Myxococcus xanthus I. cloning and sequencing the gene. J. Biol. Chem. 265: 
2702-2706.
M unoz-Dorado, J., Inouye, S. & Inouye, M. 1990. Nucleoside diphosphate kinase 
from Myxococcus xanthus H. Biochemical characterization. J. Biol. Chem. 265: 
2707-2712.
Nakane, A., Ogawa, K., N akam ura, K. & Yamane, K. 1994. Nucleotide sequence 
of the shikimate kinase gene {arol) of Bacillus subtilis. 77: 312-314.
Nakatsukasa, W.M. & Nester, E.W. 1972. Regulation of aromatic amino acid 
hïosynfhoû?,m Bacillus subtilis 168. J. Biol. Chem. 247: 5972-5979.
Nester, E.W ., Jensen, R.A & Nasser, D.S. 1969. Regulation of enzyme synthesis in 
the aromatic amino acid pathway of Bacillus subtilis. 97: 83-90.
Nnalue, N.A. & Stocker, B A D. 1987. Tests of the virulence and live-vaccine 
efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis. Infect. 
Immun. 55: 955-962.
Novick, R.P. 1990. The Staphylococcus as a molecular genetic system. In Molecular 
Biology of the Staphylococci, ppl-37. Edited by R.P. Novick. VCH. New York.
O ’Callaghan, D., Maskell, D., Liew, F.Y., Easmon, C.S. & Dougan, G. 1988. 
Characterization of aromatic- and purine-dependent Salmonella typhimurium: 
attenuation, persistence, and ability to induce protective immunity in BALB/c mice. 
Infect, hnmun. 56: 419-423.
O'Connel, C., Pattee, P. & Foster, T .J. 1993. Sequence and mapping of the aroA 
gone o f Staphylococcus aureus 8325-4. J. Gen. Microbiol. 139; 1449-1460.
O nderka, D.K. & Floss, H.G. 1969. Steric course of the chorismate synthetase 
reaction and the 3-deoxy-D-arabinoheptulosonate 7-phosphate synthetase reaction J. 
Amer. Chem. Soc. 91: 5894-5896.
References 147
Oster, T., Boddupaii, S.S. &  Peterson, J.A. 1991. Expression, purification and 
properties o f the flavoprotein domain of cytochrome P450bm-3- J* Biol. Chem. 266: 
22718-22725.
Parks, R.E. & Agarwal, R.P. 1973. Nucleoside diphosphokinases pp307-333. In 
The Enzyme. Edited by P.D. Boyer. Academic Press, New York.
Pattee, P.A. 1981. Distribution of Tn557 Insertion sites responsible for auxotrophy 
on the Staphylococcus aureus chromosome. J. Bacteriol. 145: 479-488.
Pattee, P.A., Lee, H. & Bannantine & J.P. 1990. Genetic and physical mapping of 
the chromosome of Staphylococcus aureus, pp. 41-58. In Molecular biology of the 
staphylococci. Edited by R.P. Novick, VCH publishers, New York.
Pattee, P.A. 1993. The genetic map of Staphylococcus aureus. pp489-496. In 
Bacillus subtilis and other Gram-positive bacteria. Edited by A.L. Sonenshein, J.A. 
Hoch, R.L. Losick. American Society for Microbiology, Washington, D.C.
Pittard, A.J. & Wallace, B.J. 1966. Distribution and function of genes concerned 
with axomsitichiosynthGsis in Escherichia co li. J. Bacteriol. 91: 1494-1508.
Pittard , A.J. 1987. In Escherichia coli and Salmonella typhimurium: Cellular and 
Molecular Biology. Volume 1, pp 368-395. Edited by F.C. Niedhart. American 
Society for Microbiology, Washington, D.C.
Polley, L.D. 1978. Purification and characterization of 3-dehydroquinate hydrolase 
and shikimate oxidoreductase: evidence for a bifunctional enzyme. Biochim. 
Biophys. Acta 526: 259-266.
Poirier, T.P., Kehoe, M.A. & Beachey, E.H. 1988. Protective immunity evoked by 
oral administration of attenuated aroA Salmonella typhimurium expressing cloned 
streptococcal M protein.. J. Exp. Med. 168: 25-32.
Porter, T. D. 1991. An unusual yet strongly conserved flavoprotein reductase in 
bacteria and mammals. TIBS. 16: 154-158.
Porter, T.D. & Kasper, C.B. 1985. Coding nucleotide sequence of rat NADPH- 
cytochrome P-450 oxidoreductase cDNA and identification of flavin-binding 
domains. Proc. Natl. Acad. Sci. 82: 973-977.
References 148
Ramjee, M.K., Coggins, J.R., Hawkes, T.R. Lowe, D.J. & Thorneley, R.N.F.
1991. Spectrophotometric detection of a modified flavin mononucleotide 
intermediate formed during the catalytic cycle of chorismate synthase. J. Am. Chem. 
Soc. 113: 8566-8567.
Ramjee, M.K. 1992. Ph.D. Thesis. University of Sussex, Brighton.
Ramjee, M.K., Balasubramanian, S. Abeli, C. Coggins, JR . Davies, G.M. 
Hawkes, T.R. Lowe, D.J. & Thorneley, R.N.F. 1992. Reaction of (6R)-6-F-EPSP 
with recombinant Escherichia coli chorismate synthase generates a stable flavin 
mononucleotide semiquinone radical. J. Am. Chem. Soc. 114: 3151-3153.
Ramjee, M.K., Coggins, J R. & Thorneley, R.N.F. 1994. A continuous, anaerobic 
spectrophotometric assay for chorismate synthase activity that utilizes photoreduced 
flavin mononucleotide. Analyt. Biochem. 220: 137-141.
Roberts, M., Maskell, D., Novotny, P. & Dougan, G. 1990. Construction and 
characterization in vivo of Bordetella pertussis aroA mutants. Infect. Immun. 58: 
732-739.
Rosengard, A.M., Krutzsch, H.C., Shearn, A., Biggs, J R., Barker, E., Margulies,
I.M.K., King, C.R., Liotta, L A. & Steeg, P.S. 1989. Reduced Nm23/Awd protein 
in tumour metastasis and aberrant Drosophila development. Nature 342: 177-180.
Sambrook, J., Fritsch, E.F. & Maniatis, T. 1989. Molecular Cloning: a Laboratory 
Manual. 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
Schalier, A., Afferden, M., Windhofer, V., Bulow, S., Abel, C., Schmid, J. & 
Amrhein, N. 1991. Purification and characterization of chorismate synthase from 
Euglena gracilis. Plant Physiol. 97; 1271-1279.
Schalier, A., Schmid., J., Leibinger U. & Amrhein, N. 1991. Molecular cloning 
and analysis of a cDNA coding for chorismate synthase from the higher plant 
Corydalis sempervirens Pers. J. Biol. Chem. 266: 21434-21438.
References 149
Schalier, A., Windhofer, V. & Amrhein, N. 1990. Purification o f chorismate 
synthase from a cell culture of the higher plant Corydalis sempervirens Pers. Arch.
Biochem. Biophys. 282: 437-442.
Schmidt, J., Bubunenko, M. & Subramanian A.R. 1993. A novel operon 
organization involving the genes for chorismate synthase (aromatic biosynthesis 
pathway) and ribosomal GTPase center proteins (L ll , LI, LIO, L12: rplKAJL) hi 
cyanobacterium PCC 6803. J. Biol. Chem. 268: 27447-27457.
Shen, A.L., Porter, T.D., Wilson, T.E. & Kasper, C.B. 1989. Structural analysis 
of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site- 
directed mutagenesis. J. Biol. Chem. 264: 7584-7589.
Shneir, A., Harris, J., Kleanthous, C., Coggins, J.R., Hawkins, A.R. & Abell, C.
1991. Evidence for opposite stereochemical courses for the reactions catalysed by 
type I and type II dehydroquinases. J. Am. Chem. Soc. 113: 9416-9418.
Short, J.M., Fernandez, J.M., Sorge, J.A. & W.D. Hause. 1988. X ZAP: a 
bacteriophage X expression vector with in vivo excision properties. Nucleic Acids 
Res. 16: 7583-7600.
Shuttleworth, W. A., Hough, C.D., Bertrand, K.P. & Evans, J.N.S. 1992. Over­
production o f 5-gMo/pyruvylshikimate-3-phosphate synthase in Escherichia coli: use 
o f the T7 promoter. Protein. Eng. 5 :  461-466
Somerville, R.L. 1983. Tryptophan: biosynthesis, regulation and large scale 
■ âW du^ ion . âMAàWno Bi$$\%Aesi5) and%^n%ic_aEalaâon.gEdite(l bv K.M.__
X— “ ---- - -“ — -— - —, - — — —  -------— - —  —  ^ ------ . - , -  —  -— — — gp..—  —  _ C o . . G c l UL-
Hermann & R.L. Somerville. Addison-Wesley, Massachusetts.
Sorokin, A., Zumstein, E., Azevedo, S, Ehrlich, D. & Serror, P. 1993. The 
organization of the Bacillus subtilis 168 chromosome region between the spoVA and 
serA genetic loci, based on sequence data. Mol. Microbiol. 10: 385-395.
Southern, E. 1975. Detection of specific sequences among DNA fragments 
separated by gel elctrophoresis. J. Mol. Biol. 98:503-517.
Sprinson, D.B. 1961. The biosynthesis of aromatic compounds from D-glucose 
Adv. Carbohydrate Chem. 15: 235-252.
References 150
Spryou, G., Haggard-Ljungquist, E., Krook, M., Jornvall, H., Nilsson, E. & 
Reichard, P. 1991. Characterization of the flavin reductase gene (fre) of 
Escherichia coli and construction of a plasmid for overproduction of the enzyme. J. 
Bacteriol. 173: 3673-3679.
Strugnell, R., Dougan, G., Chatfield, S., Charles, I., Fairweather, N., Tite, J., Li, 
J.L., Beesley, J. & Roberts, M. 1992. Characterization of a Salmonella 
typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. 
Infect. Immun. 60: 3994-4002.
Studier, F.W. and B.A. Moffatt. 1986. Use of bacteriophage T7 RNA polymerase 
to direct selective high-level expression of cloned genes. J. Mol. Biol. 189: 113-130.
Sutherland, J.K., Watkins, W.J., Bailey, J.P., A.K., Chapman, A.K. & Davies, 
G.M. 1989. The synthesis o f 6 a -  and 68-fluoroshikimic acids. J. Chem. Soc. Chem. 
Commun.: 1386-1387.
Takahashi, L, Ogura, K., Seto, S. 1980. Heptaprenyl diphosphate synthetase from 
Bacillus subtilis. J. Biol. Chem. 255: 4539-4543.
Tanner, J., Lei, B., Liu, M., Tu, S. & Krause, K.L. 1994. Crystallization and 
preliminary crystallographic analysis of NADPH:FMN oxidoreductase from Vibrio 
harveyi. J. Mol. Biol. 241: 283-287.
Tribe, D.E., Camakaris, H. & Pittard, J.A. 1979. Constitutive and repressible 
enzymes of the common pathway of aromatic biosynthesis in E. coli K-12: regulation 
of enzyme synthesis at different growth rates. J. Bacteriol. 127: 1085-1091
Troll, H., Winckler, T., Lascu, I., Muller, N., Saurin, W., Veron, M, & Mutzel,
R. 1993. Separate nuclear genes encode cytosolic and mitochondrial nucleoside 
diphosphate kinase in Dictyostelium discoideum. J. Biol. Chem. 268: 25469-25475.
Vaughan, L.M. Smith, P R. & Foster, T.J. 1993. An aromatic-dependent mutant 
of the fish pathogen Aeromonas salmonicida is attenuated in fish and is effective as a 
live vaccine against the salmonid disease furunculosis. Infect. & Immun. 61, 2172- 
2181.
References 151
VeUanoweth, R.L. 1993. Translation and its regulation. In Bacillus subtilis and 
other Gram-positive bacteria. pp699-711. Edited by A.L. Sonenshein, J.A. Hoch, 
R.L. Losick. American Society for Microbiology, Washington, D.C.
Verma, N.K. & Lindberg, A.A. 1991. Construction of aromatic dependent Shigella 
flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD 
genes. Vaccine 9: 6-9.
Voet, D. & Voet, J.G . 1990. Biochemistry. John Wiley & Sons, USA.
W arburg, R .J., M ah ler, I., T ipper, D.J. & Halvorson, H.O. 1984. Cloning of the 
Bacillus subtilis 168 gene encoding dehydroquinase. Gene 32: 57-66.
W atanabe, H. & Hastings, J.W . 1982. Specificities and properties of three reduced 
pyridine nucleotide-flavin mononucleotide reductases coupling to bacterial luciferase. 
Mol. Cell. Biochem. 44:181-187.
Welch, G.R., Cole, K.W. & G aertner, F.H. 1974. Chorismate synthase of 
Neurospora crassa . Arch. Biochem. Biophys. 165:505-518.
W hipp, M .J. & P ittard , A.J. 1995. A reassessment of the relationship between 
aroK- and araZ-encoded shikimate kinase enzymes of Escherichia coli,. J. Bacteriol. 
177: 1627-1629.
White. P.J., Mousdale, D M. & Coggins, J  R. 1987. A simple anaerobic assay for 
chorismate synthase. Biochem. Soc. Tans. 15: 144-145
W hite. P.J., M illar, G. &  Coggins, J  R. 1988. The overexpression, purification and 
complete amino acid sequence of chorismate synthase from Escherichia coli K12 and 
its comparison with the enzyme fxom Neurospora crassa. Biochem. J. 251: 313-322.
Williams, R.L., Oren, D.A., Munoz-Dorado, J., Inouye, S., Inouye, M. & Arnold,
E. 1993. Crystal structure of Myxococcus xanthus nucleoside diphosphate kinase and 
its interaction with a nucleotide substrate at 2.0 Â resolution. J. Mol. Biol. 234: 
1230-1247.
Willet, H.P. 1988. In Zinsser Microbiology, ppl28-161. Edited by Joklik, W., 
Willet, H.P., Amos, D.B., Wilfert, C.M. Prentice-Hall International Inc. USA.
References 152
Yanisch-Peron, C., Vieira, J. & Messing, J . 1985. Improved M13 phage clonmg 
vectors and host strains : nucleotide sequences of the M13mpl8 and pUC19 vectors. 
Gene 33: 103-119.
Yazdi, M. A. 1991. Ph.D. Thesis. University of Sheffield, Sheffield.
Zalkin, H. & Ebbole, D.J. 1988. Organization and regulation of genes encoding 
biosynthetic enzymes in J. Biol. Chem. 263; 1595-1598.
Zenno, S.& Saigo, K. 1994. Identification of the genes encoding NAD(P)H-flavin 
oxidoreductases that are similar in sequence to Escherichia coli Fre in four species of 
luminous bacteria: Photorhabdus luminescens, Vibrio fischeri, Vibrio harveyi and 
Vibrio orientalis. J. Bacteriol. 176: 3544-3551.
